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ABSTRACT 
Fourier transform infrared (FTIR) microscopy has shown promise as an analytical tool 
for detecting changes in cells and tissues, such as those due to viral infection, apoptosis induction 
or malignancy.  In many cases, diagnosis via FTIR microscopy can be undertaken on a timescale 
shorter than that required for other physical or histological techniques.  
In this work we have used FTIR microscopy to study Vero cells that have been infected 
with herpes simplex virus (type I) and adenovirus.  We have studied cellular samples at various 
time intervals following exposure to the virus.  Several spectral regions were identified that al-
low discrimination between infected and uninfected Vero cell samples at 24 hours post exposure 
to both HSV1 and adenovirus.  Spectral features were also identified that could be used to dis-
criminate infected cells within 2-6 hours after exposure to both viruses. FTIR microscopy is 
therefore a useful tool for following the kinetics of viral infection in the 2-24 hours time range, at 
least at the levels of infection used in this study. 
In a second type of study, FTIR microscopy was used to study apoptosis induction in 
acute lymphoblastic leukemia T-cells.  Apoptosis was induced in T-cells in three different ways. 
We show that FTIR microscopy can be used to distinguish T-cells in the early stages of apoptosis 
from normal cells.  We also provide data that may suggest that FTIR microscopy can distinguish 
cells that have undergone apoptosis via different pathways.  
For most of the FTIR microscopic studies on cellular samples we have focused on the 
collection of spectral data in the 1500-800 cm
-1
 region.  Spectra were collected for control cells 
and variously treated cells. The two sets of cells were then analyzed statistically using:  1) pair-
wise comparison, 2) logistic regression, 3) partial least square regression, 4) principle component 
fed linear discriminant analysis and 5) hierarchical cluster analysis.  The statistical analyses rigo-
rously quantify to what extent treated and untreated cells can be distinguished. Since different 
statistical methods give differing results for the same data, it is important the right statistical me-
thod should be applied.  The basis for these differences is discussed. 
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1 INTRODUCTION 
1.1 Background and Objective of the Project 
Viruses are responsible for a variety of (sometimes severe or even fatal) infections in 
humans and animals.  Recently, a great deal of research has focused on the use of different ana-
lytical techniques for the study of viral infection of cells.  Two viruses of considerable impor-
tance as far as humans are concerned are herpes simplex virus type 1 (HSV1) and Adenovirus 
(ADV).  HSV1 may infect the skin, eyes, genitals, lungs, and the brain [1-3], while ADV infects 
tissues that line the respiratory tract.  Fourier transform infrared (FTIR) microscopy has been 
used for preliminary studies of cells infected with HSV1 and other herpes type viruses [4], 
(FTIR) microscopy has also been used for study of cells infected with other types of viruses [5], 
as well as for the study of bacterial and fungal infections [6], malignant cells [7] and strains of 
yeast cells used in wine making [8] . 
HSV1 is a complex virus that is difficult to distinguish from other possible infections 
caused by bacteria or fungi, particularly during the early stages of the infection.  Isolation of the 
virus in cell culture and immunoassays are the main methods for the detection of herpes virus 
infections [9]. Such methods are time-consuming and relatively expensive, and an alternative 
faster approach is desirable [10]. Detection of viral infections at an early stage is often critical, as 
patient survival and quality of life may depend on it.  On this sense early diagnosis of disease is 
usually seen as necessary in improving patient outcomes.  Here we have developed the use of 
FTIR microscopy as a tool for identification of early biochemical changes within viral infected 
cells, with the goal of establishing the limits of applicability of the technique. 
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Cancer kills millions of people annually [11].  Morphological and histomorphological di-
agnosis methods for cancer classification are well established, and have remained relatively un-
changed over the last several decades.  Unfortunately, many of the methods for diagnosis and 
classification are time consuming and quite subjective, with very unsatisfactory levels of inter- 
and intra-observer discrepancy [12, 13].  New novel approaches for histological recognition are 
necessary to decrease subjectivity and provide new tools to investigate cancer in more detail. 
FTIR microscopy has been shown to be a useful tool for the detection, identification and charac-
terization of the molecular components of biological processes in cells, such as those responsible 
for the dynamic properties of cancer progression [14].  As the first step in the development of a 
robust analytical technique for use in cancer detection and diagnosis, we have used FTIR micro-
scopy to study apoptosis induction in acute lymphoblastic leukemia T-cell.  The eventual goal of 
this research is to apply it to the study of cells treated with drugs that may induce apoptosis in 
malignant cells.  In this way it may be possible to assess the efficacy of new apoptosis-inducing 
drugs for different cell lines.  Eventually it may be possible to test a priori how different patients 
may respond to new drugs actually administering the drugs.    
FTIR microscopy is a potentially rapid and noninvasive technique for the diagnosis and 
detection of cells in different states. It can therefore have application in many areas, including 
disease detection, response of cells to drugs or other environmental stresses or genetic modifica-
tions.  FTIR microscopy may be of use, especially, when little or nothing is known about an ob-
served phenomenon.  FTIR microscopy may provide a first hint that may be used to chart a path 
for further investigation.   
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1.2 Fourier Transform Infrared (FTIR) Spectroscopy 
1.2.1 Infrared (IR) Spectroscopy 
Infrared (IR) spectroscopy has long been recognized as being  a valuable tool for identi-
fying the structure and dynamics of materials, and it has been extensively employed over the 
years to investigate biological cells[15, 16]. In IR spectroscopy observed absorption peaks were 
assigned to different vibration states of molecules. However, in the spectra of biological cells 
molecular species can affect the absorption peaks. In addition, many other variables such as scat-
tering or dispersion can also modify the peaks [17, 18].  The assignment of vibration peaks of the 
molecules is very difficult. The usual approach is to repeat the experiment many times, followed 
by statistical based analysis of the IR spectrum of cells [8].  
IR spectrum is formed by measuring the wavelength dependence of the absorbance of IR 
light passing through a sample. The sample absorbs light at particular frequencies, while others 
are transmitted. Depending on the frequency, the IR spectrum is divided into three regions: near 
IR (NIR) region (above 4000 cm
-1
), mid IR (MIR) region (4000-400 cm
-1
) and far IR (FIR) re-
gion (400-10 cm
-1
)  The NIR region contains information about changes in vibrational level, 
overtones and some low energy electron transactions. The MIR region deals with changes in 
fundamental vibrational levels of molecules where as far IR gives information about rotational 
energy level changes. The FIR region provides useful information to structural studies such as 
conformation and lattice dynamics of samples which involve heavy atoms [19].  
In “IR Spectroscopy: An Introduction", the authors explain the usefulness of FTIR as fol-
lows: “Like a fingerprint of a person, the IR spectrum is highly characteristic for a substance and 
can be used for identifying it. The high specificity is based on the good reproducibility with 
which the coordinates of the absorption maxima (generally, wavenumber and transmittance) can 
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be measured.” [20]. Different molecular bonds absorb at different frequencies, so chemical 
processes can be observed by looking for different absorptions. Stretching and bending modes of 
vibrations of most molecules lie in the MIR region. 
 
1.2.2 IR Absorbance 
Infrared spectroscopy is the study of the interaction between infrared light and matter.  
Infrared radiation causes the molecular bonds in a species to vibrate with characteristic frequen-
cies. The functional groups, or common molecular bonds, vibrate within the same frequency 
range regardless of the molecule they are present in. This property is utilized in infrared spec-
troscopy to identify these functional groups within a broad range of molecules. An infrared spec-
trum is a plot of intensity versus wavenumber; higher wavenumber values traditionally being on 
the left, and lower ones on the right. Wavenumbers are defined below (Sec. 1.2.3) 
Normally absorbance or transmittance plots are obtained, in which the peaks point up-
wards or downwards respectively, showing the wavenumbers at which either process occurred. 
Apart from the qualitative information obtained from an infrared spectrum, concentration of the-
sample can also be estimated according to the Beer Lambert law as follows[18]; 
                                                  A = εlc                                                            (1.2.2.1) 
Where A= absorbance; ε = molar absorptivity; l = path length; c = concentration; 
The intensity of the absorption depends on changes in the dipole moment of the mole-
cule. The dipole moment arises due to the atoms on either side of a bond tending to attract the 
electron forming the bond by different amounts. This can be thought of as creating small 
amounts of excess charge on the atoms, positive on one, negative on the other. The electric field 
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of a passing photon causes opposing forces on the two ends of the electric dipole, and induces an 
oscillation.[21]  
Historically, many spectral analyses have been performed on known substances. By ex-
amining and comparing the results, some of the bands produced on a typical absorbance spec-
trum can be qualitatively assigned to the motion of particular bonds in the substance being stu-
died. Molecular vibrations can take different forms, such as symmetric and asymmetric stret-
ching, bending in and out of the plane of the molecule, and rocking.[22]  
 
1.2.3 IR Spectra 
An IR spectrum is usually expressed in terms of wavenumber, rather than wavelength. 
Wavenumber is often given the symbol  , and is calculated as the reciprocal of wavelength 
of IR light, measured in cm
-1
,  shown in equation 1.2.3.1.  
                                                          (1.2.3.1) 
By examining the intensity of light passing through the sample at each wavenumber, a 
transmission spectrum can be produced, according to equation 1.1.3.2. This is a dimensionless 
quantity. 
                                                           (1.2.3.2) 
The absorbance A (also called optical density) is defined as: 
    A = -log10(Io/I) = -lnT                                                       (1.2.3.3) 
I represents the light intensity after passing through the sample, and I0 represents the in-
tensity without passing through the sample. In practice, I0 must be taken in a separate step as a 
reference spectrum with no sample present. An FTIR absorbance spectrum for vero cells is 
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shown in Figure 1-1. Wavenumber range is from 2000 – 800 cm-1. Y axis represents the absor-
bance.  
 
 
Figure 1-1  An FTIR absorbance spectrum for vero cell.  
 
1.3 FTIR Instrumentation 
FTIR spectrometers are widely used. In the present study a Varian 7000 FTIR spectrome-
ter equipped with an Mercury-cadmium-telluride (MCT) detector was used for recording IR 
spectra of samples mounted on Zinc Selenide (ZnSe) Windows.  The fundamental part of the in-
strument is the so-called Michelson interferometer [23]. 
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The Michelson interferometer consists of an IR source, a beam splitter, two mirrors, one 
of which scans, a reflecting mirror, and the detector. A sketch is shown in figure 1.2. The median 
ray is shown by the solid line, and the extremes of the collimated beam are shown by the dashed 
line.[24] The infrared radiation, emitted by a broadband source, enters the interferometer and is 
split into two beams of equal intensity. Both beams are reflected back by the mirrors to the beam 
splitter. Depending on the movable mirror’s relative displacement, the beams at each cm-1 inter-
fere constructively or destructively The interferogram, which is produced by the sum of the inter-
ferences, has its maximum at x=0, because all wavelengths interact constructively, giving rise to 
a “center burst” [19]. The detected signal is amplified, processed and recorded. Finally, the inter-
ferogram is Fourier transformed to get a transmittance spectrum.  
 
Figure 1-2 The sketch of a Michelson interferometer.  
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Figure 1-3 Interferograms measured using FTIR spectrometer. 
 
 
Figure 1-3 shows interferograms measured using an unfiltered globar source (B) and a 
source with a 2000-1000 cm
-1 
filter in the light beam (A). Interferograms have been normalized. 
The x-axis represents the position of the moving mirror, which means the data point is propor-
tional to the difference in optical path length of the two interfering beams.[25] 
FTIR spectrometers have two major advantages compared to dispersive instruments. The 
first is called Jacquinot advantage [26], which is related to higher throughput of radiation in an 
FT-IR instrument. This is because there are no slits to restrict the intensity of radiation striking 
the detector in an FTIR instrument.  
9 
The second advantage is called  Fellgett’s advantage, or multiplex advantage [26], denot-
ing the fact that all the wavenumbers of radiation strike the detector at the same time, meaning a 
faster acquisition time. In a dispersive instrument only specific wavenumbers are let through the 
slit to strike the detector, slowing down the acquisition process.  
Fellgett’s advantage relates to the fact that the signal to noise ratio (SNR) is proportional 
to the square root of the number of scans taken for a particular sample [19]. So for a similar time 
period to obtain a sample spectra, an FT-IR instrument has a significant advantage vs. dispersive 
instrument since it can take more scans within the same length of time, giving a better SNR [19]. 
Besides simplicity, reliability, speed (Fellgett’s advantage), and high energy throughput (Jacqui-
not advantage)[26], a FTIR spectrometer also possesses  accuracy in frequency determination 
(Connes’s advantage).  
 
1.3.1 The Light Source 
The silicon carbide (SiC) globar source is a simple and relatively inexpensive IR light 
source covering the near to mid infrared emission region that is widely used in FTIR spectrome-
ters.  
1.3.2 The Beam Splitter 
The beam splitter is simply a piece of semi-reflective material, usually a thin film sand-
wiched between two pieces of IR-transparent material. The beam splitter equally splits the IR 
beam. 
Potassium Bromide (KBr) is commonly used for mid-IR beam splitters for FTIR spectro-
photometers. The efficiency of a KBr beam splitter greatly increases in the MIR region. There-
fore, a KBr beam splitter can be used down to 800 cm
-1
.  
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1.3.3 The Detector 
Mercury cadmium telluride (MCT) detectors are highly sensitive in the 6000-700 cm
-1
 
region. Experiments reported here a liquid nitrogen cooled 0.5x0.5 mm MCT detector was used. 
1.3.4 Filter and Windows 
In our experiments we are interested in the 2000-700 cm
-1
 region. A filter is necessary to 
cut off the unwanted radiation. A 2000-700 cm
-1
 band-pass filter was placed in front of the MCT 
detector to limit the spectral region. Gives better SNR, the spatial extent of the IR light imping-
ing on the samples was limited by variable apertures to an area of ~0.1x0.1 mm. 13 mm diameter 
x 1mm thick zinc selenide (ZnSe) infrared transmission windows, transparent in 5000-500 cm
-1
, 
were used in placing liquid sample cells used with infrared and spectrophotometers.  
Figure 1-4 shows a FTIR spectrometer layout[27]. Infrared beam is emitted from a glow-
ing black-body source (glow bar). This beam passes through an aperture which controls the 
amount of light that passes through the sample and to the detector. The beam enters the Michel-
son interferometer as we described previously. The resulting interferogram signal is transmitted 
through (or reflected off of) the surface of the sample. After the absorption takes place in the 
sample, the rest of the beam passes to the detector for measurement. Then the measured signal is 
Fourier transformed in the computer. The final infrared spectrum is then ready for further mani-
pulation and analysis[27].  
11 
 
Figure 1-4. A FTIR Spectrometer Layout 
 
1.4 Statistical Treatment of Experimental Spectra 
Many different studies have investigated the possibility of developing FTIR microscopy 
as a diagnostic method. Salman et al. (2002) have applied Cluster analysis to show that FTIR mi-
croscopic signatures can be used to differentiate normal cells from cells infected with herpes. 
According to Alam et al. (2004), activated murine (mouse) macrophage cells can be distin-
guished from live cells before activation using Principal Components Analysis (PCA) coupled 
with Linear Discriminate Analysis (LDA) and K-Nearest Neighbor (K-NN) models. Burattini et 
al. (2008) have applied two multivariate statistical analysis methods - Hierarchical Cluster Anal-
ysis (HCA) and PCA - to compare the spectral behavior of S. cerevisiae in model wine medium 
and base wine, before and after 5 days of autolysis. Babrah et al. (2009) also applied the PCA-
fed LDA model to select biomolecular signatures to discriminate the leukaemia cell lines be-
12 
tween T-cell lymphoma, B-cell lymphoid, and myeloid leukaemia. It is well known that Partial 
Least Square Regression (PLSR) has already become a very popular method in food science; it is 
also starting to develop in a novel detection scheme for viral infection using FTIR and cell cul-
ture [28]. In the following sections, the different statistical methods, along with their strengths 
and weakness, will be described. 
 
1.4.1 Hierarchical Cluster Analysis  
The first and most intuitive method for comparing two sets of spectra is to calculate the 
difference.  However, the cumulative effects of the various sources of uncertainty in the experi-
ment result in a low consistency between spectra.  Thus, it is difficult to identify spectral features 
that correlate with changes in the sample by simply comparing difference spectra.  However, the 
simplest method - repeating the experiment many times in order to average-out the errors - 
would prove too time-consuming.  Therefore, we must choose a statistical analysis method 
which is both quick and provides the optimum sensitivity/specificity, in order to reliably corre-
late changes in the sample spectra with changes in the cellular state. 
Hierarchical cluster analysis (HCA) is a commonly used statistical method for clustering 
different groups. It starts with all of the observations (spectra) in one cluster and then proceeds to 
split (partition) them into smaller clusters according to the variation in the spectra data sets. First, 
a distance matrix is calculated which quantifies the similarity of the spectra. This matrix is sym-
metric and of size n-by-n, where n is the number of spectra. We choose D-Values (explained be-
low) to obtain inter-spectral distances. Next, the two most similar spectra, defined as spectra with 
the smallest inter-spectral distance, are determined.  These spectra are combined to form a new 
object (cluster). The spectral distances between all remaining spectra and the new object are then 
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recalculated using Ward's algorithm defined in the CytoSpec Program.  A new search for the two 
most similar objects (spectra or clusters) is then initiated. These objects are merged and again, 
the distance values for the newly formed cluster are determined.  This procedure is performed n-
1 times until only one cluster remains.    
As mentioned above, for HCA the distance method we choose for our distance matrix 
calculation is called D-Values, and is formula 1.4.1.1 shown below:  
                         (1.4.1.1) 
      is known as the Pearson’s correlation coefficient: 
      
         
 
    
      
  
   
     
        
  
   
     
  
                             (1.4.1.2) 
where p is the total number of absorbance values in the spectra, and              are the i
th
 ab-
sorbance values of spectrum 1 or 2, respectively.  
Ward's algorithm is distinct from all other clustering methods. It uses an analysis of va-
riance approach to evaluate the distances between clusters. This method attempts to minimize the 
Sum of Squares (SS) of any two (hypothetical) clusters that can be formed at each step. This me-
thod is regarded as very efficient in general; however, it tends to create clusters of small size.[29]  
 
1.4.2 Principal Component Discriminant Analysis 
The principal component analysis–linear discriminant analysis (PCA-LDA) method has 
been used for statistical analysis of FTIR spectra of cells [30, 31].  
Principal Component Analysis (PCA) [32, 33] is used to reduce the dimensionality of the 
data while retaining the variation present in the original dataset as described in Equation 1.4.2.1. 
Using PCA the first step is to standardize the data by subtracting the mean and dividing by the 
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standard deviation. Second, the covariance matrix is produced. Third, by computing the eigenva-
lues from the covariance matrix, standardized data can be mapped into a lower-dimensionality 
space. This is done by sorting the new eigenvectors and choosing the first few principle compo-
nents so that allows the dimensionality reduction step to be accomplished.  
  (1.4.2.1) 
where x is the original data matrix with N dimension, and y is the new data with K di-
mension after x is mapped into a lower-dimensionality space. 
Linear discriminant analysis (LDA)[34] is used to determine which variables discriminate 
between two or more groups. Canonical analysis, which is the LDA method we used for this 
project, can perform a multiple group discriminant analysis. It determines an optimal combina-
tion of variables so that the first function provides the most overall discrimination between 
groups; the second provides second most, and so on. Moreover, the functions will be indepen-
dent or orthogonal, that is, their contributions to the discrimination between groups will not over-
lap. Computationally, we performed a canonical correlation analysis that determined the succes-
sive functions and canonical roots (the term root refers to the eigenvalues that are associated with 
the respective canonical function).  
1.4.3 Wilcoxon Signed-Rank Test 
To find what frequencies in the spectra are most significant, we applied the Wilcoxon 
Signed-Rank Test (WSRT, one sample test) to spectra data. WSRT is a non-parametric test. 
Therefore, it is very robust to the influence of outliers (individual observations that stick out 
from the pattern) and it does not require assumptions about the form of the distribution of the 
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measurements[35]. Furthermore, using signed ranks instead of the real values may be a efficient 
method for discriminating between different groups rather than differentiating different means. 
 
The procedure we used is as follows:  
1. For each wavenumber (treated as a variable), the null hypothesis H0 is that the 
mean of intra data Mintra is equal to zero. 
H0:Mintra=0 
2. Obtain WSRT statistics: the difference di between each observation and the hy-
pothesized mean Mintra, 
di= xi−Medium,  
where xi is the i
th
 observation( spectral intensity for i
th
 wavenumber). 
3. Rank of the set { | di | ; i = 1, … , n} and name them , Yi, i = 1, …, n . 
4.  Define Ri= (sign xi)Yi. Then the Wilcoxon rank statistic W is defined to be the 
sum of all positive Ri. 
5. Under the null hypothesis H0, the mean (μ) and the standard deviation (σ) of W 
is given as: 
μ = n(n +1) / 4, 
σ = n(n +1)(2n +1) / 24,  
where n is the sample size. 
6. Under the normal approximation, the p‐value is given by P(Z>|z|) 
z= (W−μ ) /σ 
We can select the significant wavenumbers by the p-value among all 182 wa-
venumbers. 
7. The Bonferroni method[36] is used to calculate the adjusted probability of type 
I error (false positive) in the multiple variables case. Therefore, the critical val-
ue for p‐value should be around 0.05 /(2*182)=0.0002. For all 182 variables, 
only the one whose p‐value of WSRT is smaller than or close to 0.0002 should 
be selected as significant variables for the next step of the analysis. 
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1.4.4 Partial Least Square Regression and Logistic Regression 
In chapters 2 to 5 Partial Least Square Regression (PLSR) or Logistic Regression (LR) is 
used to diagnose if cells are infected or not, or whether cells have undergo apoptosis.  
Variables can be categorized into observable and unobservable groups. MaDonald (1996) 
stressed that a variable can be called observable “if and only of its value can be obtained by 
means of a real-world sampling experiment”. Therefore, any variable that does not correspond 
directly to anything observable must be considered as unobservable. For example, Wold (1993) 
pointed out that the effects and properties of molecules, genes, viruses and bacteria are usually 
observed only indirectly, i.e. unobservable variables. 
Also, as presented in Equation 1.4.4.1, PLSR requires two sets of variables: independent 
and dependent. Absorbances at significant wavenumbers from the WSRT were treated as inde-
pendent variables. The dependent variables (Y, also response variables) were coded as 0 and 1 to 
represent two samples we were trying to discriminate.  
PLSR is a method for constructing predictive models when the independent variables 
(absorbances at different wavenumbers) are highly correlated. It is particularly useful when the 
matrix of predictors has more variables than observations. The overall goal is to use the predic-
tors to predict the responses in the population. First, PLSR estimates the weight relations based 
on the unobservable variables. Then case values are calculated, based on a weighted average of 
its indicators, using the weight relations as an input. Second, these case values are used in a set 
of regression equations (Equation.1.4.4.1) to determine the parameters for the structural rela-
tions.[37]  In statistics, case value is the estimated value for each latent variable in each data set. 
Latent variables, called predictors, or factors, (as opposed to observable variables), are variables 
that are not directly observed but are rather inferred (through a mathematical model) from other 
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variables that are observed (directly measured). A PLSR model can be expressed as the projec-
tion to latent structure. 
nnn EUfUfUfY  2211 ,                                       (1.4.4.1) 
where niU i ,,1,   are factors, and nifi ,1,   are the coefficients of them, and also called 
discriminators. PLSR uses variable combinations 1U (the first factor), 2U (the second factor),  , 
nU (the nth factor), such that 
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                                             (1.4.4.2) 
where niXU ii ,,1,   , S is the sample covariance matrix, X is a JI  matrix which 
contains all the values of J predictor variables collected on I observations, and Y is a 1I  matrix 
storing the I observations described by the dependent variable. The conditions 
1,,1,0  ilS l
T
i   ensure that ii XU  is uncorrelated with all the previous linear combi-
nations 1,1,  ilXU ll   [38]. 
PLSR finds combinations of the predictors that have a large variance and highly corre-
lated with the response variables. Similar to PCA, PLSR produces a linear regression model by 
projecting the dependent variables and the independent variables to a new space. Therefore, we 
can find fundamental relations between two sets of variables.  
Another popular statistical method is Logistic regression (LR). LR is also a type of pre-
dictive model that can be used when the target variable is binary. The LR model yields the prob-
ability of occurrence of an event by fitting data to a logistic curve. In other words, the correlation 
between the discriminators and response variables is not a linear function in LR. Instead, LR 
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finds a linear combination of xi (the input data), which is the logit transformation of the probabil-
ity of success g , i.e.  
nn xxx
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or equivalently, 
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where is the constant of the equation, P(Y=1|X) is the probability function when Y=1 
for any X , Y is outcome variable, X is the independent variable, and nii ,,1,  are the coeffi-
cients of the predictor variables.  
There are many ways to select the number of discriminators included in the PLSR or LR 
models. We simply use the number of discriminators which count a certain percent of the total 
variation (say 80, 90, 95%), which can be limited by certain P-values.  Then we can evaluate the 
model diagnostic performance by deriving area under the ROC curve (AUC) sensitivity and spe-
cificity as mentioned later in this chapter. 
  
1.4.5 Area Under the Curve, Sensitivity and Specificity 
After building a model, we then need to evaluate its diagnostic performance, namely the 
ability to correctly classify two categories. Usually we can use sensitivity and specificity, and the 
area under the Receiver Operating Characteristic (ROC) curve to make the evaluation. In this 
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project we used two methods to calculate sensitivity, specificity and the area under the ROC 
(AUC). 
For the first method, since the discriminators from the PLSR have approximate normal 
distribution, we can estimate AUC, sensitivity and specificity as follows.  
Let X1 and X2 be the discriminators for inner and intra-difference, respectively.  
AUC = P (X2 >X1) = P(X2 -X1>0)                 (1.4.5.1) 
where P is probability, E (X2 -X1) = 2 - 1, and Var (X2 -X1) = sq(1) + sq(2), where E 
is the expected value and Var is the variance. 
                       (1.4.5.2) 
,      (1.4.5.3) 
Therefore
 
                    (1.3.5.4) 
and 
        (1.3.5.5)
 
where Φ is the distribution function of the standard normal distribution. [39]  
The estimated AUC, sensitivity and specificity can be obtained by replacing 1, 2, 1, 2 
with the sample means and sample standard deviations. 
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The second method is the standard calculation for all three parameters. Sensitivity and 
specificity, as shown in Table 1-1, are closely related to the concepts of type I and type II errors. 
Sensitivity measures the proportion of correct identifications among actual positives, such as the 
probability of a positive test among patients with a particular disease; and the specificity meas-
ures the proportion of correct identifications among all negatives, such as the probability of a 
negative test among patients without said disease. [38]  
The estimated sensitivity and specificity can be expressed as   
      Sensitivity = a / (a+c)      (1.3.5.6) 
     Specificity = d / (b+d),      (1.3.5.7) 
Where a, b, c, and d are defined in Table 1-1.  
 Table 1-1 Data table for calculating sensitivity and specificity 
 Cells infected with virus Cells without infection (mock) 
Test is positive(infected) a b 
Test is negative(uninfected) c d 
 
 In the table above, a represents the true positives (infected samples correctly diagnosed as 
infected); b represents the false positives (uninfected samples incorrectly diagnosed as infected); 
which; c are the false negatives (infected samples incorrectly diagnosed as uninfected); d are the 
true negatives (uninfected samples correctly diagnosed as uninfected). 
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         Figure 1-5 ROC Curves. 
 
A complete description of classification is given by the area under the ROC curve (Figure 
1-5), which is a plot of the sensitivity against 1-specificity for the different possible cut-off 
points of a diagnostic model. Each point on the ROC curve represents a sensitivity and specifici-
ty pair corresponding to a particular decision threshold. As shown in Figure 1-4, the blue line 
represents a ROC curve with high AUC and the green line represents a ROC curve when AUC 
equals 0.5. When the sensitivity increases, the corresponding specificity will decrease. If the ob-
jective is to choose an optimal cut-off point for the purpose of discrimination, one might select a 
cut-off point that maximizes both sensitivity and specificity. An area of 1 represents a high accu-
racy of discrimination, and an area of 0.5 represents very low accuracy. A rough guide for classi-
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fying the accuracy of discrimination is the traditional academic point system. That is, Area Un-
der the Curve between 0.90 and 1 represents excellent discrimination; AUC between 0.80 and 
0.90 represents good discrimination; AUC between 0.70 and 0.80 represents fair discrimination; 
AUC between 0.60 and 0.70 represents poor discrimination; and AUC between 0.50 and 0.60 
represents no discrimination.[38]  
 
1.4.6 Bootstrap and Cross-validation 
In statistics, the goodness of a procedure for given sample data is frequently over-rated, 
which means most model fitting procedures often yield results that are highly dependent on the 
input data set used to build the model. In order to estimate the precision of sample statistics, es-
timate the sampling error or validate the model, we can use bootstrap methods[40] by drawing 
randomly with replacement from a set of data, or cross-validation by using random subsets from 
the original data sets. We refer to this sampling error as “shrinkage”, which is defined as the dif-
ference between the specificities (or sensitivities, or AUC) of two data sets: the population and 
the observed sample.   
Since the model derived from the observed sample could not represent the whole popula-
tion, shrinkage becomes an important indicator for the future performance of this model in dis-
criminating the unknown data set. In order to estimate the shrinkage, we calculated the difference 
of the specificities (or sensitivities, or AUC) between the model data sets and test data sets.  
We employed cross-validation and bootstrap to resample the model and test datasets. 
Cross-validation, a method of estimating sampling error, can be used to assess the shrinkage of 
the AUC and specificities of the model we built. In K-fold cross-validation, the original sample 
is randomly divided into K subsets of approximately equal size. Of the K subsets, a single subset 
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is retained as the validation data, and the remaining K-1 subsets as a whole are used as training 
data which is used to build the model. The cross-validation process is then repeated K times, 
with each of the K subsets used exactly once as the validation data. The K results can then be 
averaged to produce a single estimate. 
 In chapter 2 to 5, we employed 2-fold cross-validation to examine the accuracy of the 
AUC and specificity found in the models. The original data for building the model were random-
ly divided into two equal subsets. AUC and specificities which correspond to the sensitivities 
95%, 90% and 80% were calculated by validation data and training data respectively. We then 
obtained the shrinkages by subtracting AUC and specificities for validation data from the ones 
for training data. After we repeated the process n times, the averaged shrinkage of AUC or speci-
ficities were then subtracted from original sample estimates to obtain the final estimations from 
cross-validation. 
2-fold cross-validation normally gives an over-estimated shrinkage due to the reduction of 
the sample size. Unlike 2-fold cross-validation, bootstrap method normally gives an under-
estimated shrinkage. Model datasets for bootstrap were caculated by constructing a number 
of resamples. Resampling entailed drawing randomly with replacement from a set of data points 
of the observed dataset, which were of equal size to the original observed datasets. Test datasets 
refers to the original observed dataset. By applying  the same procedure as mentioned above, we 
obtained the AUC and specificities for the validation data and training data respectively. Repeat-
ing the whole procedure n times, we were then able to use the final averaged shrinkage to calcu-
late the final estimations from bootstrap. 
By averaging these final estimations from two methods, we can have a reasonablle 
extimate of the shrinkages. 
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In the following chapters, I will discuss the various aspects and findings of my thesis. In 
Chapter Two I will describe the studies of cells infected with different viruses at 24 hours post 
exposure. Different statistical method will be applied to the same datasets, such as HCA, PLSR 
and LR. In Chapter Three, I will present the studies of viral infected cells at 8, 12 and 24 hours 
post exposure, as well as describe the statistical results from PC-LDA and PLSR. Similarly, in 
Chapter Four, I will describe how cells infected with viruses at 2, 4 and 6 hours post exposure 
were studied as in Chapter Three. For Chapter Five, apoptosis in Acute Lymphoblastic Leukemia 
T-Cells were studied under different stresses by using FTIR and different statistical analyses will 
be described.  
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2 STUDIES OF VIRAL INFECTED CELLS AT 24 HPE  
2.1 Viral infection of cells in culture detected using infrared microscopy 
This chapter contains a manuscript that was published in July 2009, Analyst, 134(7): 1462-71. 
Reproduced with permission from Analyst, 134(7): 1462-71. Copyright 2009 American Chemi-
cal Society.  
 
Summary  
FTIR microscopy has been used to collect spectra for uninfected (mock) Vero cells, and 
cells that have been infected with herpes simplex virus type 1 (HSV-1) and human Adenovirus 
type 5 (Ad-5). Cells were infected at a multiplicity of infection of 10, and studied at 24 hours 
post exposure. The spectra for infected samples display many differences compared to spectra 
for uninfected samples.  
To estimate how well spectra for uninfected and infected samples could be discriminated 
we used logistic and partial least squares regression methods. We show that spectra for HSV-1 
and mock infected samples are well differentiated, and for a sensitivity of 95%, we calculate a 
specificity of 0.999 using partial least squares regression. Spectra for Ad-5 and mock infected 
samples are also well differentiated. We find that applying our regression models constructed 
with one data set to a new validating data set still gives very high levels of specificity for a given 
sensitivity.  
Spectra for Ad-5 and HSV-1 infected samples are also differentiable. Applying our con-
structed regression models to new validating data, however, leads to a decrease in discrimination 
capability in this instance, however.  
If one is simply interested in differentiating spectra associated with uninfected and in-
fected cells, without distinguishing the type of infection, then we show that logistic regression 
models can break down whereas partial least squares regression models perform well.  
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Introduction  
Infrared spectroscopy and microscopy of cells in culture is a rapidly growing area of re-
search, the goal of which is the ability to spectrally distinguish between cells in different physio-
logical states 
1-4
. In our lab one goal is to use infrared spectroscopy to develop robust methods 
that can rapidly and accurately differentiate between uninfected cells and cells that have been 
infected with viruses.  
Rapid and accurate detection of viral infections is of importance not only in the realms of 
disease detection in humans, animals and plants, but also in the realms of homeland security 
where a rapid detection and diagnosis of airborne and environmental biological agents is desira-
ble.  
In our work we are particularly interested in viruses that infect humans, and here we re-
port on the detection of spectral changes in African green monkey kidney cells (Vero cells) that 
occur as a result of infection with herpes simplex virus (type 1) or Adenovirus. In this sense the 
Vero cells act as sensors of viral infection, responding to the virus with morphological or bio-
chemical changes that we detect spectroscopically. Herpes simplex virus (type 1) (HSV‐1) is 
predominantly involved with infections of the skin and central nervous system, and is difficult to 
distinguish from other possible infections caused by bacteria or fungi, particularly at the early 
stages of the infection. Isolation of the virus in cell culture and immunoassays are the main me-
thods for the detection of herpes virus infections. Such methods are time‐consuming and relative-
ly expensive, and an alternative faster approach is desirable. Scientists have begun exploring the 
application of FTIR spectroscopy for detection of HSV‐1 and other herpetic infections 5‐8, as well 
as applications to other types of viral 
9
, bacterial and fungal infections 
10
. However, we believe 
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that much of this previous work has oversimplified the true capabilities of FTIR spectroscopy as 
a method for detecting infections in cells (see below). In this paper we attempt to present a more 
rigorous approach to spectral detection of pathogens in cellular material.  
One common mistake made when investigating the use of FTIR spectroscopy as a cellu-
lar monitor, is to specifically assign small changes in certain spectral regions to specific molecu-
lar changes in infected or diseased cells. For example, in FTIR spectra of cellular samples some 
investigators report that peaks at or near 1237 and 1082 cm
-1
 are unambiguously attributable to 
PO
2-
 asymmetric and symmetric stretching vibrations of nucleic acids. They then infer some 
change in cellular DNA due to infection. Such inferences are often problematic:  
Firstly, directly related to the above example, it has been established that nuclear material 
is on the whole opaque to infrared (IR) radiation 
11, 12
. Secondly, it has been established for cellu-
lar samples that any IR peak in virtually any spectral region is a composite that consists of under-
lying contributions from many cellular components 
3
. To show that specific bands are associated 
with specific molecular groups, controlled experiments have to be undertaken in which the spe-
cific molecular species under consideration is modulated. We have recently undertaken such an 
experiment to establish which IR bands are specifically associated with cellular lipids. Such an 
analysis was accomplished by specifically removing most of the cellular lipids from the cellular 
material2.  
Thirdly, we show below that spectra for cell samples can vary considerably depending on 
the location on the sample that the spectra are sampled. Even the spectra obtained for presumably 
identical single cells can vary considerably 
13
. The spectral differences are due to slightly differ-
ent light scattering characteristics of the cells, which are a function of the cell shape, size and 
sub-cellular composition 
11, 13
. Therefore, it is possible that cells that are infected may undergo 
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structural alterations that can change the infrared light scattering characteristics of the cellular 
material, compared to uninfected cellular material. Such variation in spectra due to sampling 
slightly different (structurally) cellular suspensions is virtually never considered as the possible 
origin of observed spectral changes between cells in different states. Furthermore, baseline cor-
recting IR spectra prior to analysis may serve to mask issues that may be associated with chang-
ing IR light scattering characteristic of cells. Given these considerations, we try to quantify the 
extent of spectral variation due to sampling different areas of a cellular suspension, and we then 
try to assess whether spectral changes that may be associated with cellular infection are in fact 
larger than the intrinsic spectral variation due to sampling. Even after such an analysis it is still 
difficult to unambiguously specify that the spectral changes observed in infected cells are in fact 
due to changes in cellular composition caused by the infection. That is, it is difficult to rule out 
that spectral changes may be caused by different scattering characteristics of uninfected and in-
fected cellular suspensions (see below). However, one could argue that a change in the scattering 
characteristic of cellular suspensions due to infection is still a useful diagnostic measure of infec-
tion.  
In this paper we use infrared spectra of dried suspensions of African green monkey kid-
ney cells (Vero cells) to report on the infection status of the cells. The spectral changes due to 
infection are small, especially when compared to the spectral variation that results merely from 
sampling the suspension at various locations on the dried suspensions (see below). It is almost 
impossible to infer viral infection of cells simply by collecting a single spectrum from some lo-
cation on the cellular suspension. However, by sampling (collecting spectra) at many locations 
on the suspension, and applying advanced statistical methods to the analysis of all of the spectra 
obtained, we show that it is possible to distinguish with a high degree of accuracy, infected from 
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uninfected cellular material. We also show that with the use of such statistical methods, it is 
possible to distinguish different types of viral infections.  
Experimental  
Cell Culture and Preparation. African green monkey kidney cells (Vero, American Type 
Culture Collection #CCL-81) were grown at 37°C in DMEM (Mediatech, Manassas, VA) sup-
plemented with 10% Fetal Bovine Serum (Atlanta Biologicals, Atlanta, GA), 100 units/ml peni-
cillin, and 100 μg/ml streptomycin (Mediatech, Manassas, VA). Once confluent (generally with-
in 24 hours of seeding), the Vero cell monolayers were infected with herpes simplex virus (type 
1) HSV-1 or human Adenovirus-5 (Ad-5), at a multiplicity of infection (MOI) of 10 for 2 hours. 
Following this the growth medium (plus excess virus) was replaced with new growth medium. 
For mock infections, a normalized volume of uninfected cell lysate was incubated with the cells. 
At 24 hours post exposure (for the work described here) cells were scraped from the surface of 
the growth medium and centrifuged at 800 g for 1 minute. Cells were resuspended in 5 μl of PBS 
buffer containing calcium and magnesium. Several 0.5 μl drops were pipetted onto ZnSe win-
dows and allowed to dry in a Class IIB biosafety cabinet. In the experiments reported here, cells 
were not subjected to any chemical fixation protocol (except air drying).  
FTIR measurements: FTIR microscopy measurements in transmission mode were under-
taken using a Varian 7000 FTIR spectrometer, coupled to a Varian UMA600 IR microscope 
(Stingray system). The microscope system contains only reflective optical elements consisting of 
on-axis, matched 15X Schwartzchild objective and condenser. The microscope is also equipped 
with a visible light source and a visible 640x480 CCD camera, allowing one to obtain visible mi-
croscopic images from the same region that is sampled in the IR experiment. In the experiments 
reported here a liquid nitrogen cooled 0.5x0.5 mm mercury cadmium telluride (MCT) detector 
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was used with high responsivity in the 6000-700 cm
-1
 region. The spatial extent of the IR light 
impinging on the samples was limited by variable apertures to an area of ~0.1x0.1 mm (see fig-
ure 1). A 2000-700 cm
-1
 band-pass filter was placed in front of the MCT detector to limit the 
spectral region. All measurements reported here were undertaken at 2 cm
-1
 resolution. In many 
cases the spectra we collected had amide I and II bands with absorption considerably above 1.4 
(in optical density units). For this reason we consider only data collected in the 1500-800 cm
-1
 
region, where all absorbance values are much lower (figure 2). No baseline correction algorithm 
was applied to any of the spectra collected.  
In a typical experiment we usually pipette 5x0.5μL drops of cellular material onto a ZnSe 
window. These drops form a dried suspension with a diameter of ~1-2 mm. The ZnSe windows 
are placed in the sample compartment of the FTIR microscope, which is enclosed and continual-
ly purged with dry air. Roughly 60-100 spectra are collected at various locations over the five 
sample drops. Sixty four spectra are collected at each location and averaged. Locations on the 
dried sample are selected manually so as to ensure that cellular material covers the whole of the 
sampling aperture (figure 1).  
Statistical Analysis. All statistical analysis of spectra reported here were undertaken using 
home-written code implemented within the SAS (Cary, NC) software programming environ-
ment. In this manuscript we have collected spectra for mock, HSV-1 and Ad-5 infected cells (at a 
multiplicity of infection (MOI) of 10 and at 24 hours post exposure, on two separate occasions. 
Data collected on the first occasion was used to construct a statistical model. Data collected on 
the second occasion was used to validate the constructed statistical model (see below)  
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Results  
Figure 1 shows two visible images from a single air-dried cellular suspension of mock in-
fected cells. Infrared light is only transmitted through the central “square” aperture. At each of 
the two different sampling locations spectra were collected. Usually we collected 60-100 spectra 
dispersed over 4-5 sample “drops”. Very similar images to those shown in figure 1 were obtained 
for HSV-1 and Ad-5 infected cellular suspensions.  
Figure 2 shows the raw spectral data collected for mock and HSV-1 infected suspensions 
(A), and mock and Ad-5 infected suspensions (B). The spectra of mock infected samples are 
shown in black and the viral infected samples in red. For mock/HSV-1/Ad-5 infected samples 
spectra were collected at 69/79/94 locations on the cell sample “drops”, respectively.  
Figures 2A and 2B show that there is considerable variation in the intensity of the spectra 
collected at various locations on the dried cellular suspensions. In figure 2A, the overall trend 
appears to be that the HSV-1 infected cells have decreased absorption compared to mock in-
fected cells. This could be because the mock infected cellular suspensions are thicker than the 
HSV-1 infected suspensions, or because the concentration of cells is slightly higher for the mock 
infected suspensions. In either case we have consistently found that spectra for HSV-1 infected 
suspensions display decreased absorption relative to the spectra for mock infected suspensions. 
On this basis alone, it appears that HSV-1 infected cellular suspensions can be distinguished 
from mock infected suspensions (at MOI=10 and 24 hours post exposure). A similar but less 
pronounced trend in the spectra is also observed for Ad-5 infected cellular suspensions compared 
to mock infected cellular suspensions (figure 2B).  
To eliminate effects due to sample thickness or cellular concentration, the spectra in fig-
ure 2 were standardized. A standardized spectrum is obtained by first mean centering the original 
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spectrum and then dividing by the standard deviation. The standardized spectra calculated from 
the raw spectral data in figure 2A/B are shown in figure 2C/D, respectively.  
Figure 2C and D indicate that there are several spectral differences between mock in-
fected and HSV-1 or Ad-5 infected suspensions. These features are more easily visualized in the 
averaged spectra, which are shown in figures 2E and F. To gauge the variation in the standar-
dized spectra the error bars are shown that represent the standard deviation in the spectra at each 
frequency point. The inset in figure 2E shows an expanded view of the averaged spectra in the 
1340-1360 cm
-1
 region. The error bars are more easily visualized in the inset. Importantly, there 
is no overlap of the error bars in the 1340-1360 cm
-1
 region, likely indicating a real difference 
between the spectra of mock and HSV-1 infected samples.  
Statistical Analysis: The question we wish to address in this manuscript is: To what ex-
tent can we specify whether a given spectrum is associated with a mock, HSV-1 or Ad-5 infected 
cells? That is, what are the specificities and sensitivities associated with our FTIR spectral detec-
tion methods. Sensitivity is the probability that we can correctly identify a spectrum from an in-
fected sample in the population of all spectra measured for infected samples (i.e. a true positive). 
Specificity is the probability that we can identify a spectrum from an uninfected sample given 
the whole population of spectra from uninfected samples (i.e. a true negative).  
For each of the 728 frequencies in the standardized spectra in figure 2C, D we applied the 
Wilcoxon Rank Sum Test (also known as the Mann-Whitney test) to establish which frequencies 
may be useful in discriminating HSV-1 and Ad-5 infected samples from uninfected (mock) sam-
ples. The Wilcoxon Rank Sum Test is a non-parametric test for assessing whether two sample 
sets of observations come from a distribution with the same ranks. The Wilcoxon Rank Sum Test 
differs from the two-sample T-test, which essentially tests for differences in the means of two 
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sample sets. The Wilcoxon Rank Sum Test is more robust against outliers than the two-sample 
T-test.  
The null hypothesis is that there is no difference in distributions. A two-sided alternative 
is that there is a difference in distributions. For a normal approximation to the rank distribution 
we can assign a score (Z score) relating to the probability that the given frequency can or cannot 
discriminate between HSV-1 and mock infected cells, or Ad-5 and mock infected cells. The cal-
culated Z-score at each frequency for mock and HSV-1, mock and Ad-5, HSV-1 and Ad-5, and 
mock and (HSV-1+Ad-5) are shown in figure 3A-D. A second validating data set obtained from 
a completely different sample preparation was also analyzed. The corresponding calculated Z-
scores for these validating data sets are also shown in figure 3 (red curves).  
We calculate that for a Z-score of +/-4 the data can be used as a potential discriminator at 
the p=0.05 level: Using Bonferroni's multiple test method, we divide the significance level by the 
number of tests [0.05/(2*728)=3.434x10-5] and then recognize that the percentile for a standard 
normal distribution with probability 3.434x10-5 is -3.98 (~-4). In figure 3A-D the Z=+/-4 lines 
are shown. All points above +4 and below -4 may be useful for discrimination.  
Mock vs. HSV-1 infected cells: For the original data for mock vs. HSV-1 (blue curve in 
figure 3A), there are seven broad frequency ranges that are all above the +/-4 threshold [800-885, 
918-1014, 1036-1136, 1160-1207, 1216-1288, 1312-1388 and 1410-1500 cm
-1
], and we focus 
only on frequencies in these ranges. For the Z-score data in figure 3A, 595 frequencies are above 
the +/- 4 threshold, and are deemed significant. To generate a more stable methodology only the 
average of every 5 neighboring frequencies were considered. This leads to 119 significant fre-
quency variables. Using stepwise selection in a logistic regression method frequencies at 1196, 
1450 and 1484 cm
-1
 were found to be of very high significance in discriminating spectra of mock 
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or HSV-1 infected samples. These three frequencies are indicated in figure 3A. These three fre-
quencies all have a p-value less than 0.002. It is not at all obvious that these frequencies are the 
most significant from looking at the spectra in figure 2E.  
To evaluate the performance of our logistic regression model in correctly classifying the 
two categories (mock vs. HSV-1) we calculated the sensitivity, specificity, and the area under the 
Receiver Operating Characteristic (ROC) curve. Sensitivity gives a measure of the proportion of 
correct identifications among actual positives, while specificity gives a measure of the proportion 
of correct identifications among all negatives. A ROC curve is a plot of sensitivity versus (1-
specificity). An area under the ROC curve (AUC) of 1 represents 100% accuracy of discrimina-
tion, and an area of 0.5 represents no accuracy. A rough classification guide is: AUC = 0.9-1.0 - 
excellent discrimination; AUC = 0.8-0.9 - good discrimination; AUC = 0.7-0.8 - fair discrimina-
tion; AUC = 0.6-0.7 - poor discrimination; AUC = 0.5-0.6 - no discrimination.  
Table 1 lists the specificities and AUC’s obtained from the final linear regression model 
for HSV-1 and mock, for sensitivities of 95%, 90%, and 80%. For the spectra of mock and HSV-
1 infected samples (figure 2C), with the calculated frequency variables of highest significance, 
we find that the AUC is equal to 0.97. We also find that for a given sensitivity of 95/90/80% a 
specificity of 0.899/0.957/1.00 is obtained, respectively (table 2). This is an outstanding level of 
discrimination.  
Frequently regression model fitting procedures over-estimate the accuracy of the method 
14. The regression model works well for one data set but less well for another. That is, the de-
termination capability of the model shrinks. Procedures are available, however, for estimating to 
what extent the model may overestimate the true AUC, sensitivity, and specificity. Taking this 
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over estimation into account is what is usually referred to as shrinkage15. Here we have used 3-
fold balanced cross-validation14, 16 to assess shrinkage in our logistic regression model.  
In balanced three-fold cross-validation the original data is randomly split into three ap-
proximately equal subsets16. Two subsets are used to construct the statistical model, and the 
third subset is used for validation. From this analysis, specificities, sensitivities and AUC’s are 
calculated for the training data as well as for the same model applied to the validating data. 
Shrinkage is calculated by subtracting the calculated specificities and AUC’s for the validating 
data from the training data. We repeated this process 100 times for different randomly prepared 
subsets and the average value of shrinkage obtained is subtracted from the results calculated us-
ing the complete data set15.  
After estimating shrinkage using cross-validation methods, the AUC is equal to 0.963 
(table 1). In addition, for a sensitivity of 95/90/80% we find a specificity of 0.82/0.938/0.989 (ta-
ble 1). This still represents excellent discrimination of spectra for mock and HSV-1 infected 
cells.  
To further validate our logistic regression model we repeated the experiments described 
above for a completely new set of mock, HSV-1 and Ad-5 infected cells. In this case 81/79/84 
spectra for mock/HSV-1/Ad-5 infected samples were collected, respectively. In the process of 
validation, we applied the new data to the final model constructed from the original data. We ob-
tained the AUC and specificities without changing any of the coefficients or variables calculated 
in the original model. The AUC and specificities calculated using the validating data are also 
listed in table 1. The Z-scores calculated for the new validating data are also presented in figure 3 
(red curves).  
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Using the validating data in the logistic regression model yields an AUC of 0.935 (table 
1). The calculated specificities are 0.95 for all three sensitivities. Such high scores may be ex-
pected given the similarity of the two Z-score curves in figure 2A. In particular, the discriminator 
frequencies calculated from logistic regression for the first data set, are also significant in the va-
lidating data set.  
In an alternative statistical analysis of the spectra for mock and HSV-1 infected samples 
we used all 119 frequency variables (the 595 most significant ones from the Z-score plot aver-
aged into groups of 5) to construct a partial least squares regression (PLSR)17, 18 model. In the 
PLSR model constructed using the data in figure 2C, it was found that the first 5 factors account 
for ~93.4% of the total variation (table 10, and contain almost all of the information from the 
original 119 variables. The AUC and specificities corresponding to 95%, 90%, and 80% sensitiv-
ity are also listed in table 1, and are all found to be equal to 1.0, demonstrating that our PLSR 
model is superior to our already excellent logistic regression model. The AUC and specificities 
obtained after estimating for shrinkage using 3-fold cross-validation are equal to 0.983, 0.999, 1 
and 1 (table 1). Finally after using the new data to validate the constructed model, the AUC and 
the specificities are 0.989, 0.974, 0.975 and 0.988 respectively (table 1).  
Mock vs. Ad-5: Figure 2D and F compares the standardized spectra and averaged spectra 
for mock and Ad-5 infected cells, respectively. The calculated Z-score plot for mock vs. Ad-5 is 
shown in figure 3B. For the red curves (original data sets) in figure 3B, the 925-953, 1021-1136, 
1173-1206, 1219-1271, 1311-1392, and 1410-1500 cm
-1
 regions are deemed significant. These 
regions contain 420 frequency variables that are reduced (stabilized) to 84 by averaging every 
five neighboring variables.  
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For spectra of mock and Ad-5 infected cells stepwise selection indicated that frequencies 
of 1057, 1134, 1470 and 1499 cm
-1
 are the most significant discriminators. These frequencies are 
labeled in figure 3B. Results for the logistic regression model using these four frequency va-
riables are listed in table 2. As shown in table 2, using logistic regression, the AUC and specifici-
ties for 95%, 90%, and 80% sensitivities are all unity, exhibiting excellent discrimination be-
tween spectra of mock and Ad-5 infected cells. After estimating shrinkage using cross-
validation, and also using new validating data in the original model, the AUC and specificities 
are still very close to 1.0. The Z-score plot for both of the original and validating data are shown 
in figure 3B. There are some difference between the two Z-score curves, and one of the frequen-
cy variables is near the +/-4 borderline. This does not appear to lead to poorer discrimination, 
however.  
For PLSR of the mock vs. Ad-5 spectral data, the first 4 factors account for ~95.8% of 
the total spectral variation. The AUC and specificities corresponding to 95%, 90%, and 80% sen-
sitivities are equal to 0.982, 0.958, 0.986, and 1. Again, such numbers indicate excellent discrim-
ination, which is not greatly altered after estimating for shrinkage using cross-validation, or us-
ing new spectral data files for validation.  
HSV-1 vs. Ad-5 infected cells: The calculated Z-score plot for HSV-1 vs. Ad-5 is shown 
in figure 3C. For the initial data, the 800-881, 915-938, 950-1026, 1146-1169, 1216-1297, 1336-
1378, and 1413-1455 cm
-1
 regions are deemed significant. These regions contain 390 frequency 
variables, which is reduced (stabilized) to 78 by averaging every five neighboring variables.  
For spectra of HSV-1 and Ad-5 infected samples stepwise selection indicated that fre-
quencies of 854, 922, 952 and 1276 cm
-1
 are the most significant discriminators. Results for the 
logistic regression model using these four frequency variables are listed in table 3. The AUC and 
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specificities for 95%, 90%, and 80% sensitivities obtained using logistic and PLS regression 
models are all close to 1.0, indicating excellent discrimination. Even after estimating shrinkage 
using cross-validation, the AUC and specificities are still close to 1.0. Applying the calculated 
models to new validating data, the AUC is now calculated to be 0.882 (logistic regression) or 
0.913 (PLRS), which still represents excellent discrimination. However, specificities for 95%, 
90% and 80% sensitivity are 0.646, 0.759, and 0.848, respectively. It appears that discriminating 
spectra for Ad-5 and HSV-1 infected samples is straightforward for cellular suspensions made at 
the same time and under identical conditions. It is however, more difficult to apply models con-
structed using one set of data to new data sets obtained from different samples prepared at differ-
ent times. The Z-score curves calculated from the spectra for the HSV-1 and Ad-5 infected cells, 
for the original and the validating data sets are shown in figure 3C. There are some considerable 
differences between the two Z-score curves. The 951 and 921 cm
-1
 frequency variables chosen 
from the first logistic regression model are near the border of being significant in the second va-
lidating data set. The other two frequency variables chosen from the first logistic regression 
model are both also highly significant in the second validating data set. The PLSR model also 
performs quite poorly for the two different spectral data sets for HSV-1 and Ad-5 infected cells, 
and for an 80% sensitivity a specificity of 0.911 is calculated. This is very good level of discrim-
ination, although inferior to that discussed above for mock vs. HSV-1 and mock vs. Ad-5.  
Mock vs. HSV-1 & Ad-5 infected cells: In a final analysis we decided to test how well 
our statistical modeling approach could discriminate spectra for infected and uninfected (mock) 
cellular suspensions. In this case all of the spectra for HSV-1 and Ad-5 infected suspensions are 
grouped into a single category labeled “infected”. The calculated Z-score curve for mock vs. 
HSV-1 & Ad-5 is shown in figure 2D. For the initial data, figure 2D reveals that the 800-885, 
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921-959, 973-1006, 1027-1137, 1165-1207, 1217-1279, 1310-1391 and 1410-1500 cm
-1
 regions 
are significant. These regions contain 570 frequency variables, which is reduced (stabilized) to 
114 by averaging every five neighboring variables. After stepwise selection, frequencies of 1053, 
1219, 1422, 1446, and 1460 cm
-1
 are found to be the most significant discriminators. Results for 
the logistic regression model using these five frequency variables are listed in table 4.  
The AUC and specificities for 95%, 90%, and 80% sensitivities obtained using linear re-
gression and PLSR models are all close to 1.0 (table 4), again indicating excellent discrimination 
capability between spectra from uninfected and infected cellular samples. Applying the calcu-
lated models to new validating data, the AUC is now calculated to be 0.689 (logistic regression) 
or 0.986 (PLRS). It appears that the linear regression model fails but the partial least squares re-
gression model excels. Similarly, for the logistic regression model, for 95%, 90% and 80% sensi-
tivities, specificities of 0.208, 0.375, 0.465, respectively are calculated, representing poor dis-
crimination. For the PLSR model, however, specificities of 0.938, 0.975 and 0.975 are calcu-
lated, representing excellent discrimination. Clearly the PLSR model is more appropriate when 
one is interested in merely differentiating infected from uninfected cellular samples. This result 
is likely because the PLSR method considers linear combinations of all of the variables while the 
logistic regression method considers only certain variables that may be appropriate for one type 
of infection but less so for another type.  
Discussion  
Above we have used advanced statistical methods to demonstrate outstanding discrimina-
tion of spectra obtained for mock and viral infected cellular suspensions. These methods are 
poorly understood by most non-statisticians, and it is worth considering whether there are visual-
ly identifiable features in the spectra that can be used for discrimination.  
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Although the error bars on the two spectra in figure 2E or F overlap at nearly all frequen-
cies, the averaged spectra for mock and HSV-1 infected samples (figure 2E) appear readily dis-
tinguishable in several frequency regions: 1/ Spectra for mock infected cells display higher ab-
sorbance in the ~892-800 cm
-1
 region than spectra for HSV-1 infected cells. 2/ Between ~1141-
1022 cm
-1
 mock infected samples display higher absorption than HSV-1 infected samples. 3/ Be-
tween ~1211-1302 cm
-1
 mock infected samples display higher absorption than HSV-1 infected 
samples. 4/ Between ~1302-1386 cm
-1
 mock infected samples display lower absorption than 
HSV-1 infected samples. 5/ Between ~1409-1500 cm
-1
 mock infected samples display lower ab-
sorption than HSV-1 infected samples. Such observations are consistently made over several ex-
periments (not shown). Similar, but less pronounced observations can be made upon comparing 
the averaged spectra for mock and Ad-5 infected samples (figure 2F).  
Comparison With Previous Studies For the mock infected cell spectra in figure 2E (and 
2F), for all 728 frequency points, the mean standard deviation (average error bar length) is 
0.08341 while the minimum/maximum standard deviation is 0.02027/0.17625, at 905/1090 cm
-1
, 
respectively. In contrast, previous studies on Vero cell suspensions have estimated a standard 
deviation of +/-0.001 
7, 8
. We have not been able to generate such highly reproducible spectra 
using the data collection approach outlined here.  
Salman et al., (2002)
5
 studied Vero cells infected with HSV-1 at an MOI=0.5, at one or 
three days post infection. Salman et al., (2002)
5
 used trypsin to dissociate the cellular monolayers 
from the growth medium. We have found that there is even greater variation in the averaged 
spectra for samples prepared using trypsin treatment. We have therefore avoided such a proce-
dure. We prefer to scrape cells from the surface of the growth medium.  
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Salman et al., (2002)
5
 observe a very large change in a band near 1080 cm
-1
, which they 
associate with cellular phosphates. We believe that it is more likely that the changes attributed to 
viral infection by Salman et al., (2002) are associated with different scattering effects associated 
with uninfected and infected material, and possibly due to preprocessing induced artifacts asso-
ciated with baseline correction and normalizing spectra to the amide I absorption band. This lat-
ter point is particularly important, as it has been shown recently that the amide I peak position, 
width and intensity is particularly sensitive to dispersion type artifacts 
2, 19
.  
Erukhimovitch et al., (2004)
7
 also used a trypsin treatment to prepare Vero cell suspen-
sions infected with HSV-1. These authors compared uninfected Vero cells with cells that had 
been infected with HSV-1 at an MOI=1.0 at 48 hpi. Erukhimovitch et al., (2004) indicate that 
infected cells have a much higher absorption in the 1200-1400 cm
-1
 region compared to control 
cells (see also Huleihel et al.
6
). This result is not in keeping with our data, which show that the 
HSV-1 infected samples display decreased absorption in the 1211-1302 cm
-1
 region compared to 
control samples. Erukhimovitch et al., (2004) also observe a considerable infection induced de-
crease in absorption near 1023 cm
-1
. This result is also not in keeping with our data, which shows 
an isobestic point near 1023 cm
-1
. This is important since these authors use the change in absorp-
tion at 1023 cm
-1
 to probe HSV-1 infection development as well as to monitor how polysaccha-
rides effect infection development
6
.  
Finally, Erukhimovitch et al., (2004) indicate that a band at 862 cm
-1
 in control cells 
shifts gradually to 854 cm
-1
 upon infection with HSV-1. However, we do not observe a band at 
862 cm
-1
 in spectra of uninfected Vero cells. We do observe a band at 853 cm
-1
 (fig. 2D and F). 
However, this band does not shift in spectra obtained for HSV-1 infected cells.  
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In summary, it appears that nearly all of the observations attributed to HSV-1 infection 
by Erukhimovitch et al., (2004) disagree with our data. Too little data is presented in Erukhimo-
vitch et al., (2004) to speculate further on the origin of the discrepancies.  
Conclusions  
Infrared spectra obtained for Vero cells that are uninfected or infected with HSV-1 or Ad-
5 appear to be distinguishable even by eye (for MOI=10 and 24 hours post exposure). Using ad-
vanced statistical methods to analyze the spectra confirms this point in a quantitative fashion. 
Only two data sets are considered here for mock, HSV-1 and Ad-5 infected cells, this analysis 
does therefore not allow for a rigorous investigation of sample to sample variation. This aspect 
will be explored in a future publication.  
Acknowledgements  
This work was supported by the Department of the Army (U.S. Army Medical Research 
Acquisition Activity, Contract grant number: W81XWH-06-1-0795, and the Georgia Research 
Alliance. The opinions or assertions herein are the private views of the authors and are not to be 
construed as reflecting the views of the Department of the Army or the Department of Defense. 
We acknowledge Drs. Pinhas Fuchs and Chadi Filfili for critically reviewing this manuscript.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
43 
References  
1. M. Diem, S. Boydston-White and L. Chiriboga, Applied spectroscopy, 1999, 53, 148A-161A.  
2. G. Hastings, R. Wang, P. Krug, D. Katz and J. Hilliard, Biopolymers, 2008, 89, 921-930.  
3. J. R. Mourant, R. R. Gibson, T. M. Johnson, S. Carpenter, K. W. Short, Y. R. Yamada and J. 
P. Freyer, Physics in medicine and biology, 2003, 48, 243-257.  
4. J. R. Mourant, Y. R. Yamada, S. Carpenter, L. R. Dominique and J. P. Freyer, Biophys J, 
2003, 85, 1938-1947.  
5. A. Salman, V. Erukhimovitch, M. Talyshinsky, M. Huleihil and M. Huleihel, Biopolymers, 
2002, 67, 406-412.  
19  
6. M. Huleihel, M. Talyshinsky, Y. Souprun and V. Erukhimovitch, Applied spectroscopy, 2003, 
57, 390-395.  
7. V. Erukhimovitch, I. Mukmanov, M. Talyshinsky, Y. Souprun and M. Huleihel, Spectrochi-
mica acta, 2004, 60, 2355-2361.  
8. V. Erukhimovitch, M. Karpasasa and M. Huleihel, Biopolymers, 2009, 91, 61-67.  
9. V. Erukhimovitch, M. Talyshinsky, Y. Souprun and M. Huleihel, Methods Mol Biol, 2005, 
292, 161-172.  
10. V. Erukhimovitch, V. Pavlov, M. Talyshinsky, Y. Souprun and M. Huleihel, J Pharm Bio-
med Anal, 2005, 37, 1105-1108.  
11. B. Mohlenhoff, M. Romeo, M. Diem and B. R. Wood, Biophys J, 2005, 88, 3635-3640.  
12. M. Romeo, B. Mohlenhoff and M. Diem, Vib Spectrosc, 2006, 42, 9-14.  
13. M. Romeo, B. Mohlenhoff, M. Jennings and M. Diem, Biochimica et biophysica acta, 2006, 
1758, 915-922.  
14. T. Fearn, in Handbook of Vibrational Spectroscopy Volume III: Sample Characterization and 
Spectral Data Processing, eds. L. Chalmers and P. Griffiths, Wiley, Editon edn., 2002, vol. 3, pp. 
2086-2093.  
15. T. Tang, Masters Thesis, Georgia State University, 2008.  
16. P. J. McCarthy, Journal of the American Statistical Association, 1976, 71, 596-604.  
17. P. Geladi and B. R. Kowalski, Anal Chim Acta, 1986, 185, 1-17.  
18. R. D. Tobias, SAS Institute, Cary, NC, 2007,Technical Note ts509, p. 1-8.  
19. M. Romeo and M. Diem, Vib Spectrosc, 2005, 38, 129-132.  
 
 
 
 
 
 
 
 
44 
TABLE LEGENDS  
Table 1: AUC and specificities corresponding to sensitivities of 95%, 90% and 80% for mock 
vs. HSV-1 infected cellular samples.  
Table 2: AUC and Specificities for 95%, 90% and 80% sensitivities for Mock vs. Ad-5 spectra.  
Table 3: AUC and Specificities for 95%, 90%and 80% sensitivity for HSV-1 vs. Ad-5.  
Table 4: AUC and Specificities for 95%, 90% and 80% sensitivities, obtained for spectra of 
Mock vs. HSV-1 and Ad-5.  
 
Table 1 
Mock vs. HSV-1 
Logistic regression  
Initial Data (figure 2C, E)  After Shrinkage. 
Estimated Using 
Cross-validation  
Estimate 
From  
Validating 
Data  
Area under the curve (AUC)  0.970  0.963  0.935  
Specificity for 95% Sensitivity  0.899  0.820  0.950  
Specificity for 90% Sensitivity  0.957  0.938  0.950  
Specificity for 80% Sensitivity  1  0.989  0.950  
Partial Least Squares regression  
Number of Factors = 5. Percent Variation Accounted for by 5 Factors = 93.4  
Area under the curve (AUC)  1  0.983  0.989  
Specificity for 95% Sensitivity  1  0.999  0.974  
Specificity for 90% Sensitivity  1  1  0.975  
Specificity for 80% Sensitivity  1  1  0.988  
 
Table 2 
Mock vs. Ad-5  
Logistic regression  
Initial data  
(figure 2D, F) 
After Shrinkage. 
Estimated Using 
Cross-validation  
Estimate 
From  
Validating 
Data  
Area under the curve (AUC)  0.992  0.974  0.993  
Specificity for 95% Sensitivity  1  0.951  0.965  
Specificity for 90% Sensitivity  1  0.991  0.980  
Specificity for 80% Sensitivity  1  0.996  1  
Partial Least Squares regression  
Number of Factors = 4. Percent Variation Accounted for by 4 Factors = 95.8  
Area under the curve (AUC)  0.982  0.955  0.994  
Specificity for 95% Sensitivity  0.958  0.853  0.965  
Specificity for 90% Sensitivity  0.986  0.939  0.993  
Specificity for 80% Sensitivity  1  0.971  1  
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Table 3 
HSV-1 vs. Ad-5  
Logistic regression  
Initial data  After Shrinkage. 
Estimated Using 
Cross-validation  
Estimate 
From  
Validating 
Data  
Area under the curve (AUC)  0.978  0.969  0.882  
Specificity for 95% Sensitivity  0.984  0.955  0.646  
Specificity for 90% Sensitivity  0.987  0.977  0.759  
Specificity for 80% Sensitivity  0.987  0.981  0.848  
Partial Least Squares regression  
Number of Factors = 6. Percent Variation Accounted for by 4 Factors = 94.9  
Area under the curve (AUC)  1  0.992  0.913  
Specificity for 95% Sensitivity  1  0.997  0.603  
Specificity for 90% Sensitivity  1  0.998  0.734  
Specificity for 80% Sensitivity  1  0.999  0.911  
 
Table 4 
Mock vs. HSV-1 & Ad-5 
Logistic regression  
Initial data  After Shrinkage. 
Estimated Using 
Cross-validation  
Estimate 
From  
Validating 
Data  
Area under the curve (AUC)  0.993  0.980  0.689  
Specificity for 95% Sensitivity  0.971  0.939  0.208  
Specificity for 90% Sensitivity  1  0.975  0.375  
Specificity for 80% Sensitivity  1  0.991  0.465  
Partial Least Squares regression  
Number of Factors = 5. Percent Variation Accounted for by 4 Factors = 94.1  
Area under the curve (AUC)  0.990  0.973  0.986  
Specificity for 95% Sensitivity  0.942  0.877  0.938  
Specificity for 90% Sensitivity  0.986  0.956  0.975  
Specificity for 80% Sensitivity  1  0.990  0.975  
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FIGURE LEGENDS  
Figure 1: Transmission visible images collected at 2 locations for uninfected (mock) Vero cell 
suspensions on zinc selenide windows (the yellowish hue in the images is caused by the zinc se-
lenide windows). The images show regions near the edge of the sample suspension. IR light im-
pinges on the sample through only the central square region, which is ~100 μm on one side. The 
suspensions were prepared as described in the methods section, and air dried prior to measure-
ment. Images were subjected to contrast enhancing routines available in Adobe Photoshop 8.0.  
Figure 2: (A) IR absorption spectra in the 1500-800 cm
-1
 region, for (A) mock (black), and 
HSV-1 (red) infected samples and (B) for mock (black), and Ad-5 (red) infected samples. The 
mock infected cell spectra are the same in both A and B. All samples were obtained from a sin-
gle preparation run. For HSV-1 and Ad-5 infected samples the MOI is 10 and data were col-
lected at 24 hours post exposure. 69/79/93 spectra were collected for mock/HSV-1/Ad-5 infected 
samples. (C, D) The same spectra as in (A, B) after standardization. For standardization, the 
mean absorbance is subtracted from the spectrum, which is then divided by the standard devia-
tion. Standardization is equivalent to vector normalization except for a scale factor. (E, F) (Thick 
lines) Average of the spectra in (C, D). The error bars represent the standard deviation 
(plus/minus) of all of the spectra shown in (C, D) at each frequency. The inset in E shows an ex-
panded view of the 1360-1340 cm
-1
 region, where the error bars are more easily visualized.  
Figure 3: Z-statistic obtained from the Wilcoxon Rank Sum Tests plotted as a function of wave-
number for (A) mock vs. HSV-1, (B) mock vs. Ad-5, (C) HSV-1 vs. Ad-5 and (D) mock vs. 
HSV-1 & Ad-5. The blue curves are for the original data while the red curves are for the validat-
ing data collected at a later date. The frequencies that are predicted to be of highest significance 
are explicitly indicated.  
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2.2 Supplementary Information 
2.2.1  Hierarchical Cluster Analysis (HCA)  
In addition of the logistic regression and partial least square regression, we also employed 
Hierarchical Cluster Analysis (HCA) to the same data sets described previously. The description 
of this method can be found in chapter one.  All data processing and image assembly were per-
formed by the program CytoSpec [29]. This program differs from software products available 
from instrument manufacturers in that it was designed and written to operate on entire spectral 
(imaging) data sets, rather than individual spectra[41]. 
We compared spectra between mock infected and virus infected (HSV1 and Adv-5) sam-
ples using CytoSpec. Additionally, we constructed comparisons between the raw data and nor-
malized data (vector normalized).  The raw and vector normalized data, consisting of 64 spectra 
of uninfected samples (mock), 65 spectra of samples infected with HSV1 or 81 spectra of sam-
ples infected with Adv-5, were loaded into CytoSpec in the wavenumbers range of 1500–800 
cm
-1
. 
All spectra were processed using Hierarchical cluster analysis (HCA). First, an initial in-
ter-spectral distance matrix was calculated using a D-Values algorithm (Equation 2.2.1.1). These 
distance matrices were then clustered into two groups using Ward’s Algorithm[42].  
       
 
        
                                   (2.2.1.1) 
We also employed the technique of HCA imaging, as illustrated in Figure 2-1. The den-
drogram representing different clusters can be seen on the left. On the top- right side is the chem-
ical map corresponding to the spectral intensity. On the bottom-right is a final HCA map pro-
duced by cluster analysis. 
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Figure 2-1 CytoSpec program process of the HCA imaging approach 
 
 
2.2.2 Results 
The results of the HCA cluster imaging approach are illustrated in Figure 2-2 below. Pic-
ture A: IR images of a two-class classification trial, using the raw data of Mock (first 64 spectra) 
and samples infected with HSV1 (last 65spectra). Picture B:  IR images of a two-class classifica-
tion trial, using the raw data of Mock (first 64 spectra) and samples infected with Adv-5 (last 
81spectra). Picture C: IR images of a two-class classification trial, using the vector normalized 
data of Mock (first 64 spectra) and samples infected with HSV1 (last 65 spectra). Picture D:  IR 
images of a two-class classification trial, using the vector normalized data of Mock (first 64 
spectra) and samples infected with Adv-5 (last 81spectra). Predicted Mock is red and infected 
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samples are in blue (HSV1 and Adv-5). If our HCA algorithm were to have worked with a100% 
specificity and sensitivity, the image of Figure 2-2A should have the first 64 blocks in red 
(representing the first 64 Mock spectra input) and followed with 65 HSV1 all in blue. However, 
we have red and blue blocks intermingled, which indicates that our specificity and sensitivity are 
not 100%. Based on Figure 2-2 and Equations 1.3.5.6 and 1.3.5.7, we can calculate the specifici-
ty, sensitivity and area under the curve for this dataset. Results are shown in Table 2-1.  
As mentioned previously, an AUC between 0.80 and 0.90 represents good discrimination; 
AUC between 0.70 and 0.80 represents fair discrimination; AUC between 0.60 and 0.70 
represents poor discrimination; and AUC between 0.50 and 0.60 represents no discrimination. 
From the results shown in Table 2-1, we have good discrimination between Mock and HSV1 for 
the raw data set, and fair discrimination for all the rest. From the results of AUC, it is hard to 
claim that vector normalization can improve the results of the data analysis. 
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Figure 2-2 IR imaging of samples by HCA clustering 
 
 
 
Table 2-1 The specificity, sensitivity and area under the curve for the HCA results 
Comparison 
group 
Raw Data Vector normalized data 
Specificity% Sensitivity% 
Area under 
the curve 
(AUC) % Specificity% Sensitivity% 
Area under 
the curve 
(AUC)% 
Mock(64) vs 
Hsv1(65) 
(64-2)/64 
=96.8 52/65=80 
 
89.4 64/64=100 37/65=56.9 
 
78.5 
Mock(64) vs 
Adv5(81) 
(64-2)/64 
=96.8 
38/81 
=46.9 
 
71.8 
(64-2)/64 
=96.8 39/81=48.1 
 
72.4 
  
B A 
C D  
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3 STUDIES OF VIRAL INFECTED CELLS AT 8 12 AND 24 HPE  
3.1  FTIR Micro-spectroscopy for Studies of Viral Infected Cells 
Abstract 
Fourier transform infrared (FTIR) microscopy is a promising analytical tool for detecting 
changes associated with viral infection in cells.  
In this study, we used FTIR microscopy to study Vero cells infected with herpes simplex 
type 1 (HSV1), which afflicts both humans and animals. We performed 11, 10 and 18 indepen-
dent experiments (trails) at 8, 12 and 24 hours post exposure (hpe), respectively, with spectra of 
mock infected (uninfected) and HSV1 infected cells. Spectral bands show consistent differences 
within trials between spectra of mock infected and HSV1 infected cells and between HSV1 in-
fected cells at 8, 12 and 24 hpe.  
We found absorbance intensity differences between mock and HSV1 spectra within trials 
at 1244 cm
-1
, 1450 cm
-1
 and 1424 cm
-1
. The best region for monitoring the progression of HSV1 
infection in Vero cells is in the ~1100-1000 cm
-1
 spectral region. The most notable feature is that 
the “HSV1 minus Mock” FTIR difference spectra change sign for samples between 12 and 24 
hpe. From the difference spectra alone, it is possible to distinguish between spectra from HSV1 
infected and mock-infected samples within trials at 8, 12 and 24 hpe. 
Furthermore, FTIR spectroscopy in combination with multivariate statistical analysis 
provides a very important insight into HSV1 infected and mock-infected sample identification. 
The high specificities under different sensitivities, very low shrinkage and high AUC all indicate 
that we can discriminate between spectra from HSV1 infected and mock-infected samples. 
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Introduction 
Infrared (IR) micro-spectroscopy of cells in culture is a rapidly growing area of biologi-
cal/medical research, the goal of which is to spectrally distinguish between cells in different phy-
siological states [16, 43]. One hypothesis that has gained traction recently is that IR micro-
spectroscopy can rapidly and accurately differentiate between uninfected cells and cells that have 
been infected with viruses. In this sense the cell is a sentinel or biosensor that signals the pres-
ence of the virus or pathogen. One crucial feature of the cell as a biosensor is that it has its own 
built-in signal amplifiers, which are the phosphorylation kinase cascades that occur upon infec-
tion. This gives rise to opportunities then for pathogen discrimination.  
Rapid and accurate detection of viral infections is of importance not only in the realms of 
disease detection in humans, animals and plants, but also in the realm of homeland security, 
where a rapid detection and diagnosis of airborne and environmental biological agents is desira-
ble.  
Here we focus on viruses that infect humans, and use herpes simplex virus (type 1) 
(HSV1) as our model system. Our biosensor is the African green monkey kidney cell (Vero cell). 
So, Vero cells act as sensors of HSV1 infection, responding to the virus with morphological or 
biochemical changes that we detect spectroscopically.  
HSV1 is predominantly involved with infections of the skin and central nervous system, 
and is difficult to distinguish from other possible infections caused by bacteria or fungi, particu-
larly at the early stages of the infection. Isolation of the virus in cell culture and immunoassays 
are the main methods for the detection of herpes virus infections. Such methods are time-
consuming and relatively expensive, and an alternative faster approach is desirable.  
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Recently, we have begun exploring the application of FTIR spectroscopy for detection of 
HSV1 [44], building on the work of others [5, 6, 15]. Previously, we showed that spectra col-
lected from different spots on dried Vero cell suspensions were highly variable. This was in 
agreement with other work that showed that even the spectra from single cells could vary greatly 
[45].  The question we addressed was: given this spectral variability, could we still discriminate 
between infected and uninfected cells? In addition, we also addressed the question of how sensi-
tive and how specific our approach was. We used logistic and partial least squares multivariate 
regression methods and found that for Vero cells infected with HSV1 at an multiplicity of infec-
tion (MOI) of 10 at 24 hours after exposure, we could discriminate uninfected and HSV1 in-
fected cell suspensions with very high levels of sensitivity and specificity. We also found that we 
could apply statistical models obtained using one data set to other data sets and still achieve high 
levels of discrimination between uninfected and infected cellular suspensions. Thus two data sets 
were used, one to first build a statistical model and then a second to validate the constructed 
model.  
Since this previous work we have repeated the above described experiments, up to as 
many as 17 times, and it appears that there is or could be a greater degree of inter-experimental 
spectral variability that could not be adequately assessed using only two data sets. In this manu-
script we consider the process of spectral discrimination of infected and uninfected cells with due 
consideration given to the presence of both inter and intra-experimental spectral variability. This 
led us to repeat each experiment as many as 17 times. From these measurements we are able to 
determine if discrimination is feasible in the face of both inter and intra-experimental spectral 
variability. 
58 
Previously we used advanced multivariate regression methods to analyze the spectral da-
ta. Given the very high levels of sensitivity and specificity achieved we decided to test alterna-
tive, simpler statistical methods of data analysis in order to compare the various approaches.    
In previous measurements we considered data collected at 24 hours post exposure. In this 
paper we consider the possibility of more rapid detection of HSV1 infections in cells and we 
consider spectra obtained for cells at 8 and 12 hours post exposure. In addition the question of 
whether the spectral changes are the same or display a temporal profile is addressed.  
 
Materials and Methods 
Vero cells (American Type Culture Collection #CCL-81) were grown as described pre-
viously[44].  For HSV1 infections cells were incubated in infected cell lysate at an MOI of 10 for 
one hour. Cells were then washed and reincubated for a further 8, 12 or 24 hours in virus free 
RPMI medium, as described previously [44].  
Tyrosine and threonine phosphorylation of several proteins were known to be induced at 
4 and 6 hours post exposure (hpe) in infected cells. 
After incubation for 8, 12 or 24 hours, the cells were washed in PBS containing calcium 
and magnesium and scraped into the same buffer, as described. The cells were centrifuged at 800 
g and resuspended in 5 μl of the fresh PBS. Samples were pipetted onto ZnSe windows, and air 
dried.  
FTIR spectral data collection was identical to that described previously [44].  Data was 
collected in the 2000-800 cm
-1
 region but was truncated after collection to consider only the 
1500-800 cm
-1
 region. Spectral data was collected at 2 cm
-1
 resolution. For any particular expe-
riment spectra collected were vector normalized and then averaged.   
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Results 
We have collected spectra for mock and HSV1 infected cellular suspensions at 24, 12 and 
8 hours post exposure. Transmission visible images of the samples were similar to those pre-
sented previously [44]. Figures 1A, 1B and 1C show vector normalized FTIR spectra for mock 
and HSV1 infected samples at 24 (A), 12 (B) and 8 (C) hours post exposure (hpe), respectively. 
Spectra were collected for 11, 10 and 18 independently prepared mock and HSV1 infected sam-
ples, respectively. The spectra have been shifted vertically for comparison. Figures 1C, 1D and 
1F show the same spectra as in 1A, 1B and 1C without the vertical shifting. Both views are re-
quired for an evaluation of the inter-experimental spectral variability. Certain spectral trends are 
observed in nearly all experiments on cells at 8, 12 or 24 hpe. These spectral trends differ for the 
three time points, however (see below).  
To better visualize the similarities and the differences in the spectra in Figure 1, Figure 2 
shows averaged spectra. If HSV1 and mock can be differentiated from the dataset, there will be a 
difference between the mean of the spectra density of HSV1 and mock. Therefore, Figure 2A 
compares average spectra for mock infected cells at 8, 12 and 24 hpe. The most noticeable spec-
tral differences are around 1243 cm
-1
, 1083 cm
-1
 and below ~854 cm
-1
. In addition, the peaks of 
the 1243, 1342, 1455 and 1467 cm
-1
 bands are slightly decreased in the spectrum from mock 
cells at 8 hpe compared to the bands in the spectrum of mock cells at 12 and 24 hpe.  
Figure 2B compares the averaged spectra for mock cells at 24 hpe with the spectra for 
HSV1 infected samples at 8, 12 and 24 hpe. The spectra for HSV1 infected cells clearly differ at 
8, 12 and 24 hpe. This is most clearly observed for the peak near 1083 cm
-1
, which increas-
es/decreases in intensity in the spectra of HSV1 infected cells at 8 and 12/24 hpe, respectively.  
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In the 1300-1500 cm
-1
 region, for the spectra obtained at 24 hpe, the spectra for HSV1 in-
fected cells display increased absorption intensity compared to the spectra for mock samples. 
This behavior is observed in 16 of the 18 experiments (Fig. 1A). Such an observation is less 
clear-cut for the spectral data at 12 hpe. It is also not totally clear in the spectra in Figure 2B. To 
better visualize the spectral differences between the mock and HSV1 infected cells at the differ-
ent time points Figures 3A, 3B and 3C show the “HSV1 minus mock” FTIR difference spectra 
for the 24 , 12 and 8 hpe data, respectively. Figures 3A, 3B and 3C demonstrate considerable in-
ter- experimental spectral variation. To more easily visualize the similarities and differences in 
the spectra at 8 12 and 24 hpe, Figure 3D shows the average of the 8 hpe (green), 12 hpe (blue) 
and 24 hpe (black) “HSV1 minus mock” FTIR difference spectra. Figure 3D demonstrates dif-
ferences in the spectra for HSV1 infected cells at 8, 12 and 24 hpe, particularly so in the 1169-
989 cm
-1
 region, and below ~889 cm
-1
.   
 
Multivariate Statistical Analysis   
Visual inspection of the collected spectra (Fig.1 A-C) shows significant variation be-
tween measurements obtained on different days.  This variation is considerably larger than ex-
pected from previous results from only two data sets[46].  The cause and impact of this issue is 
not yet fully understood, though it is apparent that we need to reevaluate our choice of statistical 
method(s). It should be noted that this variation is present despite our efforts to standardize the 
data collection procedure.  
In order to eliminate the influence of this day-to-day variability, we must average all the 
spectra (~50-70) obtained in a day and treat the single averaged spectrum as an independent ob-
servation.  By doing so, we reduce the sample size dramatically and also limit the statistical me-
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thods we can choose.  For example, the statistical methods which simply compare the means of 
two groups (mock vs. HSV1) will not work sufficiently with our data sets due to the small sam-
ple size.  
Before applying the in-house multivariate statistical analysis, two steps must first be tak-
en. These are the standardization and the smoothing of the spectra. Standardization entails sub-
tracting the mean from an individual intensity and then dividing this difference by the standard 
deviation of the sample population. Smoothing of the spectra involves summing and averaging 
each four adjacent data points together. The spectral range is from 1500 cm
-1
 to 800 cm
-1
 and 
contains 728 data points. The smoothing procedure reduces these 728 variables by a factor of 
four into 182, which increases the reliability of the results of our statistical method.    
 After the standardization and smoothing, data in each day for each kind (mock or HSV1) 
were randomly split into two even groups and each group was then averaged into one spectrum.  
Two types of difference spectra can be calculated after this step.  One type of difference spec-
trum, called inner difference, is obtained by taking the difference between two groups for a sin-
gle kind within each day (Fig. 4: inner 1 and inner 2).  The second type of difference spectrum, 
called intra difference, is obtained by subtracting the HSV1 spectra from mock for each group 
within each day (Fig. 4: intra 1 and intra 2).  Thus, for each day of data at each time post expo-
sure (8, 12 or 24 h) we produce two intra and two inner difference spectra. Note that the inner 
difference spectra would ideally be flat and featureless, while the intra spectra should not.     
Statistical methods can then be performed on the inner and intra difference spectra. Since 
we are assuming the inner differences are zero, and since we are comparing intra spectra to the 
inner spectra, we are essentially seeing how the intra spectra differ from zero. Thus, a one sam-
ple test, the Wilcoxon Signed-Rank Test (WSRT), would be more appropriate than a two sample 
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test, the Wilcoxon Rank Sum Test (the Mann-Whitney Test) that we used previously [46]  for 
picking the most significant wavenumbers. 
Figure 7 shows the p-value results from the WSRT.  The significant wavenumbers were 
determined according to the Bonferroni correction [47].  The criterion of p-value is equal to 5% 
divided by 182 (the number of variables), which is nearly 0.0002.  Therefore, only wavenumbers 
with a p-value < 0.0002 were selected. This selection criterion applies to all the data - inner and 
intra difference. It should be noted that the same wavenumbers were not selected for in different 
datasets.  
We then applied Partial Least Square Regression (PLSR) [48] only on the selected wave-
numbers. According to central limit theory, since we averaged the datasets, we can calculate sen-
sitivity, specificity and Area Under the Receiver Operating Characteristic (ROC) Curve (AUC) 
based on the predicted values of the results from PLSR for the observed datasets.  
Since our data size is not large enough to represent the whole population, shrinkage [49] 
becomes an important indicator for the future performance of this model in discriminating the 
unknown future data. Shrinkage is defined as the difference between the specificities (or sensitiv-
ities) of two data sets: the population and the observed sample.  In order to estimate the 
shrinkage, we caculated the difference between the specificities of the model data sets and test 
data sets.  
We employed two methods to determine the model and test datasets. First, we applied 2-
fold cross validation, which normally gives an under-estimated shrinkage. The intra or inner dif-
ferences were split into model and test groups, called model intra and test intra or model inner 
and test inner. We applied WSRT only on the model intra data to determine the significant fre-
quencies. PLSR was then applied to the selected frequencies for model intra and model inner da-
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ta sets.  By applying the same discriminators for PLSR as for the model intra and inner sets, we 
were able to calculate the predicted values for the test sets. We calculated sensitivity, specificity 
and AUC from the predicted values of PLSR for both model and test sets. By finding the differ-
ence between these two specificities, we obtained estimates of the shrinkage (Table 1, Column 
3). Specificity of Cross Validation (Table 1, Column 4) was calculated by subtracting this shrin-
kage (Table 1, Column 3) from the specificity for original data (Table 1, Column 2). 
The second method we used to determine the model and test datasets was the bootstrap 
method, which normally gives an over-estimated shrinkage. Model datasets for bootstrap were 
caculated by constructing a number of resamples. Resampling entails drawing randomly with 
replacement from a set of data points of the observed dataset, which are of equal size to the 
original observed datasets. Test datasets refers to the original observed dataset. By applying 
WSRT only on the model intra data, we determined the siginificant frequncies. PLSR was then 
applied to the selected frequencies for model intra and inner data. By applying the same 
discriminators for PLSR as for model datasets, predicted values of PLSR were caculated for the 
test datasets. Following the same procedures as for CV, we caculated column 5, shrinkage from 
Bootstrap, and Column 6, Specificity caculated using Bootstrap. Col 6 was obtained by 
subtracting column 5 from column 1.  NOTE: format the ending sentences of the last two 
paragraphs the same way. 
By finding the average of these two specificities, as in column 7, we can have fairly 
accurate final specificities and AUC for three different sensitivities. All multivariate analysis was 
performed using SAS 9.1 (SAS Institute Inc., Cary, NC, USA). 
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Discussion 
A visual inspection of the spectra reveals some differences in the spectra of mock 
infected samples at 8, 12 and 24 hpe. This may not be expected. However, the Vero cells grow as 
monolayers, and 24 hpe is one full day of growth of cells once they have already formed a 
confluent monolayer. We have observed the very beginnings of cytopathic effects in the 
monolayers in visible images of mock samples at 24 hpe. It may therefore not be totally 
surprising that there are minor differences in the spectra in Figure 2A again showing that our 
data has potential variation between days. The difference between the spectra for mock samples 
in Figure 2A can be considered as a measure of the noise in the experiments (admittedly the 
spectrum for the mock sample at 24 hpe in Figure 2A is the average of nearly 700 spectra spread 
over 17 measurements). In addition, each of the nearly 700 spectra results from the co-addition 
or average of 64 interferograms.  
The spectra in Figures 1D, 1E and 1F show that there is not a single frequency in the 800-
1500 cm
-1
 region where all of the spectra for mock samples display a lower or higher absorbance 
than that found in all of the spectra for HSV1 samples.  In fact, the inner-experimental spectral 
variability (mock in day 2 minus mock in day 1) is not considerably less than the intra-
experimental spectral (HSV1 in day 1 minus mock in day 1) variability (compare Figure 1C in 
this manuscript with Figure 2C in our previous manuscript [44]). This is in spite of the fact that 
we have taken some care in manually choosing the area of the sample suspension from which 
spectra are measured! We have measured FTIR spectra for 17 independently prepared mock and 
HSV1 sample suspensions for 24 hpe. This is a very large set of data by most standards. The 
conclusion is that simple spectral comparisons will not greatly improve the sensitivity and 
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specificity with which we can distinguish spectra associated with mock and HSV1 infected 
samples.  
There are some very clear trends in the spectra in Figure 1D (the trends are less clear in 
the spectra in Figures 1E or 1F). From Table 1, the application of advanced multivariate 
statistical methods have shown that very high levels of sensitivity and specificity (near equal to 
100%) in discriminating spectra from mock or HSV1 infected samples at 8,12 and 24 hpe 
(MOI=10) are possible when large numbers of frequencies are simultaneously considered [44], 
and we have an excellent discrimination between mock and HSV1 for all 24, 12 and 8 hpe. One 
conclusion that can be drawn is that even though we cannot monitor the large differences in the 
spectra between the mean of the infected and uninfected samples, by applying the right statistical 
analysis, and we can still discriminate the two samples successfully with a very high certainty.  
Principle component fed liner discriminate analysis with leave-one-out cross validation 
(PCA with LOOCV) [50] is another method that has been applied to do the discriminating 
analysis between two or more groups. We believe this is an inappropriate method to use when 
the datasets consist of several measurements in different days. Even the improved result from 
this method does not indicate better discrimination. Since our data had a large variation day-to-
day, spectra within each day were not treated as independent measurements. Therefore, cross 
validation with just leaving one single spectrum, but not the spectra from at least a whole day, 
out each time for LDA is no longer a fair validation method for our dataset. Furthermore, as we 
have shown, there exists significant variation between measurements obtained on different days. 
It is thus very important to measure samples on different days in order to properly represent the 
real population.  
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In all of the experiments undertaken, spectra were collected for both mock and HSV1 
infected samples that were prepared at the same time. A question one could ask: Is it possible to 
use an arbitrary spectrum for mock samples (from Figure 1A or 1B or perhaps the averaged 
spectrum in Figure 2A) and use it as a standard for assessing if an unknown spectrum came from 
a mock or HSV1 infected sample? It is off course possible to follow this procedure. The real 
question is, however, what kind of specificity and sensitivity could be associated with following 
such a procedure? The question can also be considered as, can we build spectral libraries using 
the spectra in Figure 2A as standards? If we do this, what level of specificity and sensitivity 
could be associated with assigning an arbitrary spectrum from an unknown sample? 
Another conclusion we may draw is that it is not possible to take a mock spectrum from 
any particular day’s measurements and use it as a standard for comparison to spectra for HSV1 
infected samples on different days. The important conclusion is that spectra for mock and HSV1 
infected samples need to be collected together for a proper analysis.  
If spectra are always collected for mock and infected samples together then some clear 
conclusions can be derived from the “HSV1 minus mock” FTIR difference spectra (DS) in 
Figures 3A, 3B and 3C. Firstly, for cells at 24 hpe, the FTIR DS in all 18 experiments display a 
negative intensity at ~1056 and ~1227 cm
-1
, and a positive intensity at ~1450 and 1424 cm
-1
. 
These therefore appear to be very good frequencies for distinguishing spectra from mock versus 
HSV1 infected samples at 24 hpe, at an MOI of 10. The same kind of simple analysis can be 
applied to the FTIR DS in Figure 3B or 3C and different significant frequencies can be 
established.  
From the FTIR DS in Figure 3D, if a positive signal is observed over the whole of the 
1300-1500 cm
-1
 region then we are likely dealing with HSV1 infected cells that are near 24 hpe 
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(at MOI=10). Furthermore, as can be seen in Figure 3D, a trend of decreasing intensity of the 
difference spectra between HSV1 and mock can be detected as the time post-infection decreases 
from 24 to 8 hpe. 
The FTIR DS in Figures 3A-3D indicate that by far the best region for monitoring the 
progression of HSV1 infection in Vero cells is in the ~1100-1000 cm
-1
 spectral region. The most 
startling feature is that the FTIR DS changes sign for cells at 8 and 12 or 24 hpe.  around 1100 
cm
-1
(see Figure 5),  making this a very significant area. 
It is clear from the spectra in Figure 2B that spectral changes caused by HSV1 infection 
in Vero cells are quite small. Only small intensity changes are observed, and no band frequency 
shifts are observed. This is in spite of the fact that the MOI is 10. For an MOI of say 1.0 we 
could suggest that the spectral changes caused by infection would probably be insignificant at 24 
hpe, and could probably only be inferred by applying multivariate statistical methods to the 
analysis of the spectral data. Interestingly, however, Salman et al [51] have produced FTIR 
spectra for uninfected Vero cells and Vero cells infected with HSV1, at an MOI of 1.0, at 24 hpe. 
The spectral differences between mock and HSV1 infected cells at 24 hpe at an MOI=1.0 are at 
least as large as the changes observed for an MOI=10.  
Erukhimovitch et al. 2004 [6] also obtained FTIR spectra for Vero cells infected with 
HSV1, at an MOI=1.0 at 24 hpe. After baseline correction of the spectra and then vector 
normalization, these authors found that HSV1 infection led to the loss of a band at 1023 cm
-1
 [5, 
6]. The 1023 cm
-1
 band was assigned to carbohydrates, apparently because glycogen in water 
was shown (using a diamond ATR accessory) to display a band at 1025 cm
-1
 [52].  A band at 
1023 cm
-1
 is not observed in our spectra for HSV1 infected Vero cells at 24 hpe, at an 
MOI=10.0.  
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APPENDIX 
 
 
 
Figure 1: FTIR spectra collected for mock (black) and HSV1 (red) infected cells at 24 
(A), 12 (B) and 8 (C) hours post exposure, for 18 (A) , 10 (B) or 11 (C) independent experi-
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ments. Cells were infected with HSV1 at an MOI of 10 for one hour, and then washed. Cells 
were then incubated for a further 24/12 hours in virus free RPMI medium. Each spectrum shown 
is the average of 25-70 spectra collected for each sample suspension. The spectra were vector 
normalized but not baseline corrected. Spectra have been shifted vertically. (D), (E), (F) Same 
spectra as in (A), (B), (C) except the spectra have been shifted vertically.  
 
 
 
           
Figure 2: (A) Average of the spectra for mock cells in Figure 1 at 8 (blue), 12 (red) and 
24 (black) hpe. (B) Average of the spectra for mock cells in Figure 2A at 24 (black) hpe. Also 
shown are the averages of the spectra for HSV1 infected cells (from Figure 1) at 8 (green), 12 
(blue) and 24 (black) hpe. 
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Figure 3: “Mock minus HSV1” FTIR difference spectra calculated for each of the expe-
riments at 24 hpe (A), 12 hpe (B) and 8 hpe (C) shown in Figures 1A, 1B and 1C, respectively. 
(D) Averaged “mock minus HSV1” FTIR difference spectra of the 8 hpe (red), 12 hpe (blue) and 
24 hpe (black) “HSV1 minus mock” FTIR difference spectra shown in Figure 2A,2B and 2C, 
respectively.  
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Figure 4: Simple methodology for the data preprocess and multivariate statistical analy-
sis.   
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Figure 5: “Inner verses Intra” FTIR difference spectra calculated for each of the experi-
ments at 24 hpe (A), 12 hpe (B) and 8 hpe (C) shown in Figure 1A, 1B and 1C with 36 (A) , 20 
(B) or 22 (C) difference spectra (inner or intra), respectively.  Inner is the difference spectra of 2 
groups of mock and HSV1, separately within each day (blue); Intra is the difference spectra be-
tween HSV1 and mock for 2 groups within each day (red).  We shifted each time point up for 
easy comparison. Around 1100 cm
-1
, 24 hpe has a different trend as opposed to 12 and 8 hpe, 
which also matches with our visual spectra comparison. Around 1200-1300 cm
-1
, all three time 
points have similar features for discriminating the intra from inner difference. This is also shown 
in Figure 5, from the overlay of all spectra from Figure 4. 
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Figure 6: Overlay of all spectra from Fig.4 with inner (black) and intra (red) for 24 hpe 
(Fig 5A), 12 hpe (Fig 5B) and 8 hpe (Fig 5C).  
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Figure 7: Plot for p-value results from WRST for all the wavenumbers between 1500 cm
-
1
 and 800 cm
-1
 for 24 hpe (black), 12 hpe (red) and 8 hpe (blue).  The black horizontal line 
equals 0.05. 
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Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 
Table A Specificity  
for original 
data 
Shrinkage 
from CV 
Specificity  
of cross va-
lidation 
(CV) 
Shrin-
kage 
from BT 
Specifici-
ty  of 
boots trap 
(BT) 
Average of Spe-
cificity between 
CV and BT 
Sensitivi-
ty=95% 
1 0.080277 0.919723 0.00023 0.99977 0.959746 
Sensitivi-
ty=90% 
1 0.026015 0.973985 1.66E-06 0.999998 0.986992 
Sensitivi-
ty=80% 
1 0.004561 0.995439 3.98E-09 1 0.997719 
AUC 1 0.015039 0.984961 0.001159 0.998841 0.991901 
       
Table B Specificity for 
original data 
Shrinkage 
from CV 
Specificity  
of cross va-
lidation 
(CV) 
Shrin-
kage 
from BT 
Specifici-
ty  of 
boots trap 
(BT) 
Average of Spe-
cificity between 
CV and BT 
Sensitivi-
ty=95% 
1 0.075582 0.924418 0.000114 0.999886 0.962152 
Sensitivi-
ty=90% 
1 0.027846 0.972154 1.36E-06 0.999999 0.986076 
Sensitivi-
ty=80% 
1 0.006184 0.993816 3.63E-09 1 0.996908 
AUC 1 0.013466 0.986534 0.00133 0.99867 0.992602 
       
Table C Specificity for 
original data 
Shrinkage 
from CV 
Specificity  
of cross va-
lidation 
(CV) 
Shrin-
kage 
from BT 
Specifici-
ty  of 
boots trap 
(BT) 
Average of Spe-
cificity between 
CV and BT 
Sensitivi-
ty=95% 
1 0.386616 0.613384 0.008434 0.991566 0.802475 
Sensitivi-
ty=90% 
1 0.181079 0.818921 0.001652 0.998348 0.908635 
Sensitivi-
ty=80% 
1 0.069068 0.930932 0.000101 0.999899 0.965416 
AUC 1 0.070872 0.929128 0.002237 0.997763 0.963445 
 
Table 1: Results from multivariate statistical analysis for 24 hpe (Table A), 12 hpe (Table B) and 
8 hpe (Table C). 
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3.2  Supplementary Information 
3.2.1 Principal Component Discriminant Analysis (PCA-LDA)  
The raw .csv files were processed using the PCA-LDA method as well as the leave-one-
out cross-validation method. All multivariate analysis was performed using SAS 9.1 (SAS Insti-
tute Inc., Cary, NC, USA).  
To analyze the dataset, principal component analysis (PCA) was first applied to the data 
set to reduce its dimensionality by computing the selected eigenvectors of the covariance matrix. 
Next, PCA scores were used as an input for linear discriminant analysis (LDA) in which the 
class variables corresponded to the differentiation treatments for vero cells (Mock=0, HSV1=1, 
ADV=2). Again, LDA was employed to project the PCA scores to a new space to find the most 
discriminative directions, which allowed the largest difference to be shown.  
As recommended in Babrah (2008), we also used first 25 PCs as input for LDA [30].  
The LDA results showed that our dataset had a good discrimination between different infections 
(Table 3.9), which proved that 25 PCs is enough for the discriminant analysis for this dataset. 
We also employed the same type of analysis for the T-cell data. It turned out that a much smaller 
number of PCs was needed, which I will expand upon in a later chapter. Therefore, how many 
PCs were chosen mostly depended on the dataset itself and required accuracies (Sensitivity, spe-
cificity or AUC).  
The classification accuracies were computed by performing the leave-one-out cross-
validation (LOOCV) method. LOOCV is the degenerate case of K-Fold Cross Validation, where 
K is chosen as the total number of spectra.  Leave-one-out cross-validation involves using a sin-
gle observation from the original sample as the validation data, and the remaining observations 
76 
as the training data. This is repeated such that each observation in the sample is used once as the 
validation data. 
 
3.2.2 Results 
The figures below are scatter plots for the first two LDA factors for 24h, 12h and 2h data. 
The horizontal axis is the first canonical component and vertical axis is the second canonical 
component produced from LDA.  The plot of first two LDA factors is a good representation of 
the efficacy of using the PCA-LDA to show the separation between two or three groups of data.  
For 24 hpe in Figure 3-1, the x-axis is the first canonical component and y-axis is the 
second canonical component produced from LDA.  Figure A is a scatter plot between mock 
(black) and HSV1 (red) infected samples. Figure B is a scatter plot between mock (black) and 
Adeno (red) infected samples. Figure C is a scatter plot between HSV1 (black) and Adeno (red) 
infected samples. Figure D is a scatter plot of  mock (black), HSV1 (red) and Adeno (green) in-
fected samples. For 12 hpe in Figure 3-2, the horizontal axis is the first canonical component and 
vertical axis is the second canonical component produced from LDA.  Figure A is a scatter plot 
between mock (black) and HSV1 (red) infected samples. Figure B is a scatter plot between mock 
(black) and Adeno (red) infected samples. Figure C is a scatter plot between HSV1 (black) and 
Adeno (red) infected samples. Figure D is a scatter plot among mock (black), HSV1 (red) and 
Adeno (green) infected samples. For 2 hpe in Figure 3-3, the x-axis is the first canonical compo-
nent and y-axis is the second canonical component produced from LDA.  Figure A is a scatter 
plot between mock (black) and HSV1 (red) infected samples. Figure B is a scatter plot between 
mock (black) and Adeno (red) infected samples. Figure C is a scatter plot between HSV1 (black) 
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and Adeno (red) infected samples. Figure D is a scatter plot among mock (black), HSV1 (red) 
and Adeno (green) infected samples. 
 
It is clearly indicated that there is a good separation between mock and HSV1 and also 
between HSV1 and Adeno infected samples (Fig.3-1 A and C), but for mock vs. Adeno, it is 
hard to distinguish them from each other (Fig.3-1 B and D). A similar trend can be observed in 
the sample of 12 hpe (Fig. 3-2), as well as the 2 hpe data. The overlapping in 2 hpe in Fig. 3-3 B 
is considerably more than in Fig. 3-3 A and C. The most significant feature is that as the infec-
tion time reduced, it became harder to distinguish between mock and Adeno infected samples, 
which agrees with the analysis results in previous paper [53]. 
In summary, it is possible to use canonical discriminant analysis to discriminate between 
these different infections by using two canonical components that are linear combinations of the 
PCs derived from spectral intensity. However, it should be noted that this analysis method cannot 
distinguish between all groups equally well. We speculate that there is not enough spectral dif-
ference between mock and Adeno infected samples for this method to be used effectively.  
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Figure 3-1 Plots of first 2 LDA factors for 24hpe 
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Figure 3-2 Plots of first 2 LDA factors for 12hpe. 
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Figure 3-3 Plots of first 2 LDA factors for 2hpe. 
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4 FTIR STUDIES OF VIRAL INFECTED CELLS AT 2 4 6 HPE  
4.1 FTIR Micro-spectroscopy for Studies of Viral Infected Cells at Different Hours Post 
Exposure 
 
Abstract 
Fourier transform infrared (FTIR) microscopy is a promising analytical tool for detecting 
changes associated with viral infection in cells.  
In this study, we used FTIR microscopy to study Vero cells infected with herpes simplex 
type 1 (HSV1). We performed a total of 63 independent experiments (trails) at 2, 4 and 6 hours 
post exposure (hpe) at 21 trials per time point, with spectra of mock infected (uninfected) and 
HSV1 infected cells. Spectral bands show consistent differences within trials between spectra of 
mock infected and HSV1 infected cells and between HSV1 infected cells at 2, 4 and 6 hpe.  
There were absorbance intensity differences between mock and HSV1 spectra within tri-
als at 1450-1300 cm
-1
, 1200-1000 cm
-1
, and 850-800 cm
-1
. The best region for monitoring the 
progression of HSV1 infection in Vero cells is in the ~1100-1000 cm
-1
 spectral region. The fea-
tures that the “HSV1 minus Mock” FTIR difference spectra change sign for cells between 4 and 
6 hpe is around 1460 cm
-1
, 1244 cm
-1
 and 920-860 cm
-1
. From the difference spectra alone, it is 
very possible to distinguish between spectra from HSV1 infected and mock-infected samples 
within trials at 2, 4, and 6 hpe. 
In our continuing research, we have found that FT-IR spectroscopy in combination with 
multivariate statistical analysis provides very important insights into the identification of HSV1 
infected and mock-infected samples. The high specificities under different sensitivities, very low 
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shrinkage and high AUC all indicate that we can discriminate between spectra from HSV1 in-
fected and mock-infected samples. 
 
Introduction 
Infrared (IR) micro-spectroscopy of cells in culture is a rapidly growing area of biologi-
cal/medical research, the goal of which is to spectrally distinguish between cells in different phy-
siological states [16, 43]. As was mentioned in the last chapter, there were many notable features 
found in the spectra, which could help distinguish mock infected from herpes simplex virus (type 
1) (HSV1) infected samples at 8, 12 and 24 hours post exposure (hpe), according to difference 
spectra analysis and statistical analysis.  Since rapid and accurate detection of viral infections is 
very desirable, here we shorten the post exposure time and focus on Vero cells infected by HSV1 
at 2, 4 and 6 hpe as our model system. Again, our biosensor is the Vero cell. Vero cells act as 
sensors of HSV1 infection, responding to the virus with morphological or biochemical changes 
that we detect spectroscopically.  
In previous measurements we considered data collected at 8, 12 and 24 hours post expo-
sure. In this paper we consider the possibility of more rapid detection of HSV1 infections in cells 
and we consider spectra obtained for cells at 2, 4 and 6 hours post exposure. In addition the ques-
tion of whether the spectral changes are the same between time points, or display a temporal pro-
file, is addressed.  
Previously, we showed that spectra have consistent differences within trials between 
spectra of mock infected and HSV1 infected cells and between HSV1 infected cells at 8, 12 and 
24 hpe around ~1100-1000 cm
-1
 , 1244 cm
-1
, 1450 cm
-1
 and 1424 cm
-1
 region. We also noticed 
features that the “HSV1 minus Mock” FTIR difference spectra change sign for samples between 
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12 and 24 hpe, which can be used to distinguish between spectra from HSV1 infected and mock-
infected samples within trials at 8, 12 and 24 hpe. We have repeated the above-described expe-
riments, up to as many as 18 times, and it appears that there is an increased degree of spectral 
difference as the infection time decreasing from 24 to 8 hours. This led us to repeat each experi-
ment as many as 21 times for shorter infection time points in order to observe the differences 
caused by infection.  
 
 Materials and Methods 
 Vero Samples Preparation 
African green monkey kidney cells (Vero cells, American Type Culture Collection 
#CCL-81) are treated as sample cells, and infected by different kinds of viruses (herpes simplex 
type 1 (HSV1), adenovirus type 5 (Ad-5), coxsackie virus and measles virus), which infect both 
humans and animals. The samples were 1 or 2 µl drops of sucrose gradient-purified HSV-1 in a 
buffer containing 10 mM tris, 150 mM NaCl and 1 mM EDTA, grown at 37 °C. Vero cells were 
grown at 37°C in DMEM (Mediatech) supplemented with 10% Fetal Plus Serum (Valley Bio-
medical), 5 µg/ml penicillin, and 5 units/ml streptomycin (Mediatech). Cells were seeded on 13 
mm diameter x 1mm thick zinc selenide (ZnSe) windows (for transmission experiments) that had 
been sterilized in 95% ethanol and air dried. The windows were immersed in the growth medium 
in 6 or 12-well cell culture plates. Approximately 7x10e5 viral particles were present in each 
sample. For HSV-1 strain F (purified), it was the lysate stock infecting the cells at a multiplicity 
from 10 PFU per cell (MOI=10). Tyrosine and threonine phosphorylation of several proteins 
were induced at 4 and 6 hpi in cells infected with purified virions. In cells infected with lysate 
viral stock, phosphorylation of ~35 kDa protein were likely induced by the cellular factors from 
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the infected lysate stock. At different (2, 4 and 6) hours post infection (hpi), the cells were 
washed in PBS containing calcium and magnesium and scraped into the same buffer and no tryp-
sin treatment was used for enzymatic disaggregation. The cells were centrifuged at 800 g and 
resuspended in 5 μl of fresh PBS. Samples were pipetted onto ZnSe windows, which are widely 
used due to their strong absorption in the IR wavenumber range, and cells were air dried.  The 
cells were examined under a light microscope for the appearance of the cytopathic effect (CPE) 
after 2, 4 or 6 hpi. The CPE is defined as the percentage of damaged cells in the focusing 
area[53]. 
Here is the detailed procedure for sample cell preparation. 
1- Seed 6-well plates overnight with ~ 700,000 cells/well in MEM supplemented with 10% 
FBS, 100 U/ml Pen-Strep and 2mM L-glutamine. The expected final count after O/N in-
cubation is 1 x 10
6 
cells per well. 
2- Next day virus suspensions are prepared at an MOI of 10 using HSV-1 as an example: 
a. HSV-1 (F; AAJA) titer = 4 x 108 PFU/ml. 
b. Number of cells per well = 106 cells 
c. Total cells in 6 wells (one for each time point) = 6 x 106 cells 
d. For MOI=10; PFU needed = 6 x 107 PFU 
e. Total Volume of stock of HSV-1 = (6 x 107 PFU) / (4 x 108 PFU/ml) = 0.15 ml. 
f. 6 ml of 2% heat inactivated FBS are added to 150 ul of stock, mixed by brief vor-
texing; media in 6-well removed and replaced with 1 ml of virus suspension. 
3- Note that for adenovirus the main stock adenovirus type 5 is 109 NAS units/ml.  Experi-
mentally it has been determined that the addition of 100 µl of this stock is able to com-
pletely infect 1 x 10
7 
cells. Therefore, 100 µl of the adenovirus stock is estimated to be an 
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MOI of at least 10 for each well. So 600 µl of stock are added to 5.7 ml of media and 
used to infect 6 wells, one for each time point. 
4- At 2 hours post infection, remove media containing virus from all wells and replace with 
2 ml of 2% FBS supplemented MEM. Infected cells from the 2h time point plate are also 
collected per the steps below at this time.   
5- Take pictures for CPE for documentation and remove media from wells of the 2 hour 
plate; replace with 1 ml of ice cold DPBS with Calcium and Magnesium per well. Using 
a cell scraper, scrape the monolayer into DPBS and transfer into 2 ml microcentrifuge 
tube with O-ring cap 
6- Centrifuge for 2 minutes at 2000 g. 
7- Wipe the ZnSe window with an isopropanol wipe if necessary and air dry on the biosafe-
ty cabinet grate. Divide the window into sections using a permanent marker pen. 
8- Remove all DPBS from the tube using vacuum attached to a Pasteur pipette; vortex the 
cell pellet briefly. 
9- Transfer 0.5 ul of the pellet and dot on the ZnSe window. Segregate dots into sections by 
virus type.  Let the dots air dry on the biosafety cabinet grate.   
10-  Take pictures of one dot for each virus; place the window in a clean container (e.g. 35 
mm culture dish), label with the time post infection, date and a scheme of the ZnSe win-
dow and dot distribution.  
11- Place in secondary clean container and transfer to Physics lab for FTIR analysis.  
12- Similar procedures were performed to cells with different MOI range from 0.31 to 10 
(MOI=0.31-10) for statistical analysis and unknown test.   
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 FT-IR Experiments and Instrumentations 
FTIR microscopy measurements were undertaken using a Varian 7000 FTIR spectrome-
ter (Varian, Lake Forest, CA) coupled to a Varian UMA600 IR microscope. The microscope was 
set up in transmittance mode. The microscope was equipped with a visible light source and CCD 
camera that allowed the collection of visible microscopic images from the same region that was 
sampled in the IR. The IR light was detected using a single element 0.25x0.25 mm mercury 
cadmium telluride (MCT) detector with high responsivity in the 4000–700 cm-1 region. Data was 
collected in the 4000-100 cm
-1
 region although the spectral band-width was limited to the 2000–
800 cm
-1
 region using a band-pass filter. All experiments reported here were undertaken at 2 cm
-1
 
spectral resolution.  
A spectrum was taken as an average of 64 scans. The aperture used in this study was 100 
μm2, which was found to yield the sample surface condition. Data were collected from the spec-
trometer using Varian’s Resolution software, which also computed the ratios of the sample and 
reference spectra, and then converted the data to absorbance type rather than transmission. Data 
was then exported in the Data Point Table format. 
Every sample mock infected or HSV1 infected had at least 5 spots, and we measured 
each spot at a minimum of 5 different areas (25 spectra at least). All FTIR experiments reported 
here were repeated 21 times on independently prepared samples on different days.  After the 
measurements, all the Varian files, which came directly from experiments, were truncated from 
1500cm
-1
 to 800cm
-1
 and converted into .csv format. All spectra were standardized and then av-
eraged together. Here, standardization is to the process of calculating the mean and standard dev-
iation of a spectrum.  The spectrum is then mean centered and divided by the standard deviation.  
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Standardization is equivalent to vector normalization to within a scale factor. Spectral processing 
and manipulation were undertaken using software like OPUS 4.0 (Bruker Optics, Billerica, MA), 
Origin 7.5 (OriginLab Corporation, Northampton, MA), Resolutions Pro 4.05 (Varian Inc., Palo 
Alta, CA), and Matlab 7.8 (The Mathworks Inc. Natick, MA).  
 
Results and Discussions 
We have collected spectra for mock and HSV1 infected cellular suspensions at 2, 4 and 6 
hours post exposure. Transmission visible images of the samples were similar to those presented 
previously [53]. Figures 4-1A, 4-1B and 4-1C show vector normalized FTIR spectra for mock 
and HSV1 infected samples at 2 (A), 4 (B) and 6 (C) hours post exposure (hpe), respectively. 
Twenty one spectra were collected for each independently prepared mock and HSV1 infected 
sample. The spectra have been shifted vertically for comparison. Certain spectral trends are ob-
served in nearly all experiments on cells at 2, 4 or 6 hpe. The most noticeable spectral differenc-
es are around 1243 cm
-1
 and 1083 cm
-1
. In these regions the intensity for HSV1 spectra are most-
ly higher than mock spectra.  
To better visualize the spectral differences between the mock and HSV1 infected cells at 
the different time points Figures 4-2A, 4-2B and 4-2C show the “HSV1 minus mock” FTIR dif-
ference spectra for the 2, 4 and 6 hpe data, respectively. Figures 4-2A, 4-2B and 4-2C demon-
strate considerable inter- experimental spectral variation. To more easily visualize the similarities 
and differences in the spectra at 2, 4 and 6 hpe, Figure 4-2D shows the average of the 2 hpe (yel-
low), 4 hpe (green) and 6 hpe (pink) “HSV1 minus mock” FTIR difference spectra. Figure 4-2D 
demonstrates differences in the spectra for HSV1 infected cells at 2, 4 and 6 hpe throughout the 
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whole spectral region, particularly so in the 1400-1300 cm
-1
 and 1169-989 cm
-1
 regions, and be-
low ~889 cm
-1
.  The black line is equal to zero difference. 
Figure 4-3 compares the averaged difference spectra for all the infection time points from 
2 to 48 hpe. 2 hpe (yellow), 4 hpe (green), 6 hpe (pink) , 8 hpe (blue), 12 hpe (red), 24 and 48 
hpe (black) are all marked in different colors. As was mentioned previously, we have observed 
the very beginnings of cytopathic effects in the monolayers in visible images of mock samples at 
24 hpe [54]. The dramatic differences between spectra from long time exposure (24 and 48 hpe) 
and short time exposure (2 to 12 hpe) proved that the cytopathic effects have been observed in 
spectra for  24 and 48 hpe. It is very noteworthy that 1243 cm
-1
 and around 1000 cm
-1
 are very 
useful features for differentiating the 2 and 4 hpe from the other time points. 
Visual inspection of the spectra reveals some differences between the spectra of mock 
infected samples at the range from 2 to 48 hpe. There are some very clear trends in the spectra in 
Figure 4-1. For Figure 4-2 and Figure 4-3, only if spectra are always collected for mock and 
infected samples together, some clear conclusions can be derived from the “HSV1 minus mock” 
FTIR difference spectra (DS). Firstly, for cells at 48 and 24 hpe, the FTIR DS display a negative 
intensity at ~1056 and ~1227 cm
-1
, and a positive intensity at ~1450 and 1424 cm
-1
. These 
therefore appear to be very good wavenumbers for distinguishing spectra from mock versus 
HSV1 infected samples at 24 and 48 hpe, at an MOI of 10.  
From the FTIR DS in Figure 4-2D, if a positive signal is observed over the whole of the 
1300-1500 cm
-1
 region, then we are likely dealing with HSV1 infected cells that are near 24 or 
48 hpe (at MOI=10). Furthermore, as can be seen in Figure 4-2D and Figure 4-3, a trend of 
decreasing intensity of the difference spectra between HSV1 and mock can be detected as the 
time post-infection decreases from 48 to 2 hpe. 
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The FTIR DS in Figures 4-2A to 4-2D indicate that by far the best region for monitoring 
the progression of HSV1 infection in Vero cells is in the ~1100-1000 cm
-1
 spectral region. The 
most surprising feature is that the FTIR DS changes sign for cells at 2, 4, 6, 8 and 12 or 24 hpe. 
From Figure 3, around 1100 cm
-1
 also appeared to be a very significant area. 
 
FIGURES 
 
Figure 4-1 Vector normalized FTIR spectra for mock and HSV1 
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Figure 4-2 “HSV1 minus mock” FTIR difference spectra at 2, 4 and 6 hpe  
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Figure 4-3 Averages of the “HSV1 minus mock” FTIR difference spectra at 2-48 
hpe 
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5 CHAPTER FIVE T-CELLS ANALYSIS 
5.1 Apoptosis In Acute Lymphoblastic Leukemia T-Cells Detected Using Infrared Micro-
scopy 
 
Keywords: FTIR, Infrared Microscopy, T-cells, Apoptosis. 
Abbreviations: A3 T-cells, cells that are a subclone of the Jurkat T-cell line;  ALL, acute 
lymphoblastic leukemia;  anti-Fas, anti-Fas; AV, annexin V;  AV-FITC, AV-fluorescein isothi-
ocyanate;  AUC, area under the ROC curve; CV, cross validation; FACS, fluorescence activated 
cell sorting; FTIR, Fourier transform infrared;  LOOCV, leave one out cross validation;  LDA, 
linear discriminant analysis; PLSR, partial least squares regression;  PCA, principle component 
analysis;  PS, phosphatidylserine;  PI, propidium iodide.  ROC, receiver operating characteristic;   
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Abstract 
We have used FTIR microscopy to study apoptosis induction in acute lymphoblastic leu-
kemia T cells.  Apoptosis was induced in the T cells in three different ways: 1) biochemically, by 
incubating cells in the presence of the anti-Fas antibody, 2) physically, by irradiation of the cells 
with UVC light, and 3) using hyper-osmotic shock by incubating cells in 1 M sorbitol. Following 
treatment and then a short four hour incubation period, early stage apoptosis was found to be in-
duced in 70-80% of the cells, using all three methods.  
Induction of apoptosis in T-cells gave rise to many changes in the FTIR spectra of dried 
cellular suspensions, the most prominent being in the 1100-1000 cm
-1
 region.  Using the intensity 
of a band at 1086 cm
-1
 it is possible to visually distinguish spectra of control samples from sorbi-
tol or anti-Fas treated cells, which in turn can also be distinguished from the spectra of UVC ir-
radiated cells.   
Considerable variability is observed in the spectra of cellular samples, both within one 
experiment and between several repeat experiments. To quantify how well the spectra for differ-
ent cells treatments could be discriminated in the face of both types of spectral variability, partial 
least squares regression analysis in combination with stringent cross-validation methods were 
used. The statistical analysis procedure developed indicates that the spectra for anti-Fas/sorbitol 
treated cells are well differentiated from the spectra of control cells and, for a sensitivity of 80%, 
a specificity of 0.926/0.842 is calculated, respectively.  In addition, spectra for anti-Fas/sorbitol 
treated cells are well differentiated from the spectra of UVC irradiated cells and, for a sensitivity 
of 80%, a specificity of 0.657/0.789 is calculated, respectively. The FTIR data support the idea 
that the apoptotic pathways are similar in anti-Fas and sorbitol treated cells, but different in UVC 
irradiated cells.   
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Introduction 
Apoptosis, or programmed cell death, was first described by Kerr and colleagues [55] as 
“a basic biological phenomenon with wide-ranging implications in tissue kinetics.” Indeed, ex-
tensive studies of this phenomenon established its major role in maintaining normal homeostasis 
of tissues. Defective apoptosis pathways have been linked to many pathological conditions, such 
as cancer, autoimmune disease, neurodegenerative disease, viral infection and other pathophysio-
logical states [56, 57]. 
Apoptosis is mediated by a family of cysteine proteases called caspases. Those associated 
with apoptosis are expressed in inactive forms (procaspases) in cells and are divided into two 
classes: initiator caspases (caspase-2, -8, -9, and -10) and effector caspases or executioners (cas-
pase -3, -6, -7). These caspases are engaged by two different mechanisms called the extrinsic and 
intrinsic pathways. The extrinsic pathway is initiated by ligation of transmembrane death recep-
tors (Fas, TNF and TRAIL receptors), resulting in recruitment and activation of caspase-8 and -
10 which then cleave and activate effector or excutioner caspase 3 or 7. Intrinsic pathways re-
quire disruption of mitochondrial membranes resulting in release of cytochrome-c, which works 
together with apoptotic protease activating factor-1 (Apf-1) and procaspase-9 to bring about the 
formation of a caspase-activating complex called an apoptosome. This results in the activation of 
caspase-9 to initiate the apoptotic caspase cascade. In some cases both extrinsic and intrinsic 
pathways can be engaged simultaneously [58]. 
Cells undergoing apoptosis exhibit major morphological and biochemical changes. Mor-
phological changes include membrane blebbing and cell shrinkage. Biochemical changes include 
chromatin condensation and DNA fragmentation (ladder formation) [59], changes in protein syn-
thesis [60] and translocation of phosphatidylserine (PS) from the cytoplasmic side of the plasma 
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membrane to its outer side, exposing PS to the medium [61]. Although the latter may be caused 
by non-apoptotic stimuli, it is a consistent marker present during apoptosis [62].  
Acute lymphoblastic leukemia (ALL) is a neoplasm of lymphocytes characterized by a 
clonal accumulation of immature blood cells (lymphoblasts) in the bone marrow. The cells in-
volved can be from B or T lineage and they can invade any organ in the body. Major tissues in-
volved include lymph nodes, spleen, liver, central nervous system and skin. Two distinct forms 
of ALL are recognized, the childhood and the adult diseases, and usually the first has a better 
survival rate. Treatment of ALL involves chemo, immune, and/or radiotherapy aimed at inducing 
apoptosis in rapidly dividing cells. From an understanding of the core components of the apopto-
sis machinery at the molecular and structural levels, potential new therapies for leukemia and 
lymphoma are emerging [63]. With knowledge of apoptosis-induced Fourier transform infrared 
(FTIR) spectral biomarkers, it may be possible to assess how malignant cells respond (via apop-
tosis) to some of these new therapies prior to the initiation of individual treatment.  
There is considerable clinical utility in being able to quantify the extent of cellular apop-
tosis for a number of disease states, including leukemia [56, 64]. In recent years the unique capa-
bilities of FTIR spectroscopy to study molecular processes in the cell have become more evident 
[16, 43]. In particular, FTIR spectroscopy is a nondestructive technique that may allow one to 
rapidly obtain information on a variety of macromolecules inside cells. Given this, in this manu-
script we report on the use of FTIR spectroscopy to monitor apoptosis induction in ALL cells.  
Apoptosis can be induced in cells in a variety of ways and in this manuscript we report on 
three different methods used to induce apoptosis in a Jurkat T-cell subclone. Firstly, we bio-
chemically induced apoptosis in cells by incubating them in the presence of the anti-Fas antibo-
dy. Fas (CD95) is a cell surface protein that is a member of the tumor necrosis factor (TNF) re-
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ceptor super-family. Its activation, via binding to the Fas-L ligand or antibody, results in the tri-
merization of Fas and recruitment of FADD (Fas-associated protein with death domain) [65]. 
FADD recruits pro-caspase-8, which initiates activation of caspase 8 and the subsequent caspase 
cascade that leads to apoptosis (the so-called extrinsic pathway) [65].  
A second (physical) approach we used to induce apoptosis is to irradiate cells with UVC 
light [58, 66, 67]. UVC light can induce apoptosis by activation of p53 and death receptors ex-
pressed on the cell surface via release or upregulation of death ligands. Death receptor activation 
is ligand-independent and occurs via receptor clustering. Whether the UVC-induced DNA dam-
age occurs first or in parallel to these events is unknown.[66, 67]   
A third approach used was to induce hyper-osmotic shock by incubating cells in 1 M sor-
bitol [68]. The stress response that is induced leads to activation of a family of p21Cdc42/Rac-
activated kinases (PAKs), inducing cleavage of PAK2 [69] which is closely associated with both 
DNA fragmentation and activation of caspase 3, an executioner caspase, resulting in cell death 
via apoptosis. 
FTIR spectroscopy has been used to study apoptosis induction in cellular samples pre-
viously [70-72]. In most of these studies, however, the extent of inter-experimental spectral va-
riability that could occur for cellular samples was not factored into the analyses. Without consi-
dering inter-experimental spectral variability it is difficult to unambiguously assess and quantify 
apoptosis-specific changes.   
In many previous FTIR microscopy studies of different cell types, the spectra were ana-
lyzed using statistical modeling. The results obtained from the modeling usually overestimate the 
capabilities of FTIR spectroscopy in distinguishing cells in different states, however. This over-
estimation arises because the statistical models are poorly validated. Improper validation of sta-
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tistical models can occur because inter-experimental spectral variability is not considered. For 
example, it is common in FTIR spectroscopy of cellular samples to collect many spectra for each 
sample, and then repeat the experiment several times. All of the spectra from each of the experi-
ments are then statistically analyzed simultaneously. To assess the level of sensitivity and speci-
ficity obtainable from the spectra from different cell types some type of cross validation is re-
quired - usually leave-one-out-cross-validation (LOOCV) is used [30]. However, LOOCV in-
adequately accounts for inter experiment spectral variability that is common in FTIR microscop-
ic measurements of cellular samples. One consequence of this is that spectra of different cell 
types are distinguished with very high levels of specificity and sensitivity, and the capabilities of 
FTIR spectroscopy in distinguishing different cell types is greatly overestimated. Or put another 
way, the calculated specificities and sensitivities do not properly reflect the level of accuracy 
achievable in blind tests where cell type is established based on the spectra obtained. 
In this paper we describe the induction of apoptosis in ALL T-cells using three different 
methods.  The extent of apoptosis induction was monitored using flow cytometry (FACS).  FTIR 
microscopy was then used to obtain spectra for control and apoptotic cells.  At least 25 spectra 
were collected for any one sample, and we have repeated all sample measurements 5-6 times.  
The spectra were analyzed using partial least squares regression (PLSR) methods. Our ability to 
discriminate spectra from different cell types was assessed using cross validation methods de-
signed to appropriately account for the inter experimental spectral variability that is observed in 
our experiments.  
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Materials and Methods 
Cells: In the studies reported here the A3 sub-clone of the ALL Jurkat T-cell line (ATCC 
CRL 2570) was used. This cell line is particularly sensitive to Fas induced apoptosis (REF). We 
will refer to these cells as A3 cells in the rest of this manuscript. A3 cells were grown at 37
o
C in 
a 5% CO2 humidified incubator. Cells were grown in RPMI 1640 medium supplemented with 
10% fetal bovine serum (Atlanta Biologicals, Atlanta, GA), penicillin and streptomycin. Cell cul-
tures were expanded by dilution of cells to a concentration of 3-5x10
5
 cells/ml and subsequently 
split every two to three days to maintain cell counts. 
Induction of apoptosis. For anti-Fas induced apoptosis 4-5 ml of cells (0.7-1x10
6
 
cells/ml) in the logarithmic phase of growth were centrifuged for 5 min. at 1300 rpm and resus-
pended to the same concentration with RPMI without FBS. Anti-Fas antibody (500 ng/ml) (clone 
CH11, 0.5 mg mouse IgM/ml) (Millipore, USA) was added to the cells, which were then incu-
bated at 37
o
C in 5% CO2 for 4 hours. 
For sorbitol induced apoptosis, cells (0.7-1x10
6
 cells/ml) were centrifuged as above and 
resuspended with 4-5 ml of RPMI supplemented with 2% FBS containing 1 M sorbitol. Follow-
ing 1 hr. incubation at 37
o
C in 5% CO2 cells were centrifuged again and resuspended to the same 
cell concentration with RPMI supplemented with 10% FBS. Cells were then incubated for addi-
tional 3 hours.  Control cells were treated identically except without sorbitol.  
For UVC-irradiation induced apoptosis, cells (0.7-1x10
6
 cells/ml) were transferred to 6-
well plates at 0.8 ml cells per well. The cells were placed at a distance of 30 cm from a 25 W 
Philips germicidal lamp emitting at 254 nm, and irradiated for 30 seconds. The corresponding 
dose is 250 J/m
2
, which was monitored using a General UV512C light meter (General Tools and 
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Instruments, NY). Control cells were treated identically but without the UVC irradiation. Cells 
were then incubated at 37
o
C in 5% CO2 for an additional 4 hours.  
Assessment of apoptosis by flow cytometry. Following induction of apoptosis and incuba-
tion, cells were centrifuged as above, washed once with PBS and labeled with the Annexin-V-
Fluos staining kit (Roche, USA) according to the manufacturer instructions. Labeled cells were 
then analyzed by fluorescence activated cell sorting (FACS) using a FACS Aria Cell-Sorting 
System (BD Biosciences, San Jose, CA). Propidium iodide (PI) in the kit allowed assessment of 
the fraction of early and late apoptotic cells, as well as differentiation from necrotic cells.  
Detection of DNA fragmentation by agarose gel electrophoresis. For DNA fragmentation 
analysis cells were lysed and cellular DNA was extracted and fractionated electrophoretically on 
a 1.5% agarose gel electrophoresis. Gel patterns were analyzed using ethidium bromide staining. 
Preparation of cellular material for FTIR measurements. For (transflection) FTIR micro-
scopy measurements, following induction of apoptosis and incubation, cells were centrifuged as 
above, washed once with PBS and once with saline. Cells were then resuspended with 15-
of saline diluted 1:5 (to avoid formation of salt crystals). Small drops of cells were then spread 
on MirrIR reflective windows (Kevley Technologies, Chesterland, OH) and allowed to air dry 
for 5-10 min. at room temperature. FTIR measurements were then undertaken immediately. 
FTIR Microscopy Instrumentation and Parameters. FTIR microscopy measurements 
were undertaken using a Varian 7000 FTIR spectrometer (Varian, Lake Forest, CA) coupled to a 
Varian UMA600 IR microscope. The microscope was setup in reflection mode (transflection) 
using a 15X Schwartzchild objective.  The microscope was equipped with a visible light source 
and CCD camera that allows the collection of visible microscopic images from the same sample 
region that is investigated in the IR.  The IR light was detected using a single element 0.25x0.25 
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mm mercury cadmium telluride (MCT) detector with high responsivity in the 4000–700 cm-1 re-
gion. Data was collected in the 4000-100 cm
-1
 region although the spectral bandwidth was li-
mited to the 2000–800 cm-1 region using a band-pass filter. All experiments reported here were 
undertaken at 4 cm
-1
 spectral resolution.  
Several cell suspension “spots” were pipetted onto a MirrIR slide and air-dried. The sus-
pension spot has a diameter of ~3 mm. For microscopic measurements the area sampled is ~ (100 
µm)
2. For each set of “spots” (usually 3-5) spectra were collected at about 25 different locations 
on the spots. Each spectrum collected was the co-addition or average of 64 interferograms. All 
FTIR experiments reported here have been repeated five or six times on independently prepared 
samples on different days.  We have found that FTIR spectra collected near the edges of the 
sample spots display less variation than spectra obtained near the center of the spots. In all FTIR 
spectroscopy measurements the IR absorption in the amide I region was ~0.8-1.2 in optical den-
sity units. 
Spectral Analysis. All spectra were first truncated to consider only the 1800-800 cm
-1
 re-
gion, or the 1500-800 cm
-1
 region, and then standardized. For standardization it is necessary to 
calculate the mean and standard deviation of a spectrum. The spectrum is then mean centered 
and divided by the standard deviation. Standardization is equivalent to vector normalization to 
within a scale factor. Second derivative spectra were calculated without smoothing. Spectral 
processing and manipulation were undertaken using OPUS 4.0 (Bruker Optics, Billerica, MA), 
Origin 7.5 (OriginLab Corporation, Northampton, MA), Resolutions Pro 4.05 (Varian Inc., Palo 
Alta, CA), Matlab 7.8 (The Mathworks Inc. Natick, MA) software.  All statistical analysis of the 
spectra reported here was undertaken using home-written code implemented within the SAS 
(Cary, NC, USA) software programming environment. 
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Results  
Flow cytometry assessment of apoptosis induction in ALL T-cells. We have employed 
three different methods to induce apoptosis in A3 cells (Jurkat T-cells, A3 subclone), and we 
have used flow cytometry to monitor the extent of apoptosis in the cell population. Figure 1A 
shows scatter plots derived from flow cytometry measurements on normal cells, and cells where 
apoptosis was induced by each of the three different methods.  
For UVC irradiation of A3 cells it was found that 30 seconds (at 30 cm from light source) 
was the optimal irradiation time for induction of apoptosis. Longer irradiation times of 45 or 60 
seconds had no further effect on the percentage of early apoptotic cells (not shown). With the 
anti-Fas treatment the antibodies were present in the medium during the entire incubation period. 
For the hyperosmotic shock method using sorbitol, the exposure period with sorbitol was 1 hr. 
For each method used the incubation period following the beginning of treatment was 4 hrs.  
For each of the three procedures used to induce apoptosis, for an incubation period of 4 
hours, the majority of the cells (78.3-83.7%) were found to be in the early apoptosis phase (Fig-
ure 1A). The population of cells showing late-stage apoptotis was very low (2.7-4.4 %) (FITC-
Annexin positive/propidium iodide positive), as was the necrotic fraction (0.4-1.5 %).  It should 
be noted that measurements of late-stage apoptosis can include necrotic cells as well.  The data 
show that the percentage of apoptotic cells was comparable for each of the three methods used. 
In addition, the extent of DNA ladder formation was also comparable (Figure 1B).  
Comparison of FTIR spectra from control and anti-Fas treated cells. Figure 2A shows 
raw spectral data collected for control (black) and anti-Fas (red) treated A3 cells. For control and 
antibody treated cellular suspensions, spectra were collected at 23 and 26 locations on the sample 
“drops”, respectively. The data in Figure 2A demonstrates variation in the intensity of the spectra 
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collected at various locations on the dried cellular suspensions. The variation in spectral intensity 
is similar in magnitude to that found previously for Vero cell suspensions [44]. To eliminate any 
effects on the spectra that may be due to sample thickness, or changes in cellular concentration, 
the spectra in Figure 2A were standardized. The calculated standardized spectra are shown in 
Figure 2B.  
Although considerable variation in the spectra collected from the same sample still exists, 
Figure 2B indicates that there are spectral regions where the spectra of anti-Fas treated cells can, 
for the most part, be distinguished from spectra of control cells. In particular, most of the spectra 
for anti-Fas treated cells display decreased absorption in the 1000-1100 cm
-1
 region, and in-
creased absorption in the 1800-1700 cm
-1
 region, compared to spectra of control cells. Figure 2B 
demonstrates that the spectra for control and anti-Fas treated cells are not easily distinguished 
from consideration of the amide I and II absorption bands (1680-1620 and 1560-1500 cm
-1
 re-
gions). 
To better visualize the differences in the spectra of control and anti-Fas treated cells the 
average spectra for control and anti-Fas treated cells are shown in Figure 2C. To gauge the varia-
tion in the standardized spectra the error bars are also shown in Figure 2C. These error bars 
represent the standard deviation in the spectra for the 23 or 26 spectra in Figure 2B. Figure 2D 
shows the same spectra as in 2C without the error bars.  
The data in Figure 2C demonstrate that there is no overlap of the error bars in most of the 
1780-1700 and 1130-1030 cm
-1
 regions. These two spectral regions are therefore useful indica-
tors of anti-Fas induced apoptosis in A3 cells. The averaged spectra shown in Figure 2D also in-
dicate that the whole of the 1300-900 cm
-1 
region spectra of anti-Fas treated cells display de-
creased absorbance compared to that in spectra of control cells. In the 1480-1430 cm
-1
 region, 
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absorption for anti-Fas treated cells is increased relative to control cells. Although there is some 
overlap in the error bars in these spectral regions, these regions may still be useful for discrimi-
nation, albeit with somewhat lower sensitivity than the 1300-900 cm
-1
 region.  
The data in Figure 2A-D is for a single experiment, for cells prepared on a single day. It 
is important to quantify the extent of inter-experimental spectral variation, and Figure 2E shows 
the averaged FTIR spectra of control and anti-Fas treated A3 cells obtained in five independent 
experiments. The changes in the spectra in Figure 2C or D described above were also reproduci-
bly observed in the five independent experiments. For example, at the frequencies marked by the 
dotted lines in Figure 2E the spectra for the control and anti-Fas treated samples display the same 
trends in all five experiments. That is, in all five experiments, spectra for control cells display an 
increased absorption at 1656, 1240, 1086 and 966 cm
-1
 and a decreased absorption at 1744, 1540 
and 1466 cm
-1
, relative to spectra for anti-Fas treated A3 cells.  
Qualitatively, anti-Fas treated A3 cells can be discriminated from control cells based on 
the above spectral features. However, our goal is a quantitative and robust procedure to ascertain 
what levels of sensitivity and specificity are achievable from our spectral measurements. Such an 
analysis is presented below.  
Comparison of FTIR spectra from all cell types. Figure 3A-C compares the averaged 
spectra from five or six independent measurements on cells that have been exposed to UVC light 
(blue), sorbitol (magenta) or anti-Fas (green), as outlined in the materials section.  The absor-
bance spectra were first standardized and then averaged in each independent experiment.  The 
results of the six averages are then further averaged to produce the final spectra shown in Figure 
3.  FTIR measurements on two different types of control cells are also shown in Figure 3.  One 
set of control cells is for the UVC treated cells while the other is for sorbitol and anti-Fas treated 
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cells.  The expectation is that spectra for the two types of control cells should be similar.  This is 
indeed found to be the case. Also shown in Figure 3 are the calculated, unsmoothed second de-
rivative spectra. Five absorbance difference spectra, that represent the subtraction of one spec-
trum from another, are also shown.   
In Figure 3 the original absorption spectra were standardized. However we have also con-
sidered the same spectra normalized in different ways (for example we have normalized the 
spectra so that the maximum and minimum absorbance values are the same), and we have found 
that similar difference spectra, with peaks at similar frequencies to that shown in Figure 3, are 
obtained (not shown). Therefore, the features (peaks and dips) in the absorbance difference spec-
tra in Figure 3 are not related to the normalization process.  
Statistical analysis.  Inspection of the experimental spectra demonstrates considerable 
variation both within experiments on any given day (Figure 2A), and between measurements on 
different days (Figure 2E).  This variation persists in spite of the fact that sample preparation and 
FTIR experiments were undertaken in an identical fashion.  This intra and inter-experimental 
spectral variability obviously limits our ability to distinguish spectra from control and treated 
cells.  Any statistical methods and data processing procedures developed should take steps to 
minimize and account for both intra and inter experimental spectral variability.  For analysis of 
our spectral data we have developed the following procedures: 
1 Spectra are truncated to select the 1500-800 cm
-1
 region, and then standardized. 
For initial studies we do not consider the amide I and II spectral regions (1800-1500 cm
-1
). This 
approach is taken to avoid any potential dispersion and other scattering induced artefacts that 
contribute most to spectra in the amide I and II spectral regions. 
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2 In each spectrum groups of five neighboring data points are averaged.  This re-
duces each spectrum to 73 data points (variables).  This procedure reduces the quantity of data to 
be analyzed. It also increases the robustness of the statistical method.   
3 The 20-30 spectra collected for any given sample in any given experiment are 
split randomly into two groups of 10-15 spectra, and the mean spectrum for both groups is calcu-
lated (this averaging helps reduce intra experimental spectral variability).  For example, for spec-
tra obtained using control and anti-Fas treated T-cells in any given experiment, four averaged 
spectra are produced, which can be labeled (for convenience) as control1, control2, anti-Fas1 and 
anti-Fas2.   
4 From the four spectra obtained in step 3, two statistics are generated:  One statis-
tic is the difference between the two averaged spectra from the same sample [(control1 minus 
control2) and (anti-Fas1 minus anti-Fas2)].  We will refer to these spectra as inner difference 
spectra.  The second statistic is the difference between the control and treated samples [(control1 
minus anti-Fas1) and (control2 minus anti-Fas2)].  We will refer to these spectra as intra differ-
ence spectra.  Note that the intra difference spectra (control1 minus anti-Fas2) and (control2 mi-
nus anti-Fas1) are not considered as they are correlated with the other two intra difference spec-
tra. 
The inner difference spectra provide a baseline from which to consider intra difference 
spectra.  This approach was used to help minimize effects due to inter experimental spectral va-
riability.   
Since we have collected spectra for control and treated T-cells in 5-6 different experi-
ments, we have 10-12 inner- and intra-difference spectra.  These inner and intra-difference spec-
106 
tra are shown in Figure 4A for control and anti-Fas-treated cells.  Similar figures can be generat-
ed for all other paired comparisons (not shown).   
5 In order to establish which frequencies in the intra difference spectra are of high-
est diagnostic value the Wilcoxon signed rank test (WSRT) was applied to the inner and intra 
difference spectra. The WSRT is a one sample test [48], which is appropriate since we are inter-
ested in variables in the intra difference spectra that differ significantly from zero.   
Figure 4B shows a plot of the p-values at each frequency calculated using the WSRT.  
Bonferroni’s multiple comparison method[73] suggests that frequencies with p<0.00068 should 
be highly significant.  In practice, only a few of the frequency variables have such low p-values, 
so frequency variables with higher p-values were considered (see Table 2).  From the p-value 
spectrum in Figure 4B, we find 31 frequencies with p<0.003 (see inset).  Only these 31 frequen-
cies are used in the construction of a discriminating statistic. 
6 Partial least square regression (PLSR) [74] was then applied using the significant 
frequency variables.  As described previously [46], to evaluate the performance of our PLSR 
model in correctly classifying any two categories of spectra, specificities and sensitivities were 
calculated using the constructed PLSR model.  This allowed a receiver operating characteristic 
(ROC) curve to be constructed, and the area under the ROC curve (AUC) was then calculated.  
Sensitivity gives a measure of the proportion of correct identifications among actual positives, 
while specificity gives a measure of the proportion of correct identifications among all negatives. 
A ROC curve is a plot of sensitivity vs. (1-specificity). A calculated AUC of 1 represents 100% 
accuracy of discrimination.  A rough classification guide is: AUC = 0.9–1.0, excellent discrimi-
nation; AUC = 0.8–0.9, good discrimination; AUC = 0.7–0.8, fair discrimination; AUC < 0.6-
0.7, poor discrimination.  
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Table 1 list the results of PLSR analysis applied to the spectra (significant frequencies) 
for control and anti-Fas treated cells.  For a sensitivity of 95%, a specificity of 1.0 is calculated.  
The AUC is also calculated to be 1.0.  This indicates perfect discrimination of the inner and intra 
difference spectra for control and anti-Fas-treated cells.  
7 In PLSR analysis, calculated specificities (for given sensitivities) are generally 
overestimated.  As a first step in “estimating this overestimate” we have used two-fold cross-
validation [75]. In this procedure, half the data is selected randomly, and used to build the statis-
tical model.  The constructed model is then applied to the other half of the data.  We repeated the 
two-fold cross validation procedure fifty times.  The results presented in Table 1 are the average. 
Given the small sample size (12 spectra), large variations in the calculated specificities 
are expected in the model applied to the validating data.  That is, a large shrinkage is expected. 
Shrinkage is the difference in the specificity calculated between the validating data and the origi-
nal data. Table 1 lists the values for specificity, sensitivity and AUC calculated using two-fold 
cross-validation.  For a sensitivity of 95/90/80 %, a specificity of only 0.42/0.58/0.77 was ob-
tained, and the calculated shrinkage was 0.58/0.42/0.22, respectively.  Using 2-fold cross-
validation the AUC drops to 0.868, which still represents good discrimination capability. It is not 
at all clear whether the discrimination capability will increase if further experiments are underta-
ken and included in the analysis  
Two-fold cross-validation [27,62,65,67] methods generally overestimate shrinkage. In a 
second approach we also used Bootstrap methods [76] to estimate shrinkage. Using Bootstrap 
methods for a sensitivity of 95/90/80 %, a specificity of 0.90/0.95/0.99 was calculated, along 
with a shrinkage of 0.1/0.05/0.01, respectively (Table 1). The calculated AUC was 0.983, which 
represents excellent discrimination capability.   
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Bootstrap calculated shrinkage is usually an under-estimate of the true value.  A useful 
rule of thumb is to use the average shrinkage calculated using the two different validation proce-
dures.  The final specificities and AUC calculated by subtracting the initial model values from 
the averaged shrinkage are also listed in Table 2.  The calculated AUC after accounting for 
shrinkage is 0.926, which represents a quite outstanding level of discrimination achievable from 
spectra of control and anti-Fas treated cells.  
The statistical analysis outlined above for control and anti-Fas treated T-cells was also 
undertaken for all pairs of combinations of the five sets of cells (control, control UV, UV treated, 
anti-Fas treated and sorbitol treated cells).  The calculated AUC and specificity for 80 % sensi-
tivity from these sets of analysis are listed in Table 2. Also listed are the cut-off p-values used in 
two-fold cross-validation and Bootstrap analyses.  
Several points from the data in Table 2 are noteworthy: 1) The spectra from anti-Fas and 
sorbitol treated cells could not be discriminated.  This is not surprising, as the spectra for the two 
samples were found to be very similar (Figure 3).  2) Somewhat surprisingly, the spectra from 
control UV (or control) cells could not be discriminated from spectra of UV treated cells.  3) 
Spectra obtained for anti-Fas and sorbitol treated cells were easily distinguished from spectra of 
control (or control UV) cells.  4) Spectra obtained for anti-Fas and sorbitol treated cells were dis-
tinguishable from spectra of UV treated cells.  
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Discussion  
Many anti-leukemic or lymphoma therapies are aimed at inducing or restoring apoptosis 
in malignant cells. From an understanding of the core components of the apoptosis machinery at 
the molecular and structural levels, many potential new therapies for leukemia and lymphoma 
are emerging [63]. With knowledge of apoptosis-induced spectral biomarkers one may be able to 
(rapidly) assess how malignant cells respond (via apoptosis) to some of these new therapies. 
Thus a FTIR detection technology, together with knowledge of spectral biomarkers of malignant 
lymphocytes, may be used as a new complementary tool for rapidly testing drug resistance in 
leukemic cells directly isolated from patients. Indeed the use of FTIR spectroscopy to monitor 
leukemia progression in real patients has already begun [77, 78]. For such work to be fruitful a 
detailed understanding of FTIR spectral alterations that occur upon apoptosis in cells is required.   
It has previously been established that most of the bands in the FTIR spectra of cellular 
samples contain contributions from many sub-cellular components [79]. Many sub-cellular com-
ponents have been isolated and their FTIR spectra have been obtained. From knowledge of these 
spectra of isolated components it can then be inferred which components may contribute to the 
bands in the FTIR spectra. Note that when a FTIR band changes, due to for example apoptosis 
induction, it may be suggested that the change is related to a given sub-cellular component. This 
is not a proof, however. An important realization in recent years is that scattering effects contri-
bute to spectra of cellular suspensions. Therefore, it should be kept in mind that changes in scat-
tering upon apoptosis induction may be at the heart of some of the spectral changes observed, 
rather than changes in concentration of sub-cellular components. 
With these caveats in mind it is still worthwhile indicating which sub-cellular compo-
nents may contribute to the bands in the FTIR spectra in Figure 3. Lipid ester carbonyl (C=O) 
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vibrations are known to occur in the 1750-1710 cm
-1
 region [54, 80, 81]. The weak bands at 1744  
and 1716 cm
-1
 in the spectra in Figure 3A can be associated with (phospho) ester lipids [54]. The 
asymmetric and symmetric bending of lipid methyl and methylene groups is known to occur near 
1460 and 1400 cm
-1
 [82-85]. The bands that occur near 1456 and 1398 cm
-1
 in the spectra in Fig-
ure 3B may therefore contain contributions from these species.  
The asymmetric and symmetric vibrations of the phosphodiester groups of DNA occur 
near 1240 and 1085 cm
-1
 [84]. The bands at 1241 and 1086 cm
-1 
in the spectra in Figure 3B and 
C may therefore contain contributions from these DNA modes. The band at 966 cm
-1 
in Figure 
3C may contain contributions from the vibration of the C-C/C-O conglomerate in DNA [84]. 
From examination of the spectra in Figure 3, several features are noteworthy:  
First, the spectra for the two types of control samples are very similar (compare black and 
red spectra in Figure 3). This is as expected.  
Second, bands at 1744 cm
-1
 and 1716 cm
-1
 are observed in the spectra of all five samples. 
As mentioned above, these bands are likely associated with ester lipids. Although the apoptosis 
induced changes in these bands are weak, it appears that sorbitol, anti-Fas and UVC treatment 
causes a small decrease in the intensity of the 1716 cm
-1
 band, but not the 1744 cm
-1
 band.  
Third, for all five samples the amide I band peaks at 1658 cm
-1
 and displays a shoulder at 
1639 cm
-1
. These features are readily visualized in the second derivative spectra (Figure 3A). 
Changes in the amide I band due to apoptosis are apparent in the spectra in Figure 3A: The spec-
tra for the two control samples show an increased intensity peak at 1658 cm
-1
. This gives rise to a 
negative peak (dip) at 1655-1659 cm
-1
 in all four of the FTIR difference spectra that involve a 
subtraction of one of the two control spectra. The anti-Fas, sorbitol and UVC light treated sam-
ples all appear to have amide I bandwidths that are slightly increased (by ~2 cm
-1
) relative to the 
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two control samples. The second derivative spectra in Figure 3A indicate that this is because of a 
small increase in intensity of a band near 1631 cm
-1
 in the spectra of the apoptotic cells. Such 
changes could be consistent with the transformation of some alpha helical protein content to beta 
sheet upon apoptosis [86]. However, in studies of cells, interpretation of changes in the amide I 
band are notoriously difficult to make. This is principally because IR light scattering and disper-
sion effects all have a large impact on the amide I absorption band [54, 87]. Specifically, apop-
totic cells may scatter IR light differently from non-apoptotic cells, which may lead to changes in 
the amide I band profile. It is because of these types of complications that we chose to exclude 
the amide I (and II) spectral region from our statistical analysis. However, if one is interested on-
ly in identifying spectral biomarkers that can pinpoint apoptosis in A3 cells, then the amide I ab-
sorption band may be a useful indicator of apoptosis, at least in experiments following the type 
of protocol used here.  
Fourth, the amide II band peaks near 1545 cm
-1
 and displays a distinct shoulder near 1516 
cm
-1
. Again, these features are more easily visualized in the second derivative spectra (Figure 
3A). The width of the amide II band appears to be slightly increased in spectra for cells in which 
apoptosis has occurred. However, again, this does not necessarily reflect changes in protein 
structure in apoptotic cells relative to control cells. 
Fifth, in the 1500-1150 cm
-1
 region, FTIR absorbance difference spectra 1-4 all display 
negative peaks near 1400 and 1241 cm
-1
 (Figure 3B). These peaks are most pronounced in dif-
ference spectra 1 and 2. That is, anti-Fas and sorbitol induced apoptosis each cause a greater de-
crease in absorption of the 1400 and 1241 cm
-1
 bands (relative to control spectra) than does 
apoptosis induced in cells via UVC irradiation. This may be an indication that FTIR spectrosco-
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py can distinguish cells that have undergone apoptosis via extrinsic and intrinsic pathways, al-
though further work will be required to verify or disprove this statement. .  
Six, in the 1150-900 cm
-1
 region there are many differences in the spectra obtained from 
the different sample preparations (Figure 3C). Again, the spectra for the anti-Fas and sorbitol 
treated samples are very similar as evidence by the lack of features in the anti-Fas minus sorbitol 
absorbance difference spectrum (spectrum 5 in Figure 3C). The spectra for the two control sam-
ples are also very similar, but distinct from the spectra for the anti-Fas and sorbitol treated sam-
ples. The spectrum for the UVC treated samples lies between the two extremes. This pattern can 
be seen in all of the bands in the 1150-900 cm
-1
 region.  
Seven, in the FTIR spectra for the five samples shown in Figure 3C the largest changes in 
bands are found at 1086, 1054 and 1023 cm
-1
. The second derivative spectra in Figure 3C (bot-
tom set of curves) show that all the spectra of cells display a peak at 1086 cm
-1
. The presence of 
a negative peak (or dip) at 1086 cm
-1
 in the absorbance difference spectra in Figure 3C (middle 
set of curves) indicate that the peak at 1086 cm
-1
 in the spectra of the control samples decreases 
in intensity for UVC treated samples, and decreases even further for anti-Fas and sorbitol treated 
samples.  
Eight, the second derivative spectra show a negative feature at 1054-1056 cm
-1
 for all cell 
samples (Figure 3C). A negative feature is also observed near 1049 cm
-1
 in the second derivative 
spectra for the control samples, but is absent in spectra of treated (apoptotic) cells. This differ-
ence manifests itself as a broad negative band near 1049 cm
-1
 in difference spectra 1, 2 and 4. 
The data suggest that a band near 1049 cm
-1
 in spectra of control cells is lost upon apoptosis in-
duction. 
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Comparison to previous studies: FTIR spectroscopy, at both the microscopic and ma-
croscopic levels, has been used to study apoptosis in various types of cells. Much of this work 
has been summarized in several recent reviews [70-72]. Comparison of the different studies that 
have been undertaken is difficult, partly because of the differences in the way the experiments 
were undertaken (different cell sample types and preparation techniques were used, different 
FTIR techniques were used, different methods for statistical analysis of data were employed, dif-
ferent methods for quantifying the extent of apoptosis induction were used, and in some cases it 
is not clear whether the cells under study had undergone apoptosis or necrosis).  
Given the wide variety of conditions used in different experiments there is considerable 
confusion in the literature concerning what spectral observables could be altered (and how) upon 
apoptosis induction in cells. Our studies on cells in the early apoptosis stage (measured at 4 
hours post treatment) suggest only small (but reproducible) spectral changes. In contrast, very 
large spectral changes have been observed upon apoptosis induction in some previous studies 
[64, 88, 89].  
Spectra for anti-Fas and sorbitol treated cells differ from the spectra of cells irradiated 
with UVC light. Interestingly, our results show that FTIR spectra for cells undergoing anti-Fas 
and sorbitol induced apoptosis are similar, but clearly distinct from spectra of cells with apopto-
sis was induced using UVC light. It is not clear if these spectral differences indicate differences 
in the final apoptotic state of the cells studied. Such differences are not suggested by the FACS 
data presented in figure 1A.  
The Fas signaling pathway, one of the extrinsic apoptosis pathways, involves ligand bind-
ing to the Fas receptor on the cell surface, followed by recruitment of death domain-containing 
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FADD and procaspase-8 [60] and subsequent activation of the caspase cascade, p38 MAP kinase 
and JNK [90].  
In the intrinsic pathway cytochrome c is released from the mitochondria and subsequently 
interacts with Apf-1 and procaspase-9 to promote the assembly of the apoptosome to start a cas-
cade that leads to cell death. The general dogma for UV and sorbitol induced apoptosis is that in 
both cases the intrinsic pathway is involved. However, since death domain recruitment due to 
ligand-independent receptor clustering can occur with sorbitol, it is likely that activation of the 
extrinsic pathway dominates, driving apoptosis associated with hyperisomotic shock. It has been 
reported that UVC light can induce apoptosis in mouse embryo fibroblast via both intrinsic and 
extrinsic pathways [58]. Several further reports have also shown that DNA damaging agents, 
such as UV radiation or drugs used for chemotherapy, induce apoptosis via the Fas/caspase 8 
pathway [91-94]. Different treatments may lead to apoptosis induction in cells via different con-
tributions from intrinsic and extrinsic pathways. However, it is quite unclear if this could give 
rise to spectral differences in the differently treated cells. More detailed and focused studies will 
be required to address this question.  
Statistical Analysis. A crucial feature of the statistical analysis presented here is that the 
data on different days are treated as independent single samples. Thus we have shown quantita-
tively that spectral discrimination between differently treated T-cells is possible, even in the 
presence of considerable inter experimental spectral variability. 
In a recent FTIR microscopy study of different lymphoma and leukemia cell types, a 
principle component fed linear discriminant analysis (PC-LDA) in combination with leave-one-
out cross validation (LOOCV) approach was used to discriminate the spectra of the different cell 
types [30]. The levels of sensitivity and specificity achieved using this PC-LDA LOOCV ap-
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proach were very high [30]. We have analyzed the spectral data presented here using the same 
PC-LDA LOOCV approach, and we also obtain similarly high levels of sensitivity and specifici-
ty for distinguishing spectra of differently treated cells (not shown). The levels of sensitivity and 
specificity we achieved using the PC-LDA LOOCV approach are much higher than that 
achieved using the statistical methods for cross-validation outlined here. This is because the 
LOOCV approach does not properly account for inter-experimental variability: LOOCV uses 
one spectrum from all the spectra collected over many experiments as the validation data, and the 
remaining spectra are used as training data. This is the same as K-fold cross-validation [75], with 
K being equal to the total number of spectra. If the data collected over different experiments is 
consistent then similar results from K-fold cross-validation and LOOCV should be obtained. 
However, we obtain considerably lower sensitivities and specificities (than that obtained using 
LOOCV) when we undertake cross validation with all of the spectra for one experiment are used 
as the validating data (six-fold cross validation in our case). This observation indicates that inter 
experimental spectral variability is a problem that is not properly accounted for using the 
LOOCV approach. 
One of the main goals of FTIR spectroscopy in studies of cells is to be able to accurately 
classify spectra according to specific cell type. For example, in the cases studied here, if we are 
given spectra from all five cell types, without knowledge from which cell type the spectra are 
collected, how well are we able to classify the spectra? We have found that even although we 
calculate very high levels of specificity and sensitivity for distinguishing spectra of different cell 
types using the LOOCV approach, we have a much lower accuracy in successfully classifying 
unknown spectra to a given cell type using LOOCV. The regression analysis approach outlined 
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in this manuscript gives a more accurate and realistic measure of how well we can classify spec-
tra without prior knowledge from what cell type the spectra came from.  
In summary, few FTIR studies of cells in different states have included an assessment of 
inter experimental spectral variability. The methods used to calculate sensitivity and specificity 
for distinguishing spectra from different cell types in many previous studies do not accurately 
reflect how well FTIR spectra from unknown cell types can be classified.  
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Table Legends 
 
Table 1:  Results of PLSR analysis applied to spectra from control and anti-Fas treated 
cells collected from six different experiments.  Two fold cross validation and a bootstrap method 
were used to estimate shrinkage, and provide a realistic estimate of obtainable sensitivities and 
specificities.  For the two fold cross validation /bootstrap method data points with p-values less 
than 0.05/0.003 were chosen for analysis.   
 
Table 2:  Results of PLSR analysis applied to spectra of different pairs of cell types.  The 
results listed are obtained anti-Faster including shrinkage that was estimated using 2 fold cross 
validation and Bootstrap methods.  The items listed in each cell are, from top to bottom: AUC, 
level of discrimination, specificity for 80% sensitivity and p-value used in bootstrap/two fold 
cross validation methods.  Empty cells indicate no discrimination. 
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Table 1 
 
Control versus anti-Fas treated cells 
Sensitivity Specificity Specificity 
(CV) 
Shrinkage 
(CV) 
Specificity 
(Bootstrap) 
Shrinkage 
(Bootstrap) 
Averaged 
Specificity 
95% 1 0.41723 0.58277 0.90025 0.09975 0.65874 
90% 1 0.57567 0.42434 0.94759 0.05241 0.76163 
80% 1 0.77064 0.22936 0.98764 0.01236 0.87914 
AUC 1 0.86805 0.13195 0.98381 0.01619 0.92593 
 
 
Table 2 
 
 Control  Control UV  Sorbitol  UV treated  
anti-Fas  0.926 
Excellent  
0.879 
0.003/ 0.05 
0.915 
Excellent 
0.846 
0.003/0.2 
 0.804 
Good 
0.657 
0.003/ 0.05 
Control  0.842 
Good 
0.713 
0.003/ 0.3 
 
Control UV 0.873 
Good 
0.782 
0.003/ 0.2 
 
Sorbitol  0.611 
Poor  
0.789 
0.04/0.2 
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Figure Legends 
 
Figure 1: (A) Flow cytometry data obtained for untreated A3 cells (Jurkat T-cells, A3 
subclone3) (top left), and A3 cells in which apoptosis has been induced using anti-Fas (500 
ng/ml) (top right), sorbitol (1M for 1 hr) (bottom right) and UVC irradiation (30 sec exposure) 
(bottom left). Cells were incubated for 4 hrs post treatment. FITC
+
 corresponds to early apoptotic 
cells; PI
+
/FITC
+
 correspond to late apoptotic cells; PI
+
 correspond to necrotic cells. (B) Agarose 
gels showing the DNA ladder formation, or DNA fragmentation, that occurs in apoptotic cells. 
Lane 2 shows control cells, lanes 3, 4 and 5 show UVC, anti-Fas and sorbitol treated cells. A 
100-bp size marker is shown in Lane 1. 
 
Figure 2: (A) IR absorption spectra in the 1800-800 cm
-1
 region, for control (black), and 
anti-Fas (red) treated A3 dried cell suspensions. All spectra were obtained from a single prepara-
tion. 23 and 26 spectra were collected for control and anti-Fas treated samples. Each spectrum 
shown results from the coaddition of 64 interferograms.  All spectra are at 4 cm
-1
 spectral resolu-
tion. (B) The same spectra as in (A) anti-Faster standardization. For standardization, the mean 
absorbance is subtracted from the spectrum, which is then divided by the standard deviation. (C) 
Average of the spectra in (B). The error bars represent the standard deviation (plus/minus) of all 
of the spectra shown in (B) at each frequency. (D) Averaged spectra shown in (C) without the 
error bars. (E) Same as the spectra in (D) except results are for five separate experiments for cells 
grown and treated on different days. Spectra on each day are shifted vertically for ease of com-
parison. Each spectrum in (E) is the average of ~25 spectra.  
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Figure 3: Standardized IR absorption spectra (top), second derivative spectra (bottom) 
and absorbance difference spectra (middle) in the (A) 1770-1450, (B) 1500-1150 and (C) 1150-
900 cm
-1
 regions, for control A3 cells (black), control for A3 cells that underwent the same 
treatment as UVC irradiated cells (red), sorbitol treated A3 cells (magenta), anti-Fas treated A3 
cells (green) and A3 cells that were irradiated with UVC light (blue). Absorbance spectra are the 
average of six independent measurements. In each experiment ~25 spectra were collected from 
different points on 2-3 sample “drops”. The second derivative spectra are calculated from the 
absorbance spectra and have not been smoothed.  The second derivative spectra were scaled by 
100 and shifted vertically for ease of comparison. Corresponding absorbance and second deriva-
tive spectra are displayed using the same color scheme. Five FTIR absorbance difference spectra 
were calculated from the absorbance spectra, and are numbered and colored differently accord-
ing to the labels. For example, difference spectrum 1 is the subtraction of the spectrum of control 
cells from the spectrum of anti-Fas treated cells. All absorbance difference spectra have been 
scaled by a factor of three for ease of viewing.  Abbreviations: AF - anti-Fas, S - sorbitol, UVT - 
UV treated, CUV - UV control, C-control.  
 
Figure 4: (A) Inner (black) and intra (red) difference spectra calculated from spectra of 
control and anti-Fas-treated cells obtained in six different experiments.  The individual spectra 
used to calculate the two averaged spectra in each experiment are chosen at random.  Inner dif-
ference spectra:  (control1 minus control2) and (anti-Fas treated1 minus anti-Fas treated2). Intra 
difference spectra: (control1 minus anti-Fas treated1) and (control2 minus anti-Fas treated2).  (B) 
p-values calculated using the WRST applied to the intra difference spectra shown in Figure 4A.  
The inset shows an expanded view of the p-value data.   
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5.2 Supplementary information for analyzing T-Cells datasets 
5.2.1 Principal component discriminant analysis 
As described in section 5.1, FTIR raw T-Cell data measured in 6 different days were used in 
this analysis. Since pair-wise comparison can only work for two group comparisons, here we ap-
ply a multi-group comparison method, PCA-LDA, to explore and compare the different results. 
We categorized five different treatments to into five different clusters, which are AntiFas (AF), 
Control (C), ControlUV (CUV or CU), Sorbitol (S) and UVtreated (UV), and treated them to-
gether as a whole.  
The same procedures (PCA-LDA with LOOCV using SAS (SAS Institute Inc., Cary, NC, 
USA)) that were used for Vero cell analysis were applied to T-Cell data, as described in the pre-
vious chapter.  
Data analysis procedures are listed below:  
1. Data were standardized for each treatment separately. Standardization method is to stan-
dardize data through frequencies. In other words, if mean = mean of absorbance (Abs) of 
365 frequencies (there are 365 frequencies total), and sd = second deviation of 300 fre-
quency abs., then (abs-mean)/sd. All data were merged into one file using MATLAB and 
mark each day as 1 to 6 and marked for each treatment as 1 to 5 (AntiFas=1, Control=2, 
ControlUV=3, Sorbitol=4 and UVtreated=5). 
2. Data structure were indicated as in Table 5-1 below: 365 variables (Var, wavenumbers), 
721 observations (Obs) (~120 spectra for each treatment), 5 treatments (inf) : (af, c, cuv, 
s, uv) , 6 days of repeats (date). Note: Treatment S data only has 5 days of repeats, as day 
3 was missing here.  
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3. To analyze the dataset and distinguish each treatment, principal component discriminant 
analysis (PCA-LDA) was applied to the standardized dataset. All multivariate analysis 
was performed using SAS 9.1 (SAS Institute Inc., Cary, NC, USA). The merged file was 
processed first using the principal component discriminant analysis (PCA-LDA) method 
as well as the leave-one-out cross-validation.  
4. Dataset was imported in SAS and then the principle components (PCs) were calculated. 
The first 25 principle components, representing nearly 95% of all the information from 
the spectra, are applied to the linear discriminant analysis (LDA).  
5. How many PCs we chose depended on what level of discriminant level (sensitivity and 
specificity) we required.  In order to find the best number of PCs we repeated the PCA-
LDA analysis several times by increasing the number of PCs we used.  The number of 
PCs was increased starting from 2 until the associated highest classification accuracies 
(sensitivity and specificity) were reached. For our dataset, 25 was a good number of PCs 
when balancing the minimum information input and better classification accuracies.  
6. The classification accuracies, sensitivity and specificity, were computed by performing 
the leave-one-out cross validation method. Leave-one-out is the degenerate case of K-
Fold Cross Validation, where K is chosen as the total number of total spectra.  Leave-
one-out cross-validation (LOOCV) involves using a single observation from the original 
data as the validation data, and the remaining observations as the training data. This is re-
peated such that each observation in the sample is used once as the validation da-
ta.   Therefore, the averages of all sensitivity and specificity were the final classification 
accuracies. 
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7. To better visualize the separation among clusters produced by this Multivariate analysis, 
one 3D plot and one 2D plot (Figure 5-1) below were drawn by MatLab R2009a (The 
Mathworks Inc. Natick, MA), where each cluster corresponded to the differentiation 
treatment for T-Cells. AntiFas is in blue. Control is in red. ControlUV is in cyan. Sorbitol 
is in magenta. UVTeated is in green. 
 
5.2.1.1 Results and Discussions 
Analysis results are presented in Table 5-2 and Figure 5-1. In Figure 5-1, it can be seen 
from the 2D or 3D plot that the control is well-separated from the remaining groups and that 
each cluster only slightly overlaps with any nearby group.  The 100% sensitivity and 99.8% spe-
cificity in Table 5-2 also indicate that the control is well-separated from the remaining groups. 
We also show good discrimination among all five clusters, which should indicate that PCA-LDA 
with LOOCV is a good method for multi-group analysis. 
We also examined the results by using different numbers of PCs. Table 5-3 presents re-
sults for PCA-LDA with 365 PCs applied in the analysis with a nearly 100% sensitivity and spe-
cificity. As the number of PCs decrease, classification ability decreased dramatically as shown in 
Table 5-4 (10 PCs) and Table 5-5 (7 PCs). This result agrees with the hypothesis that the more 
information (more PCs) from the datasets we  have, the better the discrimination ability that can 
be achieved. 
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Figure 5-1 Scatter Plots of PCA-LDA Using 25 PCs with 2D and 3D view. 
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Table 5-1  Data structure for all T-Cell with five different treatments. 
 Var1 … Var365 inf date 
Abs1  
Intensity 
1 1 
 … .
. 
 1 6 
 2 1 
 … .
. 
… 2 6 
 … 1 
 … .
. 
Abs721 5 6 
 
Table 5-2 Results for PCA-LDA with LOOCV 25 PCs applied in the analysis. 
25PCs 
 FT-IR predic-
tion             
AntiFas Control ControlUV Sorbitol UVTreated 
1 2 3 4 5 
AntiFas 1 123 0 0 3 14 
Control 2 0 148 0 0 0 
ControlUV 3 2 1 131 0 19 
Sorbitol 4 4 0 0 125 0 
UVTreated 5 11 0 15 0 127 
Number Correct        123 148 131 125 127 
 
Sensitivity 87.86% 100.00% 85.62% 96.90% 83.01% 
Specificity 96.90% 99.80% 97.21% 99.44% 94.11% 
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Table 5-3 Results for PCA-LDA with 365 PCs applied in the analysis. 
365 PCs 
      FT-IR prediction   AntiFas Control ControlUV Sorbitol UVTreated 
1 2 3 4 5 
AntiFas 1 139 1 0 0 0 
Control 2 0 148 0 0 0 
ControlUV 3 0 0 150 1 0 
Sorbitol 4 0 0 0 123 6 
UVTreated 5 0 0 0 6 147 
Number Correct        139 148 150 123 147 
 
sensitivity 99.29% 100.00% 99.34% 95.35% 96.08% 
specificity 100.00% 99.82% 100.00% 98.82% 98.94% 
 
 
 
Table 5-4 Results for PCA-LDA with 10 PCs applied in the analysis. 
10 PCs 
      FT-IR prediction             AntiFas Control ControlUV Sorbitol UVTreated 
1 2 3 4 5 
AntiFas 1 85 1 0 25 29 
Control 2 0 146 0 2 0 
ControlUV 3 0 5 124 1 21 
Sorbitol 4 16 2 0 104 7 
UVTreated 5 32 0 24 18 79 
Number Correct        85 146 124 104 79 
 
sensitivity 60.71% 98.65% 82.12% 80.62% 51.63% 
specificity 90.42% 98.00% 94.52% 90.42% 88.95% 
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Table 5-5 Results for PCA-LDA with 7 PCs applied in the analysis. 
7 PCs 
      FT-IR prediction             AntiFas Control ControlUV Sorbitol UVTreated 
1 2 3 4 5 
AntiFas 1 84 2 0 23 31 
Control 2 1 123 15 9 0 
ControlUV 3 0 22 108 5 16 
Sorbitol 4 16 6 1 98 8 
UVTreated 5 44 0 25 12 72 
Number Correct        84 123 108 98 72 
 
sensitivity 60.00% 83.11% 71.52% 75.97% 47.06% 
specificity 86.80% 92.35% 90.19% 88.76% 88.25% 
 
 
We have preformed PCA-LDA with leave-one-out cross validation. The results show the 
same level of accuracy of discrimination as described in the literature [30] .  However, we 
encountered another problem due to the same variation of the spectra we collected from dif-
ferent days. 
Leave-one-out cross-validation (LOOCV) involves using a single spectrum from all the 
spectra collected over different days as the validation data, and the remaining spectra as the 
training data. This is the same as a K-fold cross-validation with K being equal to the number 
of observations in the original sample.  If the data collected over different days proves to be 
consistent (no statistical difference over days among all spectra) or the distribution of the ob-
served sample is the same as the population distribution, we will get similar results from K-
fold cross-validation (with k equal to any number) as the results we got from leave-one-out, 
which represents a fair cross validation. 
However, we obtained a much lower sensitivity and specificity from leaving one out of 
six days (all the spectra collected from one day) out of the cross validation (6-fold CV) (refer 
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to 5.2.2), which showed that our sample size is too small to apply the PCA-LDA k-fold CV 
method. Statistically speaking, 20 independent datasets will be a good sample size for any 
type of statistical analysis. Therefore, we have to employ a new method to reduce the influ-
ence of the variation from the different days due to our current sample size. Thus, we have 
settled on the new pair wise comparison method (as we discussed in 5.1) that we applied to 
our T-Cell datasets with a sample size equal to 6. 
In the process of pair wise comparison, the most important step is to use inner intra dif-
ferences. Naturally, one question will arise: why do we use inner intra differences?   In order 
to test whether there is a difference between population means of any two groups (two differ-
ent treatments), our data should satisfy two conditions: 
1. The two populations have the same variance. This assumption is called the as-
sumption of homogeneity of variance. To prove this assumption, we have to prove 
that the variances of inner-differences within treatment type 1 should be the same 
as that within treatment type 2. We applied a homogeneous variance test to the 
two kinds of inner difference, and the homogeneous variance was confirmed. 
2. The populations are normally distributed. We randomly divided all spectra obser-
vation points into two equal groups for each treatment, and find their average ab-
sorbances and inner and intra differences. From central limit theorem, both inner 
and intra-differences have approximately normal distributions. 
Only by satisfying these two conditions, can the statistical results derived from all the statis-
tical methods be treated as reliable. However, most of the statistical methods employed in the 
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literature do not attempt to meet these conditions; therefore, it is unclear whether or not the re-
sults from those studies are statistically significant [30]. 
In order to reduce the influence of the variability among the data observed in different dates, 
we will only use the differences of the absorbances between two groups (two different treat-
ments) from the same date.  To apply pair wise comparison, a control group was created by find-
ing the difference between two spectra from treatment 1 and two spectra from treatment 2. Be-
fore the subtraction, we randomly divided all spectral observation points into two equal groups 
for two different treatments, and found their average absorbances.  The differences between the 
same treatments are called inner-difference, and the differences between different treatments are 
called intra-difference.  
 
5.2.2  Linear regression analysis 
As we discussed above, although the results from the PCA-LDA with LOOCV method 
turns out to indicate a good discrimination, the first LOOCV validation method does not prove to 
be sufficient to predict the new data due to the large variation from our dataset of each day.  In 
order to improve the PCA-LDA method, we expanded our test data size and used each single day 
for all five treatments as the test dataset and the other 5 days as the model dataset, which is the 
same as 6-fold cross validation. All the remaining parts of the method remain the same as in sec-
tion 5.2.  
To find the most significant variables, dummy variable coding was applied for linear re-
gression on each wavenumber, repeating the same procedure for all 365 wavenumbers. Each re-
gression returns one result with the p-value score. Only 37 variables, with a P-value smaller than 
0.0002, were then selected for principle component calculation.   Based on all 37 variables, the 
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first 25 PCs were calculated and input into LDA. To validate the model, leave one-day–out cross 
validation was applied to calculate the sensitivity and specificity for each treatment. Averaged 
sensitivity and specificity are listed in the table below. 
       To find out the shrinkage and the final sensitivity: 
1. Pick out the variables with P-value < 0.0002 from model in stand of from all 5 
single values (intercept, af, cuv, s, uv)  
2. Apply regression method (REG) to all 6 day’s datasets. 345 variables were found 
out to be significant. Find out sensitivity for each type, called model sensitivity.  
(No specificity needed here due to a multi-group comparison). 
3. Apply REG for five of the 6 days data. 339 variables were found to be significant.  
Find out the sensitivity for each type, called molde1 sensitivity. 
4. Use the same variables from model1 - 339 variables - to test left-out dataset.  
Find out the sensitivity for each type, called test1 sensitivity. 
5. Steps 2 and 3 are repeated for all 6 days datasets.  
Find the average of model1-model6 sensitivity, and the average of the 
test1-test6 sensitivity. 
6. Find the shrinkage using average of model1-6 sensitivity minus average of test1-6 
sensitivity. 
7. Find the final sensitivity using model sensitivity from step 1 minus the shrinkage. 
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5.2.2.1 Results 
Table 5-7 is an output from PCA-LDA method with leave-one-day-out cross validation 
(left) and leave-two-days-out cross validation (right).  Table 5-8 displays the results from apply-
ing regression analysis with the PCA-LDA method, along with validation using leave-one-day-
out cross validation (left) and leave-two-days-out cross validation (right). 
 The results below did not satisfy the classification requirement (less than 50%). Howev-
er, comparing the left side of Table 5-6 and 5-7, there is a small improvement on the shrinkage 
due to the regression analysis, and final sensitivity has been slightly increased by 0.1% for table 
5-7, which indicates that regression analysis is a good approach for picking out the significant 
variables.  Cross validation with leaving two days out produces smaller sensitivity rather than 
from leaving one day out. Again, this indicates that our datasets have substantial day-to-day vari-
ation. 
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Table 5-6 Results for only apply PCA-LDA (No regression analysis applied) with 25 
PCs. 
 
Leave One Day Out Leave Two Days Out 
Model 
sensitivity shrinkage 
final sen-
sitivity 
Model 
sensitivity shrinkage 
final sen-
sitivity 
Sensitivity for AF 0.921429 0.518549 0.40288 0.942857 0.582134 0.360723 
Sensitivity for C 1 0.624676 0.375324 1 0.531145 0.468855 
Sensitivity for CUV 0.854305 0.334422 0.519882 0.86755 0.663314 0.204236 
Sensitivity for S 0.790698 0.702369 0.088329 0.821705 0.704757 0.116948 
Sensitivity for UV 0.777778 0.453766 0.324012 0.810458 0.660394 0.150064 
 
 
Table 5-7 Results for applying regression analysis and PCA-LDA by using dummy 
coding REG with 25 PCs. 
 
Leave One Day Out Leave Two Days Out 
Model 
sensitivity shrinkage 
final sen-
sitivity 
Model 
sensitivity shrinkage 
final sen-
sitivity 
Sensitivity for 
AF 
0.842857 0.297309 0.545548 0.857143 0.611794 0.245348 
Sensitivity for 
C 
1 0.509837 0.490163 1 0.634292 0.365708 
Sensitivity for 
CUV 
0.854305 0.56418 0.290125 0.854305 0.607011 0.247294 
Sensitivity for 
S 
0.821705 0.521282 0.300424 0.844961 0.640492 0.204469 
Sensitivity for 
UV 
0.751634 0.580397 0.171237 0.784314 0.62643 0.157884 
 
 
 
 
 
5.2.3  “Summing by five” procedure 
Before we applied pair wise comparison, we performed the sum-by-five procedure.  
Summing by five is a routine procedure for minimizing the data variation caused by slight wave-
number shifting, which we first developed for comparing mock and HSV1 infected data sets. 
Since we obtained great accuracies from the method we developed, we naturally applied the 
same procedure to the T-Cell data. However, it was necessary to determine that summing by five 
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was a helpful step for analyzing the T-Cell data. Therefore, we applied the same method with 
and without summing by five.  
Each comparison group (AF vs C, AF vs CUV, AF vs UV, C vs S, CUV vs S, S vs UV) 
has two figures (inner intra difference data plot and P-value plot) for data processed with or 
without summing by five and one result table for the data processed with and without summing 
by five together. Figure 5-2 plots the intra (red) and inner (blue) differeences for AF vs C. Figure 
5-3 shows the p-value plot for the AF vs C with and without summing-by-five. Similarly, Figure 
5-4 plots the intra (red) and inner (blue) differeences for AF vs CUV. Figure 5-5 shows the p-
value plot for the AF vs CUV with and without summing-by-five, so on through S vs. UV.  
Table 5-8 shows results for AF vs C from multivariate statistical analysis with the sum-
ming-by-five step (Table A) and without summing-by-five (Table B). Similarly, Table 5-9 shows 
results for AF vs CUV from multivariate statistical analysis with the summing-by-five step (Ta-
ble A) and without summing-by-five (Table B), so on through S vs. UV.  For each table, we em-
ployed two methods to determine the model and test datasets. First, we applied 2-fold cross vali-
dation, which normally gives an under-estimated shrinkage. The intra or inner differences were 
split into model and test groups, called model intra and test intra or model inner and test inner. 
We applied WSRT only on the model intra data to determine the significant frequencies. PLSR 
was then applied to the selected frequencies for model intra and model inner data sets.  By apply-
ing the same discriminators for PLSR as for the model intra and inner sets, we were able to cal-
culate the predicted values for the test sets. We calculated sensitivity, specificity and AUC from 
the predicted values of PLSR for both model and test sets. By finding the difference between 
these two specificities, we obtained estimates of the shrinkage (Col3). Specificity of Cross Vali-
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dation (Col4) was calculated by subtracting this shrinkage (Col3) from the specificity for original 
data (Col2). 
The second method we used to determine the model and test datasets was the bootstrap 
method, which normally gives an over-estimated shrinkage. Model datasets for bootstrap were 
calculated by constructing a number of resamples. Resampling entails drawing randomly with 
replacement from a set of data points of the observed dataset, which are of equal size to the orig-
inal observed datasets. Test datasets refers to the original observed dataset. By applying WSRT 
only on the model intra data, we determined the significant frequencies. PLSR was then applied 
to the selected frequencies for model intra and inner data. By applying the same discriminators 
for PLSR as for model datasets, predicted values of PLSR were calculated for the test datasets. 
Following the same procedures as for CV, we calculated column 5, shrinkage from Bootstrap, 
and Column 6, Specificity calculated using Bootstrap. Col 6 was obtained by subtracting column 
5 from column 1. By finding the average of these two specificities, as in column 7, we can have 
fairly accurate final specificities and AUC for three different sensitivities.  
All the results indicated that not using the “summing-by-five” step seems to increase the 
values for specificities and AUC, except for the comparison for AF vs CUV. As can be seen in p-
value plot, summing by five not only smooth the data but also overwrites the fine details of the 
spectra, thereby, decreasing the information from spectra as well as the discrimination ability. 
Again, it proves that the discrimination method is highly depended upon the dataset itself. 
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Figure 5-2 Plot of intra (red) and inner (blue) differeences for AF vs C. 
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Figure 5-3 P-value plot for AF vs C. 
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Table 5-8 Results for AF vs C from multivariate statistical analysis with the summing-by-
five5 step (Table A) and without summing by 5 (Table B). 
Column 
1 
Column 2 Column 4 Column 3 Column 6 Column 
5 
Column 7 
Table A 
 
Specificity  
for original 
data 
Specificity  
of cross va-
lidation(CV) 
Shrin-
kage 
from CV 
Specifici-
ty  of 
boots 
trap(BT) 
Shrin-
kage 
from BT 
Average of 
Specificity 
between 
CV and 
BT 
Sensitiv-
ity=95% 
1 0.417231 0.582769 0.900246 0.09975
4 
0.658739 
Sensitiv-
ity=90% 
1 0.575665 0.424335 0.947589 0.05241
1 
0.761627 
Sensitiv-
ity=80% 
1 0.770638 0.229362 0.987636 0.01236
4 
0.879137 
AUC 1 0.868054 0.131946 0.983807 0.01619
3 
0.92593 
 
Table B Specificity  
for original 
data 
Specificity  
of cross va-
lidation(CV) 
Shrin-
kage 
from CV 
Specifici-
ty  of 
boots 
trap(BT) 
Shrin-
kage 
from BT 
Average of 
Specificity 
between 
CV and 
BT 
Sensitiv-
ity=95% 
1 0.468454 0.531546 0.897549 0.10245
1 
0.683002 
Sensitiv-
ity=90% 
1 0.62774 0.37226 0.962876 0.03712
4 
0.795308 
Sensitiv-
ity=80% 
1 0.814154 0.185846 0.994723 0.00527
7 
0.904438 
AUC 1 0.895182 0.104818 0.985263 0.01473
7 
0.940222 
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Figure 5-4 Plot of intra (red) and inner (blue) differeences for AF vs CUV. 
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With summing by 5: 
 
Without summing by 5: 
 
Figure 5-5 P-value plot for AF vs CUV. 
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Table 5-9 Results for AF vs CUV from multivariate statistical analysis with the summing-
by-five5 step (Table A) and without summing by 5 (Table B). 
Column 
1 
Column 2 Column 4 Column 3 Column 6 Column 
5 
Column 7 
Table A 
 
Specificity  
for original 
data 
Specificity  
of cross va-
lidation(CV) 
Shrin-
kage 
from CV 
Specifici-
ty  of 
boots 
trap(BT) 
Shrin-
kage 
from BT 
Average of 
Specificity 
between 
CV and 
BT 
Sensitiv-
ity=95% 
1 0.558799 0.441201 0.736558 0.26344
2 
0.647678 
Sensitiv-
ity=90% 
1 0.66786 0.33214 0.823657 0.17634
3 
0.745759 
Sensitiv-
ity=80% 
1 0.748701 0.251299 0.944113 0.05588
7 
0.846407 
AUC 1 0.876465 0.123535 0.954322 0.04567
8 
0.915393 
 
Table B Specificity  
for original 
data 
Specificity  
of cross va-
lidation(CV) 
Shrin-
kage 
from CV 
Specifici-
ty  of 
boots 
trap(BT) 
Shrin-
kage 
from BT 
Average of 
Specificity 
between 
CV and 
BT 
Sensitiv-
ity=95% 
1 0.533018 0.466982 0.724671 0.27532
9 
0.628845 
Sensitiv-
ity=90% 
1 0.660364 0.339636 0.812766 0.18723
4 
0.736565 
Sensitiv-
ity=80% 
1 0.725095 0.274905 0.94302 0.05698 0.834057 
AUC 1 0.858824 0.141176 0.954524 0.04547
6 
0.906674 
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Figure 5-6 Plot of intra (red) and inner (blue) differeences for AF vs UV. 
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Figure 5-7 P-value plot for AF vs UV. 
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Table 5-10 Results for AF vs UV from multivariate statistical analysis with the summing-
by-five5 step (Table A) and without summing by 5 (Table B). 
Column 
1 
Column 2 Column 4 Column 3 Column 6 Column 
5 
Column 7 
Table A 
 
Specificity  
for original 
data 
Specificity  
of cross va-
lidation(CV) 
Shrin-
kage 
from CV 
Specifici-
ty  of 
boots 
trap(BT) 
Shrin-
kage 
from BT 
Average of 
Specificity 
between 
CV and 
BT 
Sensitiv-
ity=95% 
1 0.126495 0.873505 0.633311 0.36668
9 
0.379903 
Sensitiv-
ity=90% 
1 0.198035 0.801965 0.741243 0.25875
7 
0.469639 
Sensitiv-
ity=80% 
1 0.40181 0.59819 0.877079 0.12292
1 
0.639444 
AUC 1 0.659719 0.340281 0.926099 0.07390
1 
0.792909 
 
Table B Specificity  
for original 
data 
Specificity  
of cross va-
lidation(CV) 
Shrin-
kage 
from CV 
Specifici-
ty  of 
boots 
trap(BT) 
Shrin-
kage 
from BT 
Average of 
Specificity 
between 
CV and 
BT 
Sensitiv-
ity=95% 
1 0.155769 0.844231 0.716519 0.28348
1 
0.436144 
Sensitiv-
ity=90% 
1 0.280485 0.719515 0.829327 0.17067
3 
0.554906 
Sensitiv-
ity=80% 
1 0.521599 0.478401 0.949026 0.05097
4 
0.735313 
AUC 1 0.727681 0.272319 0.955183 0.04481
7 
0.841432 
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Figure 5-8 Plot of intra (red) and inner (blue) differeences for C vs S. 
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Figure 5-9 P-value plot for C vs S. 
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Table 5-11 Results for C vs S from multivariate statistical analysis with the summing-by-
five5 step (Table A) and without summing by 5 (Table B). 
Column 
1 
Column 2 Column 4 Column 3 Column 6 Column 
5 
Column 7 
Table A 
 
Specificity  
for original 
data 
Specificity  
of cross va-
lidation(CV) 
Shrin-
kage 
from CV 
Specifici-
ty  of 
boots 
trap(BT) 
Shrin-
kage 
from BT 
Average of 
Specificity 
between 
CV and 
BT 
Sensitiv-
ity=95% 
1 0.192917 0.807083 0.883527 0.11647
3 
0.538222 
Sensitiv-
ity=90% 
1 0.28253 0.71747 0.937295 0.06270
5 
0.609912 
Sensitiv-
ity=80% 
1 0.438371 0.561629 0.986974 0.01302
6 
0.712672 
AUC 1 0.700088 0.299912 0.983701 0.01629
9 
0.841894 
 
Table B Specificity  
for original 
data 
Specificity  
of cross va-
lidation(CV) 
Shrin-
kage 
from CV 
Specifici-
ty  of 
boots 
trap(BT) 
Shrin-
kage 
from BT 
Average of 
Specificity 
between 
CV and 
BT 
Sensitiv-
ity=95% 
1 0.279215 0.720785 0.836632 0.16336
8 
0.557923 
Sensitiv-
ity=90% 
1 0.324684 0.675316 0.92501 0.07499 0.624847 
Sensitiv-
ity=80% 
1 0.443004 0.556996 0.985951 0.01404
9 
0.714478 
AUC 1 0.70921 0.29079 0.978099 0.02190
1 
0.843655 
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Figure 5-10 Plot of intra (red) and inner (blue) differeences for CUV vs S. 
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Figure 5-11 P-value plot for CUV vs. S.  
 bl ue- - >i nner  di f f er ence,  r ed- - >i nt r a di f f er ence
pVal ue
<. 0001
0. 1000
0. 2000
0. 3000
0. 4000
0. 5000
0. 6000
0. 7000
0. 8000
0. 9000
1. 0000
x
700 800 900 1000 1100 1200 1300 1400 1500
 bl ue- - >i nner  di f f er ence,  r ed- - >i nt r a di f f er ence
pVal ue
<. 0001
0. 1000
0. 2000
0. 3000
0. 4000
0. 5000
0. 6000
0. 7000
0. 8000
0. 9000
1. 0000
x
700 800 900 1000 1100 1200 1300 1400 1500 1600
159 
 
Table 5-12 Results for CUV vs S from multivariate statistical analysis with the summing-
by-five5 step (Table A) and without summing by 5 (Table B). 
Column 
1 
Column 2 Column 4 Column 3 Column 6 Column 
5 
Column 7 
Table A 
 
Specificity  
for original 
data 
Specificity  
of cross va-
lidation 
(CV) 
Shrin-
kage 
from CV 
Specifici-
ty  of 
boots trap 
(BT) 
Shrin-
kage 
from BT 
Average of 
Specificity 
between 
CV and 
BT 
Sensitiv-
ity=95% 
1 0.483349 0.516651 0.765434 0.07929 0.624391 
Sensitiv-
ity=90% 
1 0.566802 0.433198 0.861608 0.05832
7 
0.714205 
Sensitiv-
ity=80% 
1 0.640094 0.359906 0.924422 0.04863
6 
0.782258 
AUC 1 0.795005 0.204995 0.952125 0.02240
5 
0.873565 
 
Table B Specificity  
for original 
data 
Specificity  
of cross va-
lidation 
(CV) 
Shrin-
kage 
from CV 
Specifici-
ty  of 
boots trap 
(BT) 
Shrin-
kage 
from BT 
Average of 
Specificity 
between 
CV and 
BT 
Sensitiv-
ity=95% 
1 0.360015 0.639985 0.850202 0.14979
7 
0.605108 
Sensitiv-
ity=90% 
1 0.447298 0.552702 0.893942 0.10605
8 
0.67062 
Sensitiv-
ity=80% 
1 0.63202 0.36798 0.929031 0.07096
9 
0.780525 
AUC 1 0.79129 0.20871 0.963318 0.03668 0.877304 
 
  
160 
 
 
Figure 5-12 Plot of intra (red) and inner (blue) differeences for UV vs S. 
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With summing by 5
Without summing by 5:
 
Figure 5-13 P-value plot for UV vs. S 
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Table 5-13 Results for S vs. UV from multivariate statistical analysis with the summing-by-
five5 step (Table A) and without summing by 5 (Table B). 
Column 
1 
Column 2 Column 4 Column 3 Column 6 Column 
5 
Column 7 
Table A 
 
Specificity  
for original 
data 
Specificity  
of cross va-
lidation 
(CV) 
Shrin-
kage 
from CV 
Specifici-
ty  of 
boots trap 
(BT) 
Shrin-
kage 
from BT 
Average of 
Specificity 
between 
CV and 
BT 
Sensitiv-
ity=95% 
1 0.141767 0.858233 0.679904 0.27178
5 
0.410836 
Sensitiv-
ity=90% 
1 0.234523 0.765477 0.764398 0.19833 0.49946 
Sensitiv-
ity=80% 
1 0.376591 0.623409 0.846083 0.12957
8 
0.611337 
AUC 1 0.675637 0.324363 0.902798 0.08348
4 
0.789217 
 
Table B Specificity  
for original 
data 
Specificity  
of cross va-
lidation(CV) 
Shrin-
kage 
from CV 
Specifici-
ty  of 
boots 
trap(BT) 
Shrin-
kage 
from BT 
Average of 
Specificity 
between 
CV and 
BT 
Sensitiv-
ity=95% 
1 0.124267 0.875733 0.686234 0.25856
3 
0.405251 
Sensitiv-
ity=90% 
1 0.227962 0.772038 0.778943 0.17808
1 
0.503452 
Sensitiv-
ity=80% 
1 0.404942 0.595058 0.878393 0.09642
3 
0.641667 
AUC 1 0.656552 0.343448 0.926709 0.06051
3 
0.791631 
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5.2.4 A3 cell infected with HSV1 
We also used A3 T-Cells infected with HSV1 in different MOI (0, 1, 2.5 and 5). The 
same pair-wise comparison procedure was performed on datasets infected with MOI=0 (mock) 
and MOI=1, 2.5 or 5, as described previously. As indicated in Table 5-14, we repeated experi-
ments five times for MOI=1, nine times for MOI=2.5 and four times for MOI=5. Figure 5-14 
shows the “ Inner vs Intra” (Left) and “P-value” (Right) graphs, for comparison between unin-
fected T-Cell (mock) and T-Cell infected with HSV1 at MOI=1 (Top), 2.5 (Middle) and 5 (Bot-
tom).  It should be noted that the P-value plot for MOI=2.5 is dramatically different than the re-
sults from the other two. Fewer wavenumbers were selected as the significant variables under P-
value equals to 0.05 at MOI=2.5. 
Table 5-15 shows the results (specificities, shrinkage and AUC) from pair-wise compari-
son for T-Cells infected with HSV1 at different MOIs.  In Table 5-15, results under the final spe-
cificity column indicate that MOI=5 has a better discriminating ability between infected and un-
infected samples over MOI=2.5 and 1.  
Table 5-16 shows the common wavenumbers for discriminating the HSV1 infected sam-
ples from the mock. Significant wavenumbers were selected from WSRT under P-value=0.05. 
The blue highlights the common wavenumbers for any two datasets with different MOI. The red 
highlights the common significant wavenumbers for all three datasets with MOI=1, 2.5 and 5. 
There are only six common wavenumbers selected for all three comparison groups: 1145, 1155, 
1165, 1174, 1184, and 1550 cm
-1
. Another feature revealed in Table 5-16 is that for MOI=1 and 
5, P-values are much lower than those for MOI=2.5, which is also shown in the P-value plot for 
MOI=2.5 in Figure 5-14.    
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Figure 5-14 “ Inner vs Intra” difference spectra (Left) and “P-value” (Right) graphs 
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Table 5-14 Experiment list for T-Cell infected with HSV1 at different MOI=0 (T-Cell 
mock), 1, 2.5 and 5. 
Date T-Cell 
mock 
T-Cell in-
fected with 
HSV1 at 
MOI=1 
T-Cell in-
fected with 
HSV1 at 
MOI=2.5 
T-Cell in-
fected with 
HSV1 at 
MOI=5 
Day1 m, m 1, 1   
Day2 M 1,  5 
Day3 M 1,1  5,5 
Day4 M   5 
Day5 m,m,m  2.5,2.5,2.5  
Day6 m,m,m  2.5,2.5,2.5  
Day7 m,m,m  2.5,2.5,2.5  
repeats  5 9 4 
 
 
Table 5-15 Results from pair-wise comparison method for T-Cell data infected with differ-
ent MOI. 
MOI=5 
Pva-
lue(CV)=0.2 
Pva-
lue(BT)=0.01 
Speci-
ficity 
for CV 
model 
Speci-
ficity 
for 
cross 
valida-
tion 
Shrin-
kage 
for CV 
Speci-
ficity 
for BT 
model  
Speci-
ficity 
for BT 
test 
Shrin-
kage 
for BT 
Final 
shrin-
kage 
Final 
speci-
ficity 
Sensitivi-
ty=95% 
1 0.46583
4 
0.5341
66 
1 0.90831 0.0916
9 
0.3129
28 
0.6870
72 
Sensitivi-
ty=90% 
1 0.73993
1 
0.2600
69 
1 0.97393
3 
0.0260
67 
0.1430
68 
0.8569
32 
Sensitivi-
ty=80% 
1 0.93166
2 
0.0683
38 
1 0.99960
4 
0.0003
96 
0.0343
67 
0.9656
33 
AUC 1 0.92435
9 
0.0756
41 
1 0.98727
4 
0.0127
26 
0.0441
84 
0.9558
16 
 
MOI=2.5 
Pva-
lue(CV)=0.3 
Pva-
lue(BT)=0.05 
Speci-
ficity 
for CV 
model 
Speci-
ficity 
for 
cross 
valida-
tion 
Shrin-
kage 
for CV 
Speci-
ficity 
for BT 
model  
Speci-
ficity 
for BT 
test 
Shrin-
kage 
for BT 
Final 
shrin-
kage 
Final 
speci-
ficity 
Sensitivi-
ty=95% 
1 0.12269
5 
0.8773
05 
0.96844
3 
0.74950
1 
0.2189
42 
0.5481
23 
0.4518
77 
Sensitivi-
ty=90% 
1 0.23219
4 
0.7678
06 
0.97491
6 
0.86145
5 
0.1134
61 
0.4406
34 
0.5593
66 
Sensitivi- 1 0.49498 0.5050 0.98372 0.96374 0.0199 0.2625 0.7374
166 
ty=80% 3 17 4 84 01 99 
AUC 1 0.76766
6 
0.2323
34 
0.99308
9 
0.96138
2 
0.0317
07 
0.1320
2 
0.8679
8 
 
MOI=1 
Pva-
lue(CV)=0.2 
Pva-
lue(BT)=0.00
3 
Speci-
ficity 
for CV 
model 
Speci-
ficity 
for 
cross 
valida-
tion 
Shrin-
kage 
for CV 
Speci-
ficity 
for BT 
model  
Speci-
ficity 
for BT 
test 
Shrin-
kage 
for BT 
Final 
shrin-
kage 
Final 
speci-
ficity 
Sensitivi-
ty=95% 
1 0.19970
7 
0.8002
93 
0.91017
5 
0.48375
3 
0.4264
23 
0.6133
58 
0.3866
42 
Sensitivi-
ty=90% 
1 0.26500
7 
0.7349
93 
0.94641 0.62700
5 
0.3194
05 
0.5271
99 
0.4728
01 
Sensitivi-
ty=80% 
1 0.41770
5 
0.5822
95 
0.97467
4 
0.84202
1 
0.1326
52 
0.3574
74 
0.6425
26 
AUC 1 0.71218
8 
0.2878
12 
0.98137
8 
0.90659
4 
0.0747
84 
0.1812
98 
0.8187
02 
 
 
 
Table 5-16 Significant wavenumbers selected from WSRT under P-value=0.05. 
MOI=1 MOI=2.5 MOI=5 
P-value<0.05  Wavenumb-
ers  
P-
value<0.05  
Wavenumbers  P-
value<0.05  
Wavenumb-
ers  
        0.0391 856.3923 
        0.0391 866.0363 
        0.0234 875.6804 
0.0488 885.3245     0.0234 885.3245 
0.0371 894.9685     0.0234 894.9685 
0.0371 904.6126     0.0234 904.6126 
0.0371 914.2566     0.0234 914.2566 
0.0098 923.9007     0.0234 923.9007 
0.0039 933.5447     0.0156 933.5447 
0.0039 943.1888     0.0078 943.1888 
0.0039 952.8329     0.0078 952.8329 
0.0039 962.4769     0.0078 962.4769 
0.002 972.121     0.0078 972.121 
0.002 981.765     0.0078 981.765 
0.002 991.4091     0.0078 991.4091 
0.002 1001.053     0.0078 1001.053 
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0.0098 1010.697     0.0156 1010.697 
0.0098 1020.341     0.0156 1020.341 
0.0137 1029.985     0.0156 1029.985 
0.0137 1039.629     0.0156 1039.629 
0.0098 1049.273     0.0156 1049.273 
0.0273 1058.917     0.0156 1058.917 
0.0273 1068.562     0.0234 1068.562 
0.0273 1078.206     0.0234 1078.206 
0.0273 1087.85     0.0234 1087.85 
0.0273 1097.494     0.0234 1097.494 
0.0137 1107.138     0.0234 1107.138 
0.0137 1116.782     0.0156 1116.782 
0.0098 1126.426     0.0156 1126.426 
0.0059 1136.07     0.0078 1136.07 
0.0059 1145.714 0.0237 1145.714 0.0078 1145.714 
0.0059 1155.358 0.0304 1155.358 0.0078 1155.358 
0.0059 1165.002 0.3247 1165.002 0.0078 1165.002 
0.0098 1174.646 0.766 1174.646 0.0078 1174.646 
0.0273 1184.29 0.6095 1184.29 0.0781 1184.29 
    0.0208 1242.155     
    0.0104 1251.799     
    0.0385 1261.443     
0.0273 1348.239     0.0234 1348.239 
0.0137 1357.883     0.0156 1357.883 
0.0098 1367.527     0.0156 1367.527 
0.0098 1377.171     0.0078 1377.171 
0.0098 1386.815     0.0078 1386.815 
0.0039 1396.459     0.0078 1396.459 
0.0039 1406.104     0.0078 1406.104 
0.0039 1415.748     0.0078 1415.748 
0.0059 1425.392     0.0078 1425.392 
0.0059 1435.036     0.0078 1435.036 
0.0059 1444.68     0.0078 1444.68 
0.0059 1454.324     0.0078 1454.324 
0.0059 1463.968     0.0078 1463.968 
0.0059 1473.612     0.0078 1473.612 
0.0059 1483.256     0.0078 1483.256 
0.0098 1492.9     0.0078 1492.9 
0.0137 1502.544     0.0078 1502.544 
0.0273 1512.188     0.0078 1512.188 
0.0488 1521.832     0.0078 1521.832 
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        0.0781 1531.476 
    0.01
82 
1541.1
2 
0.00
78 
1541.
12 
0.0059 1550.764 0.0159 1550.764 0.0156 1550.764 
        0.0156 1560.408 
0.0098 1570.053     0.0078 1570.053 
0.0039 1579.697     0.0078 1579.697 
0.0039 1589.341     0.0078 1589.341 
0.0039 1598.985     0.0078 1598.985 
0.0098 1608.629     0.0078 1608.629 
0.0098 1618.273     0.0078 1618.273 
    0.0268 1627.917 0.0078 1627.917 
        0.0781 1637.561 
0.0137 1647.205     0.0156 1647.205 
0.0371 1656.849     0.0078 1656.849 
0.0488 1666.493     0.0078 1666.493 
0.0488 1676.137     0.0078 1676.137 
0.0488 1685.781     0.0234 1685.781 
    0.0056 1695.425 0.0391 1695.425 
    0.0047 1705.069     
    0.0139 1714.713     
        0.0391 1743.646 
        0.0391 1762.934 
        0.0391 1772.578 
        0.0391 1782.222 
0.0488 1791.866     0.0234 1791.866 
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6 CONCLUSIONS  
As we discussed in chapters two through four, infrared spectra obtained for Vero cells 
that are uninfected or infected with Herpes Simplex Virus type I can be distinguished using ad-
vanced statistical methods (pair-wise comparison) under certain experimental conditions. 
From the results of T-cell analysis, with knowledge of apoptosis-induced spectral bio-
markers we are able to (rapidly) assess how malignant cells respond (via apoptosis) to three dif-
ferent stresses. Thus a FTIR detection technology, together with knowledge of spectral biomark-
ers of malignant lymphocytes, may be a useful tool for rapidly testing drug resistance in leukem-
ic cells directly isolated from patients.  
The results of this study showed that Fourier transform infrared (FTIR) microscopy can 
be a promising analytical tool for detecting changes in cells due to viral infection and different 
treatment approaches under certain conditions. We can discriminate samples infected with virus-
es (HSV1 or coxsackie virus) from samples without infection at 6, 8, 12 and 24 hours post expo-
sure. Different statistical analyses (PCA-LDA, LR and PLSR) and appropriate validation proce-
dures were applied to our datasets. It should be noted that inner and intra variability should be 
carefully considered.  We observed significant differences in specific areas of the spectra, which 
allowed us to obtain different levels of discriminations, and nearly perfect discriminations be-
tween samples with and without infection for pair wise comparison at certain hours post expo-
sure.  
For statistical analysis procedures, FTIR studies of cells in different states should include 
an assessment of variation within each treatment for each experiment and variation between dif-
ferent repeats. The methods used here to calculate sensitivity and specificity for distinguishing 
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spectra from cells under different treatments accurately reflect how well FTIR spectra from un-
known cell types can be classified.  
In summary, FTIR microscopy can be a useful analytical tool for detecting changes in 
cells under certain types of conditions, and it certainly seems worthwhile to continue with the 
development of FTIR microscopy for the purpose of viral infection diagnosis and treatment dis-
crimination.  
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